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ABSTRACT 
The work presented in this thesis describes the synthesis of labd-13-en-8p, IS-diol (46) a stable 
reduced derivative of an unstable marine natural product aldehyde [8p-hydroxylabd-13E-en-IS-al 
(6)] isolated by Cimino, et al.' from the skin of a Notaspidean mollusc Pleurobranchaea meckelii. 
The rationale for the synthesis was to provide sufficient 46 for eventual mild oxidation to 6 and 
investigation of the biological activity of this latter compound. 
(-)-Sclareol (32), a common diterpene synthetic precursor, was the starting point for the ten step 
synthesis of 46 described in this thesis. A search of the literature revealed that only one non 
stereospecific synthesis of 46 had been previously reported. To provide the necessary background 
to the synthetic component of this thesis, both the occurrence of labdane and ent-labdane in the 
marine environment and the use of sclareol in the synthesis of marine natural products, was 
reviewed. 
The initial step in the synthesis of 46 was the potassium permanganate oxidation of sclareol to give 
a bisnorlabdane ketone. Reduction of this ketone with lithium aluminium hydride produced a 
mixture of diols which, through t-butyldimethysilyl triflate protection, afforded a quantitative route 
to protecting the C-13 ketone in an effort to prevent unwanted intramolecular cyclization reactions. 
Dehydration of the tertiary alcohol moiety at C-8 with phosphorous oxychloride yielded the 
t. '.15exocyc1ic alkene required for the next oxidation step. Ozonolysis succeeded in producing the 
desired C-8 ketone after much deliberation and research into alternative oxidation strategies. Methyl 
lithium methylation quantitatively afforded the desired a-methyl substitution at C-8, identified at 
the onset as the key step in the synthesis. Tetra-butylarnmonium fluoride deprotection yielded the 
8P,13-dihydoxylated product, which was in tum subjected to a Swern oxidition to give the desired 
8p-hydroxy-bisnorlabda-1 3-one. A modified Horner-Wadsworth-Emmons reaction allowed for 
elaboration at C-13 to yield a to ll olefin with a terminal C-15 ethyl ester. Diisobutylaluminium 
hydride reduction of the ester produced the desired labd-13-en-8p, IS-diol (46) in a low overall yield 
of 3.4%. Although opportunities for optimization of at least three steps in the synthesis exist, time 
constraints prevented both optimization of these steps and an investigation of the oxidation of 46 to 
c,. 
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1. INTRODUCTION 
1.1 The Role of Synthesis in Marine Natural Product Chemistry 
The marine environment is an exceptional reservoir of bioacti ve natural products, many of which 
exhibit structural features not found in terrestrial natural products. I The evolution of some phyla of 
marine organisms, e.g. sponges, over enormous time periods (500 million years) has meant that these 
organisms have been able to evolve unique biosynthetic pathways or adapt established pathways to 
produce complex natural products.' The secondary metabolites produced by certain organisms 
e.g. Coelenterata (soft corals, sea fans), Porifera (sponges), Bryozoa (bryozoans) and Echinodermata 
(sea stars, sea cucumbers),2 are thought to act as antifeedants or toxins in preventing predation on 
the producing organism. Other roles for these metabolites include growth inhibition of competing 
organisms on a marine reef in an environment characterized by limited nutrients and space. 
One of the major problems facing marine natural product chemists, interested in exploring the 
bioactivity of secondary metabolites, either in chemical ecology studies or as potential 
pharmaceuticals or agrochemicals, is the often extremely low abundance of marine natural products 
in marine organisms. Several reasons have been proposed for the paucity of these secondary 
metabolites in the organisms that produce them. These reasons include the enhanced toxicity or 
bioactivity of marine natural products, relative to the secondary metabolites produced by terrestrial 
plants, thus requiring less of the compounds to elicit a physiological response in another organism. 
Other reasons include the variations in the biosynthesis of marine natural products, a process which 
has been shown to be related to several factors including reproduction, predation, competition for 
habitable space and seasonal changes relating to physical changes (e.g. temperature). Frustratingly, 
as a result of our very limited knowledge of the factors affecting biosynthesis in marine organisms, 
underwater collections often do not coincide with periods of maximum biosynthetic activity. 
There are three approaches to overcome the problem of the supply of sufficient amounts of marine 
natural products for biological screening. The first approach is to make larger collections of 
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invertebrate and/or algal marine material. Most marine natural product studies are carried out on one 
kilogram or less wet mass of a marine invertebrate or algae. Given the sensitivity of marine reefs to 
over-exploitation, the collection of more than this amount would have negative ecological 
ramifications, with permits for such collections being denied by government conservation agencies. 
Ideally, collections should encompass as many species as possible and should be collected from a 
large number of sites in order to be representative of the diversity found in the marine environment. 
A good example of bioassay guided isolation of a bioactive marine natural product and its current 
status as an anti-tumour drug candidate is ecteinascidin 743 (1). Isolated from the asci dian 
Ecteinascidia turbinata, sufficient quantities ofthe tetrahydroisoquinolone alkaloid ecteinascidin 743 
for clinical trials were obtained by harvesting natural populations of the ascidian? 
(1) 
The second approach to providing sufficient material for bioactivity studies is the aquaculture of the 
marine organisms producing the desired bioactive metabolite. Due to the non-invasive means of 
acquiring more of the desired metabolite via laboratory fermentation or aquaculture of the marine 
organism, there is an increasing shift in this direction by research organizations. An example of this 
approach is the isolation of the anti-cancer metabolite bryostatin (2) from the bryozoan Bugula 
neritina. Although an adequate sufficient supply of bryostatin required for preclinical trials was 
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provided by harvesting wild populations, due to the low yield and large variability from collection to 
collection exhibited in harvesting, sufficient compound required for Phase I and Phase II clinical trials 
was provided via an aquaculture approach sponsored by the United States National Cancer Institute' 
o o 
(2) 
HO 
OCH3 
o 
o 
Another example of a successful marine metabolite produced via aquaculture is halichondrin B (3), 
a complex macrolide isolated from the sponge Halochondria okadai. This compound was identified 
as a potent inhibitor of tubulin polymerization, showing promising in vivo activity against a number 
of human cancer cell lines. The very limited supply of halichondrin B from naturally occurring 
sponges prompted the in situ production of the compound in the sponge LissodendO/yx via 
aquaculture techniques. 5 
H I,! 0 
H 
HO" .. 
o 
H 
-
HO 
(3) 
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The third approach to solving the marine natural product supply problem is the laboratory synthesis 
of bioactive, or potentially bioactive marine secondary metabolites. Academic syntheses can also 
provide valuable structure-activity relationship data. Unfortunately, few synthetic endeavours are 
short enough or use reagents that are cost effective or safe enough to scale up to large-scale industrial 
syntheses. These efforts therefore often favour the use of the natural product as a ' lead' structure 
for synthetic medicinal chemistry, helping to identify synthetically accessible and simpler analogues 
that exhibit the same or similar bioactivity.! 
Despite their complexity, several important bioactive marine natural products have been synthesized 
successfully, most notably the anti-turnour agent eleutherobin (4). Eleutherobin, isolated from the 
rare soft-coral Eleutherobia albiflora, was found to possess significant cytotoxicity against breast, 
renal, ovarian and lung cancer celllines.6 Chen, et al. 7 reported the first total laboratory synthesis 
of eleutherobin in 1999. This important synthesis has allowed further investigations into the 
biological activity of the natural product and the development of possible synthetic analogues. 
H OCHJ 
°rOJ;o 
HJC r-< 
HO OH 
(4) 
We have adopted the latter synthetic approach to the bioactive marine natural product supply 
problem and in continuation of four decades of diterpene natural product research at Rhodes 
University and a developing collaboration with Professor Cimino of the Instituto per la Chimica di 
Molecole di Interesse Biologico (Napoli), we present in this thesis our synthetic approach to the 
diterpene aldehydes (5 and 6) isolated by Cimino, et al. 8 from the opisthobranch mollusc 
Pleurobranchaea meckel/i. 
I' 
(5) 
·jr 
(6) 
eRO 
.-:::;. 
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1.2 Labdane Aldehydes from the Opisthobranch Mollusc Pleurobranchaea meckelli 
1.2.1. Opisthobranch Molluscs 
Many shell-less opisthobranchs, more commonly referred to as nudibranchs or sea slugs, are brightly 
coloured, using this aposematic colouration to warn potential predators that they contain toxic 
metabolites. Hence, there have been numerous studies of the chemical defence strategies responsible 
for the almost complete absence of predation on these seemingly unprotected molluscs. Most 
nudibranchs sequester toxic or deterrent bioactive metabolites from their prey species, efficiently 
moving these metabolites from their gut to glands in their outer mantle or skin tissue without 
appearing to suffer any ill effects. As nudibranchs prey primarily on sponges, bryozoans and 
coelenterates,9 these organisms serve as sources of the nudibranch's sequestered metabolites, with 
the highest incidence and diversity of these metabolites being found in habitats such as coral reefs that 
are characterised by intense competition and feeding pressure .lO In some instances opisthobranch 
molluscs are able to create new chemical defense metabolites through the biotransformation of dietary 
compounds in a process known as de novo biosynthesis. ll Geographical variance in the metabolites 
of certain nudibranch species have served as a good predictor of the de novo biosynthetic origin of 
the metabolites . 12 With cold water species often exhibiting this form of chemical defence, the de novo 
biosynthesis of polygodial (7) by Dendrodoris grandiflora has been established. l3 
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CHO 
rfrCHO ~ 
(7) 
Opisthobranchs are divided into eight orders, namely: Cephalaspidea; Saccoglossa; Anaspidea; 
Acochlidiacea; Thecosomata; Gymnosomata; Nudibranchia and Notaspidea. Past research has 
focused on the chemistry of the sea slugs from the orders Cephalaspidea, Saccoglossa, Anaspidea and 
Nudibranchia with very little attention given to the study of Notaspidean chemistry. 8,14 
Pleurobranchaea meckelli, which produced the metabolites we attempted to synthesize in this thesis, 
is a member of the order Notaspidea which displays very interesting evolutionary characteristics. The 
order Notaspidea contains species protected by a relic shell ( Umbruculum umbruculum, Tylodina 
perversa ), those that possess an internal shell (Pleurobranchus memranaceus, Berthella auranliaca) 
and those that are completely shell-less ( Pleurobranchaea meckelli ). 8 Although four nudibranchs 
of the Pleurobranchus species occur off the South African coast, the natural product chemistry of 
the South African species has not been studied. 
Figure 1: The Notaspidean nudibranch Pleurobranchaea mecke/li. 
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Nudibranchs have yielded a variety of metabolites, such as monoterpenes, sesquiterpenes, diterpenes, 
sesterterpenes, steroids, diacylguanidine, and the degradation products thereof.ls Overall, nudibranch 
skin metabolites tend to be primarily terpenoid, with sesquiterpenes being the most abundant, 
followed by diterpenes. '2 Studies of the sequestered or de novo biosynthesized natural product 
chemistry ofnudibranchs is complicated by three factors. Firstly, the low abundance of nudibranchs 
in the marine environment. Secondly, the small size of the organism «5cm in length) and thirdly, the 
conservation restrictions imposed to prevent the negative impact of the wholesale removal of 
nudibranchs from the marine ecosystem. Therefore, often the only viable route to follow to explore 
the bioactivity ofnudibranch metabolites is the laboratory synthesis of these metabolites. 
1.2.2. The Isolation of the Diterpenes from Pleurobranchaea meckelli 
The first chemical investigation of the shell-less notaspidean mollusc Pleurobranchaea meckelli was 
reported by Cimino, et al. 8 and yielded the isomeric aldehydes 8P-hydroxylabd- !3E-en-15-al (5) and 
8P-hydroxylabd-13Z-en-15-al (6) . P.meckelli was collected in the Gulf of Naples by SCUBA at a 
depth of 6 meters in June, 1993. P.meckelli was found to produce an acid secretion that is a 
characteristic of most Notaspideans and was initially considered as the main protection of these 
molluscs against predation. To isolate the natural products, the live animal was sonicated in acetone, 
the acetone extract concentrated and the concentrate extracted further with diethyl ether. TLC 
analysis indicated the presence of two UV absorbing compounds, with final separation of these two 
compounds achieved by preparative TLC to yield 5 (3 mg) and 6 (4mg). The structures of 
compounds 5 and 6 were established from 'H_NMR and 13C_NMR data with supportive 2D NMR 
experiments ('H_'H-COSY, HMQC, HMBC, 'H_'H decoupling)8 
Cimino noted that these metabolites were unstable and hence their isolation was performed as quickly 
as possible. The biological role of these two compounds, located in the skin of the mollusc, were 
correlated to their probable involvement in the protection of the mollusc against predation, as 
established for other bioactive aldehydes.s The biological role of these molecules has still to be 
investigated and it is hoped that our synthetic endeavours presented here will enable these 
investigations to be carried out. It must also be noted here that Cimino, et al. 8 postulated that the 
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labdane aldehydes 5 and 6 were sequestered by P.meckelli from its invertebrate or algal prey and 
were not produced by de novo biosynthesis. 
1.3 Labdane and ent-Labdane Diterpene Metabolites in the Marine Environment 
Over the last three decades, marine natural products investigations have yielded a variety of related 
terpenoid metabolites. Using the computer database MarinLit, lOwe reviewed only diterpenes isolated 
from marine organisms. Our choice for the search encompassed compounds possessing a basic 20 
carbon diterpene skeleton, and the metabolic derivatives thereof with fewer carbon atoms. The 
connection between the different terpenoid metabolites and their structural similarities all stem from 
the fact that marine organisms share similar biosynthetic pathways. This review serves to illustrate 
the fairly limited occurrence oflabdane and ent-labdane diterpenes in marine organisms, given that 
approximately 10000 marine natural products are known. 
1.3.1. Diterpene Metabolites Isolated from Marine Algae 
Algae comprise a range of aquatic plants from single-celled to filamentous species and include the 
taxonomic groups Rhodophyta (red algae), Chlorophyta (green algae) and Phaeophyta (brown algae). 
Halogenated sesquiterpenes and diterpenes predominate in algae. Due to their abundance in shallow 
waters and ease of collection, algae were one of the first groups of marine organisms whose natural 
products chemistry was extensively studied.! 
H01h-
HO J 
(8) (9) (10) 
The chemistry of red algae has also been extensively investigated because of their propensity to 
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incorporate halogens (bromine, and occasionally chlorine) in their secondary biosynthetic pathways. 
The marine red alga Laurencia snyderae, collected off the coast of Mexico, yielded the brominated 
ent-labdane diterpene isoconcinndiol (8).17 Isoconcinndiol is related to one of the early pioneer 
marine diterpene metabolites aplysin-20 (9), isolated from the Japanese sea hare Aplysia kurodai. l8 
A brominated ent-labdane diterpene triol closely related to 9, venustanol (1 0), was obtained from the 
Japanese red alga L. venusta by Suzuki, et al"l' Aplysia sea hares commonly sequester their 
defensive chemicals from Laurencia seaweeds. 
o ACO~ 
;/,) OAc 
Br ~ 
(11) (13) 
Another halogenated diterpene, 3 p-bromobisnorlabda-8-eth-18-ene-13-one (11), obtained from the 
red alga L. pelforata collected on the Canary and Madeira archipelagos, was isolated by GonzaJez, 
et al. 20 The red algaeL. panicu/ata yielded an ent-labdane bromoditerpene (-)-paniculatol (12)21 
Interestingly, paniculatol was the first tetrahydropyran containing ent-bromolabdane to be found in 
a marine organism. Finally, a bicyclic diterpene with a labd-7 -ene skeleton (13) was found in several 
species of green algae, Caulerpa trifaria, C. brownii, C. flexilis, C. peltata and C. racemosa22 
1.3.2. Diterpene Metabolites Isolated from Marine Ascidians 
Ascidians, also known as tunicates or sea squirts, usually inhabit shallow waters, but have also been 
found up to depths of2000m. The natural products chemistry investigations of these organisms have 
primarily unearthed new amino acid derived biologically active metabolites and labdane diterpenes 
are rare?J A single example of an ascidian labdane diterpene of mixed biosynthesis is the cytotoxic 
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dichlorolissoclimide (14), isolated from Lissoclinum voeltzkowi, collected off New Caledonia2 ' 
Dichlorolissoclimide was the first chlorinated compound to be isolated from the phylum Urochordata 
and exhibited strong cytotoxic activity against human carcinoma KB cells and P388 leukemia cells. 
(14) 
1.3.3. Diterpene Metabolites Isolated from Marine Sponges 
Sponges (phylum Porifera) are the simplest multicellular organisms and are mostly of marine origin. 
They differ from other groups of invertebrates in that they maintain an almost protozoan 
independence for their constituent cells, which as a consequence form no true tissue layers or organs. ' 
Sponges have become one of the dominant sources of biologically active marine natural products 
because they are abundant, easy to collect and as discussed earlier, because of their long evolutionary 
history, able to biosynthesize a wide variety of natural product structural classes. 
\.A 
(15) 
I/O 
,,; 
) 
o " HO\~ "~
(16) 
J; RO g3 .... 
(17)R=Ac 
(18) R = H 
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Agelosine-D (15) is one offour novel bicyclic diterpenoids isolated from the orange Okinawan sea 
spongeAgelas sp .. 25 Interestingly, agelosine-D has been shown to act as powerful inhibitors ofNa,K-
ATPase enzymes and also exhibits strong anti-microbial properties. Ciavatta, et al.26 obtained 
blanesin (16), an ent-labdane furanoditerpenoid with an a-hydroxyketone moiety, from the red 
sponge Raspaciona aculeata collected off the coast of Spain. The furanoditerpenoids cacofuran A 
(17) and B (18) were the first bridged tetracyclic diterpenes isolated from the marine sponge 
Cacospongia Sp.27 Both 17 and 18 showed moderate cytotoxicity against P388 and K562 cancer cell 
lines. 
1.3.4. Diterpene Metabolites Isolated from Marine Pulmonate Molluscs 
Pulmonate molluscs are a subclass of intertidal gastropods possessing secondary gills, a muscular foot 
and a shell. The Pacific ocean pulmonate Trimusculus reticulatus was found to contain 6P-
isovaleroxylabda-8, 13-dien-7a, IS-diol (19) and 2a, 7a-diacetoxy-6p-isovaleroxylabda-8, 13-dien-15-
01 (20).28 T. reticulatus, from the family Trimusculidae, was the first pulmonate molluscan source 
of labdane diterpenoids. Preliminary chemical ecology studies revealed that these metabolites 
function as a repellant to predatory starfish. The related mollusc T. peruvianus, collected on the 
coast of central Chile, yielded five similar labdane metabolites : 6p-acetoxylabda-8, 13-dien-7a, 15-
diol (21); 7a, 15-diacetoxylabda-8, 13-dien-16p-ol (22); 6P,7a,IS-triacetoxylabda-8, 13-diene (23); 
6P,7 a -diacetoxylabda-8, 13-dien-15-01 (24) and 6p-acetoxylabda-8,13-dien-15-0129 Gray, et al. 30 
isolated 6P, 7 a-diacetoxyladba-8, 13-15-01 (25) and 2a,6p, 7a-triacetoxylabda-8, 13-dien-15-o1 (26) 
from the only South African member of this species T. costatus. Both the latter labdanes exhibited 
marked antifeedant properties in bioassays carried out with the omnivorous South African predatory 
fishPomada.;ys commersonnii (spotted grunter). The structures of the compounds discussed above 
are presented in Table 1. 
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--, fI 
"" R2 
Table 1: A summary of lab dane diterpenes isolated from Trimusculus sp_ 
Compound Substituents 
19 RI=H R' = OCOCH,CH(CH,), 
R'= OH R' = CH,OH 
20 R' =OAc R' = OCOCH,CH(CH,), 
R' = OAc R' = CH,OH 
21 R' =H R' = OAc 
R'= OH R'= CH,OH 
22 R'= H R' =OH 
R'= OAc R' = CH,OAc 
23 R'= H R' = OAc 
R' = OAc R'= CH,OAc 
24 RI=H R'= OAc 
R'= H R'= CH,OH 
25 R'= H R' = OAc 
R' = OAc R' = CH,OH 
26 R' = OAc R' = OAc 
R' = OAc R' = CH,OH 
1.3.5. Diterpene Metabolites Isolated from Marine Opisthobranch Molluscs 
Opisthobranch molluscs (nudibranchs and sea hares) are an order of molluscs in which the shell and 
mantle cavity are absent. As discussed in section 1.2.1., the loss of the shell in opisthobranch 
molluscs requires those organisms to utilize chemical defense to protect themselves from predation_ 
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:I~H ,y 
- -
- -
".-W' ' OH 
Br '. H 
~ 
Br,,·0r
OH 
~ 
(27) (28) 
Aplysin 20 (9) was first isolated from the Japanese sea hare Aplysia kurodai by Yamamura, et at. _ 31 
Further investigation of A. kurodai yielded the new brominated ladbane-type diterpenes, epi-aplysin 
20 (27) and ent-isoconcinndiol (28).17 
R20 
R1O'\ 
0 
0 
\H 
(29) Rl=H ; R2=Ac 
(30) R 1=Ac ; R2=H 
0 
0 ~ 
AcO 
(31) 
The antarctic nudibranch Austrodaris kerguelenesis is thought to produce the l,3-glyceryl ester, 3'-
acetoxyglyceryl(SR, I OR, 13R)-labda-8-en-15-oate (29), and its corresponding 1,2-derivative, 2'-
acetoxyglyceryl(SR, lOR, 13R)-labda-8-en- IS-oate (30) by de novo biosynthesis.32.33 Both these 
metabolites show potent activity as activators of the protein kinase C enzyme. Finally, a study of the 
skin extracts and egg mass collections of the Northeastern Pacific dorid nudibranch Cadlina 
luleomarginata gave rise to the isolation and identification of several terpenoid metabolites, including 
the labdane diterpene lutenolide (31) .34 
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1.4 Sclareol as a Synthetic Precursor for the Synthesis of Marine Metabolites 
(-)-Selareol (labd-14-ene-8a, 13 P-diol, 32) is a commercially available natural product ideally suited 
for use as a chiral synthon in labdane diterpene syntheses and was first isolated from the terrestrial 
plant Salvia sclarea (Labiatae)35 A complete synthesis of32, in nine steps from podocarp-8(14)-en-
7-one, was reported by Bigley, et of. 3G in 1960. 
16 
20 17 
9 
10 fr 8 "" OH 
l 
\ii: 
18 19 
(32) 
Sclareol possesses significant biological activity including fungal growth regulation, plant growth 
inhibition, cytotoxic activity and good antibacterial activity.37,38,39 Commercially, selareol has become 
widely used in a number of industries, where it is used as a fixative and synthon for the preparation 
of Ambra odourants in the perfume industry, as a flavouring agent in the tobacco industry, as a 
flavourant in food products and fragrance component in soaps, detergents, creams lotions and tabac-
type fragrances. 35 
The stereochemistry of sclareol, makes it ideal for use as a synthetic precursor for the synthesis of 
the labdane diterpenes described in this thesis. A review of the use ofsclareol as a synthetic precursor 
reveals the widespread use of 32 in the syntheses of both terrestrial and marine metabolites. 
Highlights of the successful use ofsclareol in the synthesis of marine metabolites are presented below. 
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1.4.1. The Synthesis of Polygodial and Albicanyl Acetate from (-)-ScIareol 
Polygodial (7) and a1bicanyl acetate (33) are both biologically active drimanes possessing potent fish 
antifeedant properties. The synthesis of these two marine natural products was undertaken to provide 
sufficient material to test for antifeedant activity using chemoreceptor protein studies. Some new 
structurally related active drimanes were concurrently synthesized from 32 in an effort to compare 
their antifeedant, antitumour and antimicrobial properties with those of polygodial. These compounds 
included 7 -oxo-8, 12-drimen-II-a1 (34), 13,1 4,15, 16-tetranorlabd-7-ene (35) and 7-oxo-13, 14, 15, 16-
tetranorlabd-8(I7)-en-12-a1 (36)40 Interestingly the latter two proved to be significantly more 
bioactive than polygodial. The synthesis of compound 33 is represented in Scheme 1. The synthesis 
of compounds 7, 34, 35 and 36 are presented in Scheme 2. 
OTBS 
eRO 0 
(32) ·."OAc (ii) . '''OAc 
'--H ~ \H 
(37) 
"ill j 
OAc OAc OAc 
''''OAc (iv) "" OR • 
\,H " H , 
(33) 
SCHEME 1 : The synthesis ofalhicanyJ acetate from (-)-sclareol (0 (i) OsO/NaI0 4• PfOH, 45"C, 6h, 73%. (ii) TBSCI. NaH. THF, _78°C, 4h, 
99%. (iii) 0" MeOHlCH1Cl1• -noc, NaBH., MeOH. ft, 30min., 95%. (iv) Ac20, Et,N. 4-0MAP, THF. reflux, 18h, 92%. (v) Collidine, reflux. 
(32) Iii) I 
". H= 
'-
R= CH20H R= CH20Ac 
R= CH2CH20H R= CH2CH20Ac \trrno 
(7) R= CHO 
(35) R= CH2CHO 
OH 
(vi) 
R=CH20Ac 
R= CH2CH20Ac 
R (v) 
stc 
R=CH20Ac 
R= CH2CH20Ac 
(34) R= CHO 
(36) R= CH2CHO 
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R= CH20Ac 
R= CH2CH20Ac 
(vii) 
R=CH20H 
R=CH2CH20H 
SCHEME 2 : The synthesis of polygodial and related compounds from (-)-sclareoI. 40 (i) OsOlNaJO 4, PtOH, 45°C, 6h, 73%. (ii) Collidine. 
170°C, 8h, 60%. (iii) NaBH., MeOH, rt, 30m in, 93%; Ac20, PYJ rt , 2h, 94%. (iv) t-BuOOH. SeOl • CH1Cl1• rt. (v) MsCI, PYJ rt. (v i) NaOAc, 
acetone-Hpj reflux. (v ii) 2N KOHIMeOH, rI. (vi ii) (CICO)!I)MSO, CH2CI!> Et]N, -78°C, 15min. 
1.4.2. The Synthesis of (+)-Puupehenone from (-)-ScIareol 
(+)-Puupehenone (38) is a very bioactive marine natural products possessing a wide variety of 
activities including cytotoxic, antiviral, antifungal and imrnunomodulatory properties.' 1.'2 Some (+)-
puupehenone derivatives are showing inhibition of HIV and cholesteryl ester transfer protein 
(CETP).'J Barrero, et al.4J reported the first enantiospecific synthesis of38 in an effort to allow for 
further investigation into the bioactivity of this compound and analogues thereof. The synthesis, 
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represented in Scheme 3, included the use of an aromatic synthon prepared from 
protocatechualdehyde, 
(32) j Ii ) 
CHO 
OBn 
rr""OH W 
+ 71 ~ 
*
OBn 
''''' Br 
OTBS 
OBn 
OBn 
(viii) 
--
AcO 
'.."H 
(38) 
OBn 
~ ...... OBn 
""I 
OTBS 
"I'OH~ 
OBn 
OH 
I 
a 
OBn 
a 
AcO 
OBn 
~I 
"" 
, I 
OTBS 
OBn 
OBn 
OBn 
SCHEME 3 : The synthesis of (+)~puupehenone from (+sclareoI.41 (i) OsOiNaIO~, PtOH, 45°C. 6h. (ii) t-BuLi. EtlO. _78ee, 88%. (iii) 
SOelz• Py, rt f lh, 94%. (iv) TBAf, TIlF, It, 15 min, 81%. (v) NaB Hh EtOH, rt, 20 min, 91%. (vi) NPSP, SnClu CH2C11• -78'"C, 2h, 91%. 
(vii) Raney Ni, THF, rt, 20h, 75%. (viii) POC, CH2Cl1, rt, 3h, 70%. 
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1.4.3. The Synthesis ofWiedendiol-A and Wiedendiol-B from (-)-Sclareol 
Wiedendiol A (39) and wiedendiol B (40) are marine natural products consisting of drimane and 
polyphenolic moieties resulting from mixed biosynthesis. Both compounds are of great interest 
because of their ability to inhibit CETP and hence can potentially be used to reduce the risk of 
coronary heart disease . 44,45 This synthesis was undertaken in order to provide a route for the synthesis 
of these bioactive compounds, aiding research relating to this class of compounds. This was the first 
enantiospecific synthesis ofwiedendiol A and wiedendiol B from 32 and (+ )-cis-abienol (Scheme 4)46 
OBn OBn 
(ii) • 
\.H '. H ~ 
(32) 
OH 
'" j B,O OBn HO 
.. J! \ H 
DB, j "" OBn q (~ ij) 
DCH, BnO 
OBn (39) OBn OH 
BnO HO 
HO 
(40) 
SCHEME4; Thes:ynth.-:sis of wiedatdio[·A and wiedendio[·B trom (·)-sclareoL46 ( i) OsOlNaIO~, Pr'OH, 45°C. 6h. (ii) CoHidim:, 200"C, 3h, 78%. 
(iii) n-BuLi, EltO ·TMEDA, _78°e Ie OcC, lh. 65%. (iv) ZnIl·NaBH]CN, CH!Cl!. rt, 50 min, 71 %. (v) Raney Ni, Hp·THF, rt, 20h, 81%. (vi) H!. 
Pd·C, MeOH·EtOAc, aoc, lh. 70%. (\'ii) n·SuLi, EtP -TMEDA. ·40°C to aoc, Ih 30 min, 55~·o. (viii) TsOH, Bcnz.:ne, 35°C, 13h, 82~;'. (i.-.:) Hz. 
Pd-C, MeOH-EtOAc. O°C, 2h. 93%. 
Introduction 20 
1.4.4. The Synthesis of enf-Chromazonarol and Related Compounds from (-)-Sclareol 
ent-Chromazonarol (41), isolated from the sponge Disidea pallescens, has been shown to possess 
antifeedant, antifungal and antitumour activity:7 ent-IsozonaroI (42) and ent-isozonarone (43) 
exhibited similar bioactivity. Compounds 41- 43 were prepared as part of a structure-activity 
relationship study of this class of compounds (Scheme 5). 
CHO 
~ ,~ C1 J"OH 
XA~ 
(32) 
(il) r 
Y i'ii) Aoen j OBo 
DeH, BoO :/, 
HO 
OBo OBo 
BoO 
(39) OBo OH 
BOO~ HO J 
~ I 
(40) 
SCHEME 5 : The synthesis of enr·chromazonarol and rel ated compounds from H -sclareol." (i) OsO/NaJO 4, P~OH, 45°C, 6h. (ii) n-BuLi, 
Et10, _78°C, J h 30 min, 91 %. (ii i) CI1SO, Py. _14°C, 20 min, 97%. (iv) TBAF, EtOH, rt, 5 min. (v) NaBH4, EtOH, rt, 25 min, 40%. (vi) 2N 
KOH-McOH. rt, 10 min, 85%. (vii) NaBH4• EtOH, reflux, ISh, 47%. (vi ii) TBAF. THF, rt, 15 min, 90%. (ix) Jones, acetone, O°C, 5 min. 
93%. (x) BF).OEt1, CH1CI2, _14°C, 5 min, 90%. 
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1.4.5. The Synthesis of Puupehedione from (-)-Sclareol 
As we have seen previously, compou"nds of mixed biosynthesis consisting of drimane and 
, 
polyphenolic moieties are among the most active of marine metabolites. Their biological activities 
range from cytotoxicity, antifungal and immunomodulatory properties to CETP inhibition. ,",49 There 
have been several approaches to their syntheses. The Verongid sponge metabolite puupehedione 
(44), related to (+)-puupehenone (38), was prepared via an enantiospecific synthesis in order to 
obtain sufficient material for comparative' antitumour assays. 50 The synthesis of 44 is represented in 
scheme 6. 
OBn aBn 
OBn 
" H-
'. 
(ix) 
OH ""'1 h OH d QYo '0 OH " H ~ 
OH 
c?" 
~ 
, 0 
(32) 
(44) 
SCHEME 6 : The synthesis ofpuupehedione From (+sc\arcol.)O (i ) OsO/ NaIO .. PfOH, 45°C. (ii) Collidine. 200:C. (iii) t-BuLi, EI!O, ·78°C, 
50 min. Ar; EtzO, ~78°C, 40 min; EtJSiH, TFA. CHICl!. -78°C, 45 min, 791!-o. (iv)TBAF, THF, ft, 15 min, 95~o. (v) .-\c10, NaAcO. reflux. 2h, 
98%. (vi) m-CPB.t\., NaHCOJ. CHICl!. _20ec. 2h .. 98%. (vii) 2N-J.:.OH-MeOH, ft, 48h, 95%. (viii) H2• 10% PdlC, )o!eOH. rt, lh, 91°0. (ix) Silica 
gel, 45%. (x) NaIO~. EtOH -H~O, rt, 15 min. 80%. 
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CHAPTER 2 
RESULTS AND DISCUSSION 
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2. RESULTS AND DISCUSSION 
2.1 An Overview of the Synthetic Approach Adopted for the Synthesis of the Labdane 
Alcohols 45 and 46. 
Initially the primary objective of our synthesis was to synthesize the two isomeric marine natural 
products S~-hydroxylabd-13E-en-I5-al (5) and S~-hydroxylabd-13Z-en-J5-al (6) . However, we 
noted that Cimino, et at., 8 during their structural studies of these metabolites, first reduced the 
unstable aldehydes 5 and 6 with lithium aluminium hydride (LiAJH4) to give the more stable alcohols 
45 and 46. We anticipated similar stability problems of the aldehydes arising towards the end of our 
synthesis and therefore rather directed our synthesis towards the preparation of the alcohols 45 and 
46. We assumed that mild oxidation of the alcohols would give the corresponding aldehyde natural 
products if so required. 
OH 
20 17 13 ·" "/16 
• 14~ 
10::' 8"'IOH 
, H 
"-- H ~ 
18 19 
(32) 
\.H 
(5) Z 
(6) E 
CHO 
.& 
···.~H 
(45) 
OH 
····~H 
(46) 
OH 
Having decided on sc1areol (32) as the starting point of our synthesis, we envisioned that the main 
challenge in this synthesis would be an inversion of the substituents on C-S . Obviously the 
preservation of the chirality ofC-5, C-9 and C-JO in 32 during synthetic transformations would also 
be critical. 
Before we embarked on our synthesis of the aldehydes, an extensive search of available literature 
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resources was undertaken to identify syntheses of identical or similar structures to either 5 and 6 or 
45 and 46. While there are no syntheses of 5 and 6 reported, this search yielded a single reference 
for a synthesis reported in 1970 by Popa, et al. 51 in which the synthesis of the natural product 
peregrinol (47) from scJareol was described. 
\.H 
(47) 
OH 
(48) 
:/OCH' 
rpi'''' )d;J 
(49) 
Popa's synthetic strategy initially involved the introduction ofa I:!. 8 double bond (48) into the starting 
material, labd-8(20),13-dien-15-01, by regioselective epoxidation with monoperoxyphthalic acid 
(MPPA), followed by LiAlH4 reduction of the proposed C-8 - C-9 cx-epoxide to give peregrino\. 
A mixture of epoxides were separated prior to the reduction step, From the limited available data, 
the supposed p-epoxide (49) was suggested as the minor product. Although LiAlH, reduction of 49 
gave 46, the evidence given in support of the structure of 46 was tenuous. 
HO 
~~' .. 
(50) (51) 8(R) 
(52) 8(S) 
HO 
-::". 
A further low yielding preparation, introducing a C-8 - C-17 epoxide at C-8, was reported by Leite, 
et al. 52 The m-chloroperbenzoic acid (m-CPBA) epoxidation ofmanool (50) yielded a mixture of 
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8, 17-epoxy-14-labden-13-0Is (51 and 52) in a 3: 1 ratio respectively. LiAlH. reduction of these 
epoxidesresulted in the formation of the 8, l7-epoxy-14-labden-13-ols (53 and 54) . Even though this 
procedure offers the formation of the desired stereochemistry at C-8 in the former alcohol, the 
reactions were non-stereoselective and low yielding. The lack of stereoselectivity and low yields in 
the two published syntheses necessitated that we approach the synthesis of 45 and 46 from another 
direction and Scheme 7 represents a summary of our proposed synthetic approach to the synthesis 
of 45 and 46. 
(ij 
(32) -"---
'- Ii ~ 
(55) 
'-- R ~ 
(86)l3(R) 
(87)l3(S) 
("'ll 
".R 
(88) l3 (R) 
(89)J3(S) 
o 
OTBS 
(vi) 
OR 
" '111 (viii),(ix) 
OR 
"" OR (iii) 
". R ~ 
(57) l3(R) 
(58) 13(S) 
". H 
~ 
(91) Z 
(92) E 
OTBS 
o 
CRPOEt 
o 
('l 
OTBS 
"" OR 
.~ Ii 
~ 
(61) 13(R) 
(62) l3(S) 
U-
ll 
".R 
(67)l3(R) 
(68)13(S) 
\H 
(45) Z 
(46) E 
OTBS 
SCHEME 7 : Summary of our proposed synthetic approach to compounds 45 and 46. (i) KMNO. Oxidation (ii) LiAlH~ Reduction (iii) TBDMS 
Tritlate Protection (iv) POCIJ Dehydration (v) Ozonolysis (vi) MeLi Methylation (vii) TBAF Deprotection (viii) Swem Oxidation ( ix) Homer-
Wadsworth-Emmons Reaction (x) DlBALH Reduction. 
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It should be noted at the outset that all synthetic products were fully characterised, where possible, 
by Nuclear Magnetic Resonance (NMR) spectroscopy, in addition to Infra Red (IR) and Mass 
Spectrometric (MS) techniques. NMR experiments used for signal assignments included IH and J3C 
spectra, Distortionless Enhancement by Polarisation Transfer (DEPT), IH)H Correlation 
Spectroscopy (COSY), Heteronuclear Multiple Quantum Coherence (HMQC) and IH_J3C 
Heteronuclear Multiple Bond Correlation (HMBC) spectra. Molecular formulae were provided from 
High Resolution Fast AtomBombardment Mass Spectrometric (HRF ABMS) data. Where applicable, 
if synthetic intermediates were known compounds, spectroscopic data was supported by comparison 
of melting point and optical rotation with published data. 
In all the compounds prepared in this thesis there is very little change in the NMR chemical shifts of 
the protons and carbon atoms in ring A which greatly facilitated the assignment of these resonances 
in compounds with previously unassigned NMR data. The structural modifications to ring B and the 
side chain at C-9 obviously affected the chemical shifts of proton and carbon atoms in these regions 
ofthe molecules. Accordingly, to avoid unnecessary repetition, only the assignment of resonances 
affected by the synthetic transformations are discussed where necessary in support of proposed 
stru ctures. 
2.2 Oxidation of ScIareol. 
As discussed in Section 1A.1., the stereochemistry at C-5, C-9 and C-10 in sclareol (32) favoured 
its use as the precursor in our proposed synthesis. Initial oxidative removal of the terminal alkene 
in 32 would yield a ketone at C-13 and allow for the stereoselective introduction of a carbon-carbon 
double bond at C-13 at a later stage in the synthesis. Accordingly, loss of the terminal double bond 
was achieved by potassium permanganate (KMnO.)oxidation in acetone as described by Bigley, et 
al. ,53 a well established procedure in our laboratory having being used with success in syntheses of 
other related diterpenes. The reaction yielded an equilibrium mixture of the required ketone, (55), 
and the cyclized enol ether (56) . 
\H 
(55) 
o 
·Jr 
(56) 
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Obviously a method of shifting the equilibrium in favour of 55 was desirable. A procedure reported 
by Ruzicka, et aI.," involving hydration of the enol ether with either methanolic acetic acid or 
semi carbazide acetate, apparently yielded mostly the ketone. Bigley, et aI.53 later refuted this 
method, reporting that interconversion could only be obtained through treatment of 56 with an 
aqueous oxalic acid dihydrate solution, followed by extraction of the ketone with ether. In our 
hands, neither method provided satisfactory conversion of 55 to 56. The separation of 55 and 56 by 
silica gel chromatography was further hampered by the facile conversion of 55 to 56 on contact wi th 
silica gel. Purification of the ketone was finally achieved by recrystallization from cold hexane, to 
give an overall modest isolated yield of 51 % for this compound. 
An alternative method of oxidizing sclareol has been described by Barrero, et aI.55 who used an 
osmium tetroxide-sodium periodate mixture to improve the yields of 55 to 85%. The improved yield 
of 55 was attributed to the more favourable reaction conditions, ie.1 DoC, and shorter reaction time, 
as opposed to the relatively higher temperatures and longer reaction duration required for the KMnO 4 
oxidation. Unfortunately, the cost and the hazardous properties of osmium tetroxide precluded its 
use in our laboratory. 
Spectroscopic data established the structure of the ketone 55, with !H and !3C spectra confirming the 
product purity. The 13C spectrum of 55 clearly showed the presence of the C-13 ketone (Oc 210.4) 
and the loss of the C-14 and C-15 vinylic carbons (oc 147.5 and 110.7). HRF ABMS established the 
molecular formula of 55 as C!SH320 2 (280.2402, L>mmu -OJ). The IRspectrum exhibited a prominent 
carbonyl absorption band at vm,,1712 cm'!, while the melting point (8l-82°C) and the optical 
rotation ([ a:lD = +5°) were consistent with literature values (78_80°C)53.55 and (+6.7°)56 
Results and Discussion 28 
2.3 Reduction of the Aliphatic Ketone 55. 
The ease with which the hydroxyl group at C-8 cyclizes with the C-13 ketone necessitated protection 
of the ketone early in our synthetic strategy. Reduction of the ketone to form the secondary alcohol 
was carried out as a prerequisite for the t-butyldimethylsilyl protection of this functionality . 
OR 
\ Ii: 
(57) R= H 
(59) R = (S)-MTPA 
(61) R = (R)-MTPA 
.. ,DR 
(58) R = H 
(60) R = (S)-MTPA 
(62) R = (R)-MTPA 
The reduction of ketones to form secondary alcohols is a well documented procedure and using the 
same LiAlH4 reduction reported by Hinder and co-workers,57 for the reduction of 55, we obtained 
diol (57) as a colourless oil and diol (58) as white crystals in an overall yield of 96% and in a ratio 
of 3:2 respectively. The diastereomeric mixture of these alcohols was easily separable by silica gel 
flash column chromatography (EtOAc:hexane!70:30). 
HRFABMS data established the molecular formulae of 57 and 58 as C18H340 2 (282.2551 , 6mmu-
0.8). The melting point (97-99°C) and the [a]o (+8°) of 58 were consistent with literature melting 
point (102°C) and [a]o (+ 11 0) values for this compounds7 The lH and l3C NMR data for both 
compounds were assigned using a combination of 2D NMR techniques and are presented in the 
experimental section (Chapter 3). As an example of the effective use ofHMBC and COSY data in 
the structure elucidation of the compounds prepared in our synthesis, the HMBC and COSY 
correlations for compound 57 are presented in Figures 2 and 3. HMQC data in conjunction with 
HMBC correlations were crucial in resolving the problem of overlapped signals in the proton 
methylene envelope. 
The absolute configuration of the C-13 secondary alcohol moiety in 57 and 58 was established using 
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Figure 2: The HlVIBC NMR spectrum (CDCI3, 400MHz) for compound 57 with some key HMBC 
correlations shown in the accompanying figure. 
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Figure 3: The COSY NMR spectrum (CDCl,> 400MHz) of compound 57. 
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Mosher's method." Unfortunately, the paper providing the physical data for diastereomer 5857 only 
came to our attention after we had established the absolute chemistry of 57 and 58. 2-Methoxy-2-
phenyl-2-(trifluoromethyl)acetic acid (MTPA), is the most frequently used Moshers derivatising agent 
and has been successfully used for such determinations in other marine terpenoids.s9,60 Mosher, et 
at. 58 hypothesized that the most stable conformation of the molecule in solution is one in which the 
carbinyl proton, the ester carbonyl and the trifluoromethyl groups of the MTP A moiety lie in the same 
plane (Figure 4). In this conformation the proton signals of the alkyl chain (U) on the same side of 
the plane to that of the phenyl substituent of the (R)-MTP A ester will be shielded (ie. they will appear 
upfield in the NMR spectra) as a result of the diamagnetic effect of the benzene ring. Conversely, 
the protons of the other alkyl chain (L') will be deshielded (ie. they will appear downfield in the NMR 
spectra) by the methoxy functionality (Rl) Hence, in summary, the signals ofL 2 protons of the (R)-
MTP A ester will be shielded relative to the L 2 protons in the corresponding (S)-MTPA ester. 
(R)-MTPA; R1=OMe, R2=Ph 
(S)-MTPA ; R1=Ph, R2=OMe 
Figure 4: The most stable conformation of (R)-MTP A and (S)-MTP A esters as proposed by 
Mosher.59 
Mosher put this hypothesis forward at a time when the complete assignment of protons in complex 
organic molecules was not viable as the available NMR instruments operated only in the 60-1 OOMHz 
range. Mosher, et al. made use of 19F NMR or lanthanide shift reagents to disperse the overlapping 
'H signals, with the knowledge that steric repulsion between the MTP A phenyl moiety and the p- and 
P '-substituents (Figure 5) resulted in the chemical shift difference of the CF3 C'F) or OMe CH) 
functionalities. The advent of Fourier Transform NMR overcame the limitations inherent in assigning 
the absolute configuration from only two data points. 
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Ohtani, et al. 59 proposed a modification to Moshers method by usmg high-field IH-NMR 
spectroscopy to determine the absolute configuration of secondary alcohols. High-field FT NMR, 
in addition to two-dimensional NMR experiments, enables one to calculate the chemical shift 
differences (ll.o = Os - OR) between several of the assigned protons in the (R)- and (S)-MTPA esters 
and hence permits the use of a larger number of data points for a more reliable determination of 
absolute stereochemistry. Figure 5 illustrates the assumed conformation of the respective (R)- and 
(S)-MTPA esters, wherein the HA> He and He protons of the (R)-MTPA ester will be upfield relative 
to those in the (S)-MTPA ester. Conversely, the opposite holds true for the Hx, Hy and Hz protons 
left of the MTP A plane. 
(R)-MTPA ; R1=OMe, R2=Ph 
(S)-MTPA ; R l=Ph, R2=OMe 
Figure 5 : The most stable conformation of (R)-MTP A and (S)-MTP A esters as proposed by 
Ohtani. 59 
As a result of the difference in chemical shifts, we see a negative ll.o value for the protons on the 
left and a positive ll.o value for the protons on the right of the model structure illustrated in Figure 
6. Once the ll.o values for the protons in the molecule have been determined, it is possible to 
elucidate the stereochemistry of the chiral secondary alcohol. Generally, it was also noted that 
validity of the hypothesis was enhanced if the ll.o values were proportional to the distance of the 
protons from the MTP A moiety. 59 
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Hx 
Hy 
Hz 
Figure 6: Model used in the modified Moshers method to determine the absolute configuration of 
secondary alcohols. 
The Moshers (S)-MTPA esters (59 and 60) and (R)-MTPA esters (61 and 62) were prepared using 
20mg of each alcohol (57 and 58) respectively, Assignment of the proton signals for each MTP A ester 
was confirmed using COSY experiments, The /16 values for each pair of diastereomers was 
determined and is represented in Table 2, The tabulated data in Table 2 are reproduced in Figures 7 
and 8 in order to clearly illustrate how the (l3R) and (13S) configurations were assigned in 
compounds 57 and 58, 
Figure 7: /16 values calculated for the 
MTP A esters of compound 57. 
OMTPA r+o.o9l (+liJ14] 
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Figure 8: /16 values calculated for the ~I\ (( , 
[+0]01 HO ,,----..r+D.02l MTP A esters of compound 58, 
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Table 2: Results from the Modified Mosher's Method (0 represented in ppm). 
Proton Mosher's Esters for Compound 57 Moshers Esters for Compound 58 
o (S)-MTPA o (R)-MTPA OS - OR o (S)-MTPA o (R)-MTPA OS - OR 
H-1 1.67 1.73 -0.06 1.67 1.56 +0.11 
H-2 1.46 1.52 -0.06 1.39 1.37 +0.02 
H-3 1.34 1.39 -0.05 1.31 1.22 +0.09 
H-5 0.83 0.88 -0.05 0.89 0.89 0.00 
H-6 1.62 1.65 -0.03 1.57 1.53 +0.04 
H-7 1.8 1 1.84 -0.03 1.81 1.79 +0.02 
H-9 0.90 1.00 -0.10 1.02 0.88 +0 .14 
H-ll 1.15 1.36 -0.21 1.22 1.18 +0.04 
H-12 1.30 1.52 -0.22 1.63 1.54 +0.09 
H-13 5.1 3 5.12 +0.01 5. 12 5.10 +0.02 
H-14 1.34 1.25 +0.09 1.27 1.33 -0.06 
H-15 1.10 1.12 -0.02 1.09 0.99 +0.10 
H-16 0.83 0.83 0.00 0.85 0.84 +0.01 
H-17 0.74 0.76 -0.02 0.77 0.76 +0.0 1 
H-18 0.63 0.73 -0.10 0.75 0.71 +0.04 
2.4 t-Butyldimethylsilyl (TBDMS) Protection of the Aliphatic Alcohols 57 and 58. 
In addition to the prevention of the cyclization mentioned in Section 2.3, the TBDMS protection of 
the C-13 alcohols also conferred stability of this hydroxyl functionality to the organometallic 
reagents, bases and acids we planned to use in the next few steps of our synthesis. Although acetate, 
tosyl and trimethylsilyl protecting groups were considered, TBDMS protection was chosen as 
TBDMS ethers are reported to be very stable.61 It was also noted that t-butyldimethylsilyl ethers 
could be rapidly cleaved back to the alcohol by treatment with tetra-n-butylammonium fluoride 
(TBAF). 
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Protection was first achieved using t-butyldimethylchlorosilane, a standard method described in 
numerous syntheses.62 Accordingly, a solution of 57 in CH2Cl2 was stirred at O°C with imidazole and 
4-dimethylaminopyridine (4-DMAP) under nitrogen for 5 hours to yield 63 (71%). We were 
disappointed that a theoretically quantitative reaction should only give a 71 % yield and tried another 
approach to the TBDMS protection of the alcohol. Using 2,6-lutidine and I-butyldimethylsilyl 
trifluoromethane sulphonate under slightly altered reaction conditions (CH2Cl2, _78°C, Ihr) resulted 
in an improved yield of 63 (97%). The TBDMS ether of 58 was similarly prepared (64). 
R 
(63) = ~-R 
(64) = a -R 
Identification of the TBDMS ethers was achieved using NMR spectroscopy where the dimethyl 
signals of the TBDMS moiety are characteristically seen as isolated peaks at DH O.04 and Dc-4.62. 
The signals of the I-butyl methyl groups are, likewise, also easily identifiable appearing as single large 
peaks at DH 0.S7 and Dc 25.92 as depicted in Figure 9 and 10. HRFABMS data determined the 
molecular formulae of 63 and 64 as C24H48Si02 ([M+ I -H20 r 379.3395, t>mmu -0 .1 and [M+ I-H20 r 
379.3397, t>mmu -0.09 respectively) . IH and l3C NMR data for 63 and 64 data have not previously 
been reported and these data, carefully assigned from 2D NMR experiments, are presented in Chapter 
3. 
2.5 Dehydration of the TBDMS Protected Alcohols 63 and 64. 
In order to facilitate the introduction of a ketone at C-8, we first needed to prepare the I:!.. 8,15 exocyclic 
alkene. The most readily identifiable means to achieve this was by regioselective dehydration of the 
tertiary alcohol at C-S. Reagents used for such transformations include phosphorous oxychloride 
(POCI3) and thionyl chloride (SOCI2).63 However, at the outset we anticipated the formation of a 
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Figure 9: IH NMR spectrum (CDC]3' 400MHz) of compound 63. 
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Figure 10: BC NMR spectrum (CDC]3' 100MHz) of compound 63. 
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mixture of the endocycJic and exocyclic dehydration products (e.g. 65, 66 and 67). The procedure 
followed was that of McCreadIe and co-workers" for a series of labdadienol interconversions in 
which a similar exocycJic dehydration was achieved. 
R R 
(65) (66) (67) = ~-R 
(68) = cx-R 
Initially using the thionyl chloride dehydration protocol of McCreadIe et al. we obtained a mixture 
of products. After purification of the mixture using normal phase HPLC (hexane:EtOAc-9S:S), the 
desired exocyclic alkene was obtained in a disappointing 41 % yield. In order to improve the yield 
of the desired product, we considered the use ofa milder dehydrating agent, i.e.POCI3.63 
A solution ofPOCI3 , 63 and 4-DMAP in pyridine was stirred at room temperature for three hours . 
Final purification ofthe reaction products was achieved via flash column chromatography to give the 
desired exocyclic alkene in 73% isolated yield. The structures of67 and 68 were confirmed using IH 
and 13C NMR spectroscopy in conjunction with 2D NMR experiments (HMQC, HMBC and CO SY). 
The protons of the I:!. 8,15 vinylic functionality appeared in the IH NMR spectrum as a distinctive 
doublet at 4.64ppm. Significant changes in chemical shifts were also seen in the 13C NMR spectrum, 
with regards to the C-IS carbon resonance which shifts from Oc 23 .63 in 63 to Oc 106.36 in 67 and 
the C-8 carbon signal which shifts from Oc 74.17 in 63 to Oc 148.82 in 67. Three bond HMBC 
correlations from H2-IS to C-7 and C-9 unequivocally confirmed the presence of the I:!. 8, 15 exocyclic 
alkene (Figure II). 
Following the precepts of Zaitsev 's Rule,63 which predicts that in elimination reactions the more 
highly substituted alkene is formed, it is somewhat surprising that although we did encounter a 
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mixture of products, including Li',· and Li',7 alkenes in small amounts, the least substituted Li·,l5 
alkene predominates in this reaction. HRF ABMS data provided the molecular formulae of 67 and 
68 as C24H46SiO (378.3318, t>mmu -0.05 and [M+ 1 r 379.3396, t>mmu -0.05 respectively) . Thefully 
assigned 'H and l3C NMR data for these TDBMS derivativtls have not previously been reported and 
are provided in Chapter 3. 
Figure 11 : The HMBC NMR spectrum (CDCI3, 400MHz) of compound 67 showing two key 
HMBC correlations. 
H-lSH-15' 
ij ~ C-7 
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2,6 Ozonolysis of the TBDMS Protected Alkenes 67 and 68, 
Ozonolysis has frequently been used as an efficient means of introducing a ketone into a compound 
via a carbon carbon double bond6',.o The ketone arises from a dipolar addition of ozone across the 
double bond resulting in the eventual formation of an ozonide. Common reagents used for the 
reduction of ozonides to ketones include zinc/acetic acid, HiPd, dimethyl sulphide (Me,S) and 
triphenyl phosphine (TPp)66 Of these possible reduction methods we chose to use Me,S because of 
the success encountered previously with this method in our laboratory and the ease with which the 
oxidized product, dimethyl sulphoxide (DMSO), could be removed from the reaction products. 
Initial attempts at ozonolysis of either 67 or 68 followed by work up with up to four equivalents of 
Me,S proved unsuccessful. The identification of the desired ketone product in the reaction mixture 
was based primarily on the appearance of the ketone carbon signal in 13C NMR. spectra and TLC. 
Development of the TLC plate with 2, 4-dinitrophenylhydrazine reagent (2, 4-DNP) produced a yellow 
spot on the TLC if the ketone was present. NMR. analysis of the reaction products revealed a 
complex mixture and not the single expected. After numerous unsuccessful attempts at ozonolysis, 
it was decided to start a parallel investigation into alternative methods of oxidizing the alkene to a 
ketone (see Section 2.7). 
(69) 
Frustrated by our lack of success with a straight forward ozonolysis reaction, we eventually isolated 
a product via normal phase HPLC (hexane:EtOAc/90: 1 0) of the reaction mixture from a fairly large 
scale ozonolysis of67 in CH,Cl2 with a Me,S (4 equivalents) reductive work Up61,6' Using lH and 
13C NMR spectroscopy, combined with 2D experiments, we identified the ozonolysis product as being 
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being the ozonide (69). The 'H NMR spectrum of 69 showed the loss of the double doublet at 
4.64ppm in 67 and the appearance of a doublet at 5.03ppm. Changes in chemical shifts were also 
seen in the llC NMR spectrum, where the C-15 carbon resonance shifted from Oc 106.36 in 67 to Oc 
93.37 in 69 and the C-8 carbon signal which shifted from Oc 148.82 in 67 to Oc 111.50 in 69. 
Unfortunately, the ozonide degraded into several products within a period of 72 hours before we 
were able to obtain mass data. So the conclusion drawn was that we did indeed form the ozonide 
after ozonolysis. However, our means of reductive cleavage appeared to be non-effective and we 
therefore required an alternative reductive work up procedure. 
yR 
I 
(70) = P-R 
(71) = a-R 
Accordingly, we then focused our attention on the ozonolysis of67 in CH,CI, with a TPP reductive 
work Up69 The presence ofunreacted TPP reagent made identification of the ketone difficult and it 
proved vital to sufficiently remove all traces ofunreacted TPP from the final product. We found a 
hydrogen peroxide wash of the reaction mixture to be very effective and excess TPP was removed 
as triphenyl phosphine oxide to yield 70 (97%). Purification of the ketone was achieved by normal 
phase HPLC (hexane:EtOAc/95:5). The ozonolysis of68 was also undertaken to give (71) in similar 
yields. 'H and llC NMR spectroscopy, in addition to 2D NMR experiments, confirmed the structure 
of the ketones 70 and 71. The loss of the C-15 signal at Oc I 06.86 and the shifting of the C-8 carbon 
signal at Oc 148.82 to 211.95 reflected the change at C-8 (see Figure 12). HRF ABMS data indicated 
that the molecular formulae of the isomers 70 and 71 was C23H44 SiO, (380.3119, ilmmu = -0.8 and 
[M+lr 381.3188, ilmmu = -0.07 respectively). IH and llC NMR data for these TDBMS 
derivatives have not been reported before and are presented in Chapter 3. 
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Figure 12: !3C NMR spectrum (CDC I" IOOMHz) of compound 70. 
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As mentioned previously, the initial problems associated with the ozonolysis of 67 necessitated the 
investigation of an alternative approach for introducing a C-8 ketone in 67. Preliminary studies were 
carried out on the TBDMS protected alkenes (67 and 68) and the ketone (72). No sufficiently high 
yielding oxidation alternative to ozonolysis was identified. 
2.7.1 Ruthenium Trichloride Oxidation of Compounds 67 and 72. 
Ruthenium compounds are recognized as powerful oxidizing agents which have been used for the 
cleavage of alkenes to yield either ketones, aldehydes or carboxylic acids. Ruthenium chloride-
periodic acid oxidation was attempted using the procedure reported by Beukes, et al.. 70 
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The TBDMS protected alkene (67) was reacted with periodic acid and a catalytic amount ofRuCI3 
in a CH2CI/ acetonitrilelH,0 solvent mixture over 4 hours to yield unchanged starting material. It 
was thought that the TBDMS moiety might, due to its steric bulk, have inhibited the formation of 
possible ruthenium oxidation complexes. Therefore the same oxidation was attempted using the 
unprotected keto-olefin (72), prepared by POCI3 dehydration of compound 5564 The oxidation 
procedure followed was the same as described above, however, the solution was stirred vigorously 
for 13 hours. The reaction yielded the dihydroxylated product (73, 63%) and the lactone ether 
isomers (74 and 75, 23%). Although 74 had been prepared previously by the by Francis, in his PhD 
research, in a series of oxidations ofmanool using KMnO, and Jones reagent (Cr03), no mention of 
the isomeric lactone 75 was made in the paper describing the PhD thesis work. 71 Compounds 74 and 
75 were separated using normal phase HPLC (hexane:EtOAc/95 :5). When the reaction mixture was 
heated to 30°C over a period of 16 hours, we observed a change in the yields of each compound, with 
the yields of 73 reduced to 32% and 74 and 75 increased to 58%. It stands to reason that 73 is 
probably an intermediate product in which facile oxidation of the primary alcohol followed by 
cyclization of the tertiary alcohol moiety and the C-13 ketone occurs with heating. 
o 
(72) 
\ .fI 
(73) 
o 
\ fI , '.. fI , 
(74) (75) 
13C NMR data for 73 indicated that conversion to the cyclized products had occurred on standing in 
CDCI3, and hence, the NMR data for 73 could not be fully assigned. The 'H and 13C NMR for "pure" 
73, represented in Figure 13, reveals the signals used for the identification of the dihydroxylated 
product in the mixture induced by CDCI3. The molecular formulae of the isomers 74 and 75 
(C18H2,0 3), ([M+ It 293 .2115, bmmu = -0.19 and [M+ It 293.2116, bmmu = -0.07 respectively) 
established from HRF ABMS data, suggested a double bond equivalence of five for both these 
compounds. A single lactone carbonyl ester resonance (Dc 175 .29 and 175 .37) in the 13C NMR 
spectra of74 and 75 respectively, accounted for one of the double bond equivalents required by the 
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by the molecular formulae, The absence of any olefinic signals in the lH and 13C NMR spectra of 
74 and 75 would therefore require these compounds to be tetracyclic, The only tetracyclic structure 
that would feasibly accommodate the three oxygen atoms, suggested by the molecular formulae, is 
the unusual lactone ether structure shown here for 74 and 75, As mentioned earlier, 74 has been 
prepared previously and a comparison of the lH and 13C NMR data of 74 and 75 with those of 
compound 74 prepared by Francis is presented in Table 3 (Note : the majority of the lH NMR signals 
were not assigned by Francis), 
Table 3: Comparison of relevant lH and 1JC NMR data of74 and 75 with the limited reported data 
for 74 prepared by Francis,72 
Carbon Compound 74 Compound 74" Compound 75 
OH Dc OH Dc OH Dc 
C-I 0,S7 (m), 1,62 (m) 39.3 - 39.2 0,S7 (m), 1.62 (m) 39,2 
C-2 1.43 (m) IS.3 - IS,3 1.59 (m) IS,3 
C-3 1.15 (m), 1.42 (m) 41.S - 41.S 1.15 (m), 1.43 (m) 41.S 
C-4 - 33, I - 33, I - 33, I 
C-5 0,93 (m) 55,0 - 55,0 0,97 (m) 55,0 
C-6 1.71 (m) 19,1 - 19,0 1.70 (m) 19, I 
C-7 1.50 (m), 2,07 (dt) 32.5 - 32,S 1.77 (m), 2,09 (dt) 32,5 
C-S - SI.1 - S1.1 - S1.3 
C-9 1.39 (m) 51.9 - 51.9 1.42 (m) 51.9 
C-IO - 37,S - 37,5 - 37,S 
C-II 1.53 (m), I.S0 (m) 17,9 - IS,O 1.41 (m), 1.74 (m) 17,9 
C-12 1,94 (m) 32,7 
-
32,7 1,54 (m), 1,94 (m) 32,7 
C-13 - 10S,0 - 10S,0 - 10S,0 
C-14 1,54 (8) 23,S 1.54 (s) 23,S 1.59 (8) 24.3 
C-15 - 175.3 - 175.4 - 175.4 
C-16 0,S9 (8) 33,7 0,91 (s) 33,7 0,90 (8) 33,7 
C-17 0.S4 (s) 21.8 0,S6 (s) 21.8 0,S5 (s) 21.8 
C-IS 0,91 (s) 13.4 0,93 (s) 13.4 0,92 (s) 13.4 
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Figure 13: 'H NMR spectrum (CDCI), 400MHz) of compound 73. 
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Figure 14: !3C NMR spectrum (CDCI), IOOMHz) of compound 73. 
C-8 
C-13 
2.0 
i 
1.5 1.0 
....,,--r-"r"~T'"' iii i j 
ppm 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm 
Results and Discussion 45 
Unfortunately the physical data ([aD] and melting point) for 74 was not reported by Grant, e/ ain 
and because Francis' thesis was not accessible to us, our assignment of the stereochemistry of74 and 
75 was based on tenuous comparison of 'H and 13C NMR data of our compounds with the limited 
published data (Table 3). In particular, we noted a small, but significant shift in the C-14 methyl 
resonance of74 (Dc 23.80) versus 75 (Dc24.33) which aided our stereochemical assignment. The 
absolute stereochemistry of74 was provided by the crystallographic data reported by Godfrey, e/ al. 
which identified 74 as 13 (R)-8 a,!3 : 13,17 -diepoxy-14, 15 -bisnorlabdan-l 7 _one73 Hence, the data 
suggests that 75 is 13(S)-8~, 13: 13, 17-diepoxy-14, 15-bisnorlabdan-17-one. 
Even though ruthenium oxidation proved unsuccessful with regards to the production ofthe desired 
ketone (70 and 71), it provided an interesting alternative to the preparation of the dihydroxylated 
product (73) which may undergo oxidative cleavage to give the resulting C-8 ketone as discussed in 
Section 2.7.2. However, the ease with which 73 cyclizes to 74 and 75 necessitated the handling of 
this compound with care. 
2.7.2 Attempted Cetyl Trimethyl Ammonium Permanganate cis-Hydroxylation and Oxidative 
Cleavage of Compound 67. 
The oxidative cleavage of 1,2-diols using sodium metaperiodate or lead tetra-acetate was identified 
as an alternative means of introducing a ketone at C-8. Phase transfer catalysis has been used as a 
means to improve the permanganate oxidations ofalkenes to 1,2-diols.74 This alternative method of 
oxidation was considered as our substrates, unlike KMN04, are all insoluble in water which may mean 
that the KMnO. concentrations are often too low in the organic phase containing the substrate, in 
these mixed phase systems, to result in successful oxidation. Another way to overcome this problem 
is to find a solvent in which both reagents and substrate are soluble. We had used acetone previously 
(Section 2.2) as a solvent for permanganate oxidation, however, no oxidation was observed when 
these reaction conditions were applied to the TBDMS protected alkene 67. To overcome solubility 
problems associated with permanganate oxidations, Bhushan, e/ al. 74 reported the preparation of the 
phase transfer catalyst cetyl trimethyl ammonium permanganate (CTAP; [n-C,6H33-
N(CH3)3]"Mn049 ) and its use in the cis-hydroxylation ofalkenes. 
Results and Discllssion 46 
The general procedure for the preparation ofCT AP is given in Chapter 3, Bhushan, el a/. 74 reported 
two methods for the cis-hydroxylation of alkenes, The first method involved the dissolution of 
CTAP in CH2Cl2 and its dropwise addition to a solution of the substrate in CH2Cl2 at room 
temperature (RT) with stirring for 1 to 5 hours , When this method was applied to the hydroxylation 
of 67, no change in 67 could be identified by NMR spectroscopy, An alternative method reported 
by Bhushan, el ai, involved the dissolution of CT AP in a solvent mixture of I-butanol and H20 and 
its dropwise addition to a solution of the substrate in I-butanol at RT with stirring for 1 to 5 hours, 
When the latter method was applied to compound 67, after a tedious work-up, the dihydroxylated 
product 76 was identified in an undesirably low yield of 22%, 
"'~H 
(76) (77) 
OH 
IH and 13C were used to confirm the formation of the dihydroxylated product 76 by identification of 
characteristic signals seen in a related compound (77) prepared by Grant, el a/. 72 possessing a C-13 
methylene (OH 3,60,3,51, J = 11.OHz and Oe 63,8) and quartenary C-8 (Oe 74,0), Compound 76 
showed similar chemical shifts for the corresponding C-15 methylene (OH 3.59, 3,50, J = 12,2Hzand 
Oe 67,7) and quarternary C-8 (Oe 76, I), HRF ABMS determined the molecular formula of 76 to be 
C24H44Si03 ([M+lr 413.3451, t,mmu -0,17), 
As was discussed previously the purpose ofthe synthesis of 76 was to produce the C-8 ketone by 
I ,2-diol oxidative cleavage, The oxidative cleavage of76 was unsuccessfully attempted firstly using 
Pb(OAc)4 and secondly using NaI04, Reagent insolubility in the organic solvent used was thought 
to be a possible limiting factor. However, even with the use of an aqueous I-butanol solvent system, 
only starting material was found, 
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2.7.3 Epoxidation followed by Oxidative Cleavage of 67 and 72. 
As we continued to be frustrated by the limited success of ozonolysis and other potential oxidation 
strategies for introducing a ketone at C-8, we decided to reassess the introduction of oxygen onto C-8 
by epoxidation. As was mentioned in Section 2.1 , epoxidation has previously been used with 
questionable success in introducing a p-epoxide at C_8 .51 This nevertheless provided us with an 
alternative means of deriving the desired 8P-hydroxyl through the opening of the p-epoxide ring 
with LiAIH4. Chauvet, et al. 75 reported an epoxidation of the /18.17 olefin in compound 78 using m-
chloroperbenzoic acid (m-CPBA) to produce the cx-epoxide in a quantitative yield. Confusingly, 
Chauvet's quantitative preparation of the ct-epoxide with m-CPBA appears to contradict the findings 
of Leite, et al. 52 who carried out an m-CPBA epoxidation of manool (50), mentioned previously in 
Section 2.1, to get a mixture ofct- and p-epoxides. We therefore decided to investigate the m-CPBA 
epoxidation of our compounds 67 and 72. The procedure for the LiAlH4 reduction of epoxides used 
has been reported in numerous publications.76•77 As the epoxidation results in a mixture of the cx- and 
p-epoxides, we used reported epoxide IH shifts to identify the cx- and p-epoxides in these mixtures. 
Grant, et al. 78 reported the IH chemical shift of the exocyclic methylene protons in the ct-epoxide 
(79) to be 2.79ppm (J = 1.8Hz) and 2.47ppm (J= 4.0Hz) and in the p-epoxide (80) to be 2.3lppm 
(J = 4.0Hz) and 2.52ppm. 
o 
(78) (79) (80) 
Compound. 67 was reacted with m-CPBA in CHICII at -78°C to yield a mixture of epoxides, 
identified by IH and 13C NMR (Figure IS). Separation of the epoxides was achieved by normal 
phase HPLC (hexane:EtOAc-97:3) which gave the ct-epoxide (81, 31 %) and the desired p-epoxide 
(82, 8%). Due to the instability of the compounds, complete 2-D NMR data could not be collected 
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degradation took place at RT. Given the poor yield of the p-epoxide, we decided to discontinue any 
further investigation of this alternative method for the preparation of the C-8 ketone from 67. 
(81) (82) 
Realizing that the TBDMS functionality may be adversely affecting the stereo selectivity of the 
epoxidation reaction, we decided to attempt the epoxidation on the unprotected keto-olefin (72) as 
described by Grant, et al. 78 The m-CPBA epoxidation of72 yielded a mixture of (X- and p-epoxides 
identifiable from 'H NMR spectrum (Figure 16). Rather than carrying out LiAlH4 and thereby losing 
the C-13 ketone functionality required for later chain extension, we opted instead for an oxidative 
cleavage with periodate79 Oxidation using periodic acid (HsI06) yielded a mixture of cyclized 
crystalline products although TLC indicated a single spot. The mixture was finally separated using 
normal phase HPLC (hexane:EtOAc/90 : 10) to give the acetal ( 83,13% yield) . 
(83) (84) 
There have been several reported syntheses of83 and 84, commonly known as ambraketal and nor-
ambraketal respectively.79,80,81 These isomeric acetals (83 and 84) were first prepared by Jeger, et al. 8' 
from the permanganate oxidation of manool (50). Ambraketal has also been prepared by Martres, 
et al. 80 
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Figure 15: IH NMR spectrum (CDCI3, 400MHz) of the epoxide mixture of79 and 80 . 
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Figure 16: 'H NMR spectrum (CDCl,> 400MHz) of the epoxide mixture of 81 and 82. 
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via the m-CPBA epoxidation of the keto-olefin (72) followed by copper sulphate work up. Ours is 
the first reported synthesis of ambraketal via periodic acid cleavage of an epoxide. 
HRFABMS data identified the molecular formula of 83 to be C1,H300 2 (278.2246, t>mmu -0.39). 
Physical data obtained for 83 ([ o:lD = _2°, Mpt = 117-119°C ) corresponds well to literature values 
([o:lD = _9°, Mpt = 120-121 0 C)'1 respectively. The structure of 83 was unequivocally confirmed by 
X-ray analysis. (Figure 17, Appendix 1). 
Figure 17: A view of compound 83 from the crystal structure showing the numbering scheme 
employed in the analysis. Anisotropic displacement of ellipsoids for the non-hydrogen 
atoms are shown at the 50% probability level. Hydrogen atoms are displayed with an 
arbitrarily small radius. 
The IHNMR data of83 was compared to the selected IHNMR data reported by Jeger, eta!' '1 (Table 
4). We believe Jeger, et a!. incorrectly reported compound 83 as being (13S)-80:, 13: 13,20-diepoxy-
/-----=-=~ ... 
~ .. r"f)Dr"'" " ;l!'h)/ Li.-) \ . U " 1\/" " " '-I'" \ \ Hirc.1H}1 I.I \ Li 8~ARY ,..; 
·', .. ~A"· 
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14,IS-bisnorlabdane. The 'H chemical shift of the C-lS methyl and the C-IS methylene protons of 
Jeger, et al. ' s nor-ambraketal are consistent with ambraketal. 
Table 4: Comparison of selected 'HNMR data of our compound 83 with those of compound 83 and 
84 as reported by Jeger, et al .. 8' 
Carbon Compound 83"(OH) Compound 84"(OH) Compound 83( 0 H) 
C-14 1.41 (8) 1.43 (8) 1.41 (8) 
C-15 3.36 (d), 4.3 1 (d) 3.31 (d), 3.77 (d) 3.35 (d), 3.74 (d) 
C-16 0.9 1 (8) 0.89 (8) 0.87 (8) 
C-17 0.9 1 (8) 0.89 (8) 0.86 (8) 
C-18 0.81 (8) 1.11 (8) 1.08 (8) 
2.8 Preparation of the TDBMS Protected Alcohols 86 and 87. 
The eventual successful preparation of the ketone8 70 and 71 via ozonolysis facilitated the next step 
in our synthesis, namely the stereoselective alkylation of the ketone at C-8. The a-face (equatorial) 
delivery ofa methyl nucleophile at the C-S ketone is crucial in order to produce the required axiaI8~­
hydroxy group. In doing so, we would achieve the inversion ofC-8 stereochemistry required in our 
synthesis of the marine natural product derivatives 45 and 46. 
With numerous methods of alkylation available e.g. Grignard reagents and organometallic reagents,63 
we needed to identify which procedure provided exclusive a-face delivery. MacDonald. et at. 83 
reported results from a study involving the addition of nuc1eophiles to ketones. They found that 
methyllithium (MeLi) reacted with 4a-methyl-trans-2-decalone (85), a similar system to our bicyclic 
diterpenes, to produce an axial alcohol with high stereo selectivity and in a high yield. Variable 
temperature studies also indicated that a-face methylation was enhanced by lower reaction 
temperatures i.e. -78°e. A similar but more in depth study of the carbonyl alkylation process in 
cyclohexanone systems was reported by Maruoka, et al .. 84 They discussed the use of MeLi and 
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several Grignard reagents in producing axial and equatorial alcohols in differing ratios. It was found 
that Grignard reagents preferentially result in the formation of equatorial alcohols, but always in a 
mixture with the axial alcohol. They also found that the formation of the axial alcohol, by alkylation 
with MeLi, is enhanced when the targeted ketone possesses ~-alkyl substitution, resulting in a 
quantitative yield of axial hydroxylated product. Given the substantial p-alkyl substitution in 70 and 
71 we concluded that MeLi was the reagent of choice for the methylation step in our synthesis. 
r--~ -" ~0'1 
(85) (86) = P-R 
(87) = a-R 
(63) = P-R 
(64) = a-R 
The procedure for organolithiurn alkylation was taken from the PhD thesis ofP.T. Kaye. 85 MeLi was 
add dropwise to a solution ofTBDMS protected ketone (70) in aprotic anhydrous THF cooled (-
78°C) under N2• TLC of the reaction mixture indicated the formation of a polar product. With 
purification using normal phase flash column chromatography, we obtained 86 in an isolated yield 
of73%. The isomer 87 was similarly prepared from 71. 
Ashby, et al. 86 in a study of the stereoselective alkylation of cyclic ketones used GLC as a means of 
determining relative yields of axial and equatorial mixtures. When GLC chromatograms of our 
diastereomeric methylation products (86 and 87) were compared with GLC chromatograms of their 
epimers (63 and 64 respectively), it was apparent that we had quantitatively prepared the 8~-hydroxy 
product. The combined GLC chromatogram for compounds 63, 64, 86 and 87 is shown in Figure 
18. HRF ABMS data provided the molecular formulae of 86 and 87 (C24H48Si02, 396.3424, Ammu 
+0.07 and 396.3425, Ammu +0.13 respectively). IR spectra indicated the presence of a hydroxyl 
functionality (vm.x = 3427 em-I) in both 86 and 87 and the loss ofthe carbonyl stretching frequency 
(vmax = 1710 em-I) in both 70 and 71. The differences in the 1JC chemical shift of63 and 86 are 
highlighted in Table 5. 
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A change in stereochemistry around C-8 results in chemical shift changes primarily in the ex and ~­
carbons closest to the stereocenter. As can be seen in Table 5, this holds true for the inversion of 
stereochemistry at C-8 in compound 86. The optical rotations of 86 ([ exlo = + 15°) and 87 ([ exlo = 
+ 11°) differ significantly from the epimers 63 ([ exlo = _14°) and 64 ([ exlo = _9°) respectively. 
Table 5: I3C Chemical shift (1 OOMHz, CDCl3)comparison between compound 86 and compound 63, 
with significant changes in chemical shifts indicated by shading. 
Carbon Compound 86 (liol Compound 63 (lie) 
C-l 39.1 39.8 
C-2 18.3 18.4 
C-3 43.8 43.0 
C-4 33.2 33.2 
C-5 5S .9 56.2 
0<6 121 21M; 
C-7 42j .t4,5-
01$ 73.2 14,.1 
69 ~~u 64 .9 
C-1O 39.0 39.83 
C-ll 21.3 21.2 
C-12 42.1 42.1 
C-13 69.1 69.4 
C-14 23.6 23.6 
C-J;j . ~O $ 2:>,9 
C-16 33.4 33.4 
C-17 21.7 21.5 
C-18 IS.0 IS.3 
C-19 -4.4 -4.3 
C-20 -4 .7 -4 .6 
C-21 18.2 18.1 
C-22, 23, 24 2S .9 2S.9 
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OR 
OR 
(45) (46) 
Finally, Cimino, et al" used two pieces of NMR evidence to support their assignment of an axial 
alcohol functionality at C-8 in the alcohols 45 and 46 prepared from the natural products 5 and 6. 
Firstly, a or p orientation of the alcohol moiety at C-8 apparently influences the 'H chemical shift of 
the methyl group (H3-20). An a-equatorial alcohol at C-8 induces an upfield shift of the H3-20 
methyl protons (OH 0.80) while a p -axial alcohol C-8 alcohol causes a downfield shift ofHr 20 methyl 
protons (OH 0.96)"7.88 In 86 and 87 the equivalent methyl protons are Hr18 which are shifted upfield 
(OH 0.93 for both), thus implying a C-8 axial hydroxyl functionality in these two compounds. The 
second piece of evidence provided by Ciminio, et al. 8 in support of the C-8 stereochemistry in 44 and 
45 was the BC chemical shift of the methyl carbon C-17. An a-equatorial methyl substituent at C-8 
has a downfield BC chemical shift (Oc 30.0) while a p-orientated methyl group resonance appears 
upfield (Oc 25 .0) .87.88 The equivalent methyl carbon in 63, 64, 86 and 87 is C-15 . From the chemical 
shifts of C-15 in these four compounds (Table 5), it is clear that the methyl substituent at C-8 in 86 
and 87 is a-equatorial and in compounds 63 and 64 it is p-axial. 
2.9 Synthesis of the a,p-Unsaturated Esters 91 and 92 from the Protected Alcohols 86 and 87 
In order to facilitate chain extension at C- 13 , we required the reintroduction of the ketone 
functionality at this carbon. TDBMS deprotection was therefore necessary to expose the side-chain 
hydroxyl group for further oxidation to the ketone. TBAF has been identified as a means to readily 
cleave the TDBMS moiety to generate the free alcohol61 and has been used as an effective method 
of de protection on numerous occasions in marine natural product syntheses. 89.90 Therefore individual 
solutions of the 8P-hydroxy TBDMS protected products (86 and 87) and TBAF in anhydrous THF 
were refluxed for four hours to produce the 8P, l3-diols (88 and 89) in isolated yields of 85% and 
74% respectively. 
(88) R = ~-OH 
(89) R = a-OH 
R 
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Compounds 88 and 89 were both fully characterized using lH, 13C and 2D NMR experiments. The 
lH NMR spectra indicated the loss of the protective group methyl proton peaks (OH 0.03ppm and 
0.87ppm) and the BC NMR spectra showed the loss of the protective group methyl carbon signals 
(oe -4.72, -4.45 and 25.90). HRFABMS data gave the molecular formulae of 88 and 89 as 
C1sH3.o2 (282.2559, Llmmu = +0.19 and 282.2558, Llmmu= -0.66 respectively). The optical 
rotations of 88 ([ a)o = +8°) and 89 ([ a)o = + 18°) also differed from the isomeric forms of 57 ([ a)o 
= _30°) and 58 ([a)o= +8°) respectively. The presence of the secondary alcohol functionality at C-
13 was further confirmed by the H-13 multiplet (OH 3.75) in the lH NMR spectrum and the 
deshielded oxymethine carbon resonance (oe 68.46) in the BC NMR spectrum. 
To prevent dehydration of the tertiary alcohol at C-8 and reduce potential cyclic hemi-acetal 
formation during oxidation, we needed to identifY a method of mild oxidation for our next synthetic 
step. Interestingly, during our literature search of mild oxidation processes, we identified a neat 
method for alcohol oxidation to a ketone via hydride abstraction of trimethylsilyl ethers 91 Jung 
rep0l1ed that the oxidation was facilitated using triphenylcarbenium (trityl) tetrafluoroborate as the 
hydride extractor. The oxidation takes place through the formation of a carbo cation intermediate 
followed by fluoride ion attack from BF 4' to give the desired ketone (Scheme 8). Jung also mentioned 
that the bulky trimethylsilyl group reduces complexation between the trityl salt and the ether oxygen. 
We concluded that this oxidation method could possibly be effectively applied to our protected 
alcohols which possessed the bulkier t-butyldimethylsilyl group. Using commercially available trityl 
fluoroborate and following Jung' s procedure, we attempted the oxidation of86 in CH2Cl2 at room 
temperature. NMR indicated no change in the starting material and this method of oxidation was 
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pursued any further. 
Scheme 8: Mechanism oftrityl tetrafluoroborate oxidation ofTMS protected alcohols· ' 
Other alternatives for mild oxidation included pyridinium chlorochromate,n tetrapropylammonium 
perruthenate/3 raney nickel,.' and chromium trioxide (Collin's oxidation?S oxidations. We, however, 
decided to opt for Swern oxidation, which was a well established procedure in our laboratory 9U·97 
Accordingly, the S~, 13-diols (88 and 89) were independently added to cooled (-78°C) solutions of 
oxalyl chloride and dimethylsulphoxide in CH2Cl2 under N2. Triethylamine was added to the mixtures 
and the reaction stirred for one hour and extracted to yield the crude ketone (90) . 
o 
(90) 
"",H 
(55) 
o 
13C NMR showed the undeniable presence ofa ketone functionality (Dc = 209.9). The IR spectrum 
also confirmed the presence of a ketone functionality (vmru< = 1720 cm'I) . Due to the problem of 
cyclic herni-acetal formation as described in Section 2.2, we were reluctant to purify 90 and opted 
to proceed with the crude ketone instead. 
With the successful formation of the Sp-hydroxy ketone (90), we were now in a position to 
reintroduce a f:!" 13 olefin as required to synthesize our marine natural product derivatives (45 and 46). 
The Horner-Wadsworth-Emmons (HWE) modification of the Wittig reaction is a well known 
Results and Discussion 59 
synthetic strategy used to introduce carbonyl derived olefinic functionalities·8,99 In our synthesis, we 
anticipated that the HWE procedure would utilise the reaction of metal enolates [derived from triethyl 
phosphonoacetate (TEPA) and sodium hydride (NaH)] and the ketone (90) to yield the desired 
olefinic ester (91 and 92) and a water soluble phosphate ester (Scheme 9). 
o 0 
II II (OEt)2P~OEt NaB TBF 
Na 
0' '0 
II J (OEthP~OEt 
o 
II + EtO-P-O"Na 
I 
OEt 
+ 
1 R\=s'C02Et 
R2 
Scheme 9: A generalized Horner-Wadsworth-Emmons reaction mechanism. 
Variations of the HWE procedure have been used for the stereoselective preparation of both E- and 
Z-isomers, however, this stereoselectivity is somewhat diminished when the HWE reaction is applied 
to ketones. 100,101,102 Both E- or Z-isomers, would lead to either one of our target molecules (45 or 46), 
so stereoselectivity was not initially of concern to us. We, however, decided to attempt the HWE 
reaction on 55, easily prepared from sclareol (See Section 2.2), to validate this synthetic approach 
and to prevent the unnecessary use of an already dwindling supply of the 8~-hydroxy substrate, 90. 
13 
""j\: 
(91) cPZ 
(92) t,,'lE 
C02Et 
h 
13 
\H 
(93) cYz 
(94) tYE 
C02Et 
,,;:; 
Compound 55 was added to a stirred solution ofNaH and TEPA in anhydrous THF under N2. The 
reaction gave a mixture of the a, ~-unsaturated esters in a 94% overall yield. Separation via normal 
phase HPLC yielded Z-isomer (93) and the E-isomer (94) in a ratio of2:1 respectively" 
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Table 6: IH and 13C Chemical shift (1 OOMHz and 400MHz respectively, CDCI,) for compounds 91, 
92, 93 and 94 (multiplicities in parentheses, coupling constants given in Chapter 3). 
Carbon Compound 91 Compound 92 Compound 93 Compound 94 
OH Oc OH Oc OH Oc OH Oc 
C-I 0.S7(m) 39.1 0.96(m) 39.1 0.94(m) 39.S 0.96(m) 37.4 
1.65(m) 1.79(m) 1.64(m) 1.74(m) 
C-2 1.40(m) IS.2 1.39(m) IS.3 1.41(m) IS.4 1.4 J(m) 19.5 
1.57(m) l.56(m) l.56(m) 1.56(dt) 
C-3 1.14(m) 41.7 I.II(m) 44.6 1.16(m) 42.0 1.19 (m) 39.3 
I.3S(m) I.3S(m) U6(m) U4(m) 
C-4 - 33.2 - 33.3 - 33 .3 - 33.3 
C-5 0.S2(m) 55.9 0.90(m) 55.9 0.91(m) 56.1 0.91(m) 56.1 
C-6 1.4S(m) 18. 1 1.49(m) IS.2 1.24(m) 20.6 1.22(m) 20.3 
1.63(m) 1.62(m) 
C-7 1.44(m) 42.2 1.49(m) 42.0 1.37(m) 44.S 1. 44(m) 43.2 
1.72(m) 1.74(m) I.S5 (d!) I.S4(dt) 
C-8 
-
73. 1 - 73.3 - 74.2 - 73.9 
C-9 O.77(m) 5S.S 0.S3(m) 59.3 1.04(t) 61.5 I.II(m) 61.5 
C- IO - 39.0 - 39.1 - 39.2 - 3S.S 
C-II I.3S(m) 23.6 1.16(m) 23.S 1.37(m) 23.6 1.46(m) 24.3 
1.55(m) 1.43(m) 1.56(m) 
C-12 2.12(m) 44.6 2.56(ddd) 42.4 2.16(m) 44.4 2,21(m) 42 .0 
2.74(ddd) 2.28(m) 2.93(m) 
C-13 - 160.2 - 159.9 - 160.9 - 161.7 
C-14 5.65(s) 115.3 5.60(s) 115.9 5.66(s) 115.2 5.64(s) 11 5.6 
C- 15 - 166.9 - 166.2 - 167.0 - 166.6 
C-16 1.24(m) 14.3 1.23(m) 14.3 I.2S(t) 14.3 1.23(t) 14.3 
C-17 1.12(s) 30.6 1.23(s) 30.6 1.14(5) 24.0 1.16(5) 24.2 
C-IS O.SO(s) 21.6 0.82(5) 21.7 0.7S(s) 21.5 0.77(5) 21.5 
C-1 9 0.S5(s) 33 .4 0.86(s) 33.4 0.S6(s) 33.4 OS5(s) 33.4 
C-20 0.93(5) 15. 1 0.94(s) 15.1 0.7S(s) 15.4 0.75(s) 15.5 
C-21 4.II(m) 59.4 4.13(m) 59.4 4.14(q) 59.4 4.12(q) 56.8 
C-22 215(5) 19.0 1.90(s) 19.0 2.15(5) 19.1 I.S9(d) 25.7 
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Each isomer (93 and 94) was identified by 'H, l3C and 2D NMR techniques, and the fully assigned 
NMR data are presented in Table 6. The 'H NMR spectra for compounds 93 and 94 showed the 
distinct chemical shift of the C-14 olefinic proton (OH 5.66 and OH 5.64 respectively) and the C-21 
ethyl ester methylene (OH 4.14 and OH 4.12), which confirmed the introduction of the vinylic 
functionality and the anticipated C-15 ester. The l3C NMR chemical shifts of C-13 (Oc 160.9 and Oc 
161.7 respectively) and C-14 (oc ll5 .2 and Oc 115.6 respectively), in conjunction with the C-1 5 
carbonyl shifts (Oc.l67.0 and Oc. 166.6,respective1y) in the '3C NMR spectra of93 and 94 further 
confirmed the formation of the c,l3,14 moiety and the anticipated ethyl ester. The difference in vinyl 
methyl chemical shifts between E- and Z-isomers has been reported by Bates, et al. '03 who stated that 
the methyl proton signals (C-17 in this case) in E-isomers appear further upfield in 'H NMR spectra 
when compared to vinyl methyl protons in Z-isomers. We applied this principle to the identification 
of93 and 94, and as can be seen in Table 6, the chemical shift ofH3-17 in 93 varies significantly from 
that in 94. IR spectra of both compounds showed characteristic carbonyl (vmax = 1715 cm-') and 
hydroxyl (vm" = 3500 cm-') absorbances. 
HRF ABMS data provided the molecular formulae of93 and 94 (C22H3s03), ( [M+ l-CH3r 33 5.2429, 
c'mmu = - 0.12 and [M+ l-CH3r 335.2429, c'mmu = - 0.05 respectively). The spectroscopic data 
thus confirmed the structures of93 and 94 as i 3(Z)-8<x-hydroxy-ladb-1 3-en-15-ethanoate and 13(E)-
S<x-hydroxy-ladb-13-en-15-ethanoate respectively. 
Having established that the HWE olefination was viable, we carried out the same reaction on our 
limited amount of compound 90. It should be noted that again the Swern oxidation of the Sp,13 -
diols (88 and 89) was directly followed, after work-up, with the HWE reaction in order to reduce 
hemi-acetal cyclization and hence, in theory improve yields. The HWE of compound 90 gave the 
anticipated mixture of E and Z isomers (91 and 92) in a low overall yield of3 5%. The low yield 
could be possibly explained by our inability to establish the rigorous anhydrous environment necessary 
when performing the HWE reaction using crude 90 directly from the Swern oxidation. Normal phase 
HPLC was used to achieve separation of the E-isomer (92) and Z-isomer (91) in a ratio of 10: 1 .. 
respectively. 
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Compound 91 and 92 were identified as per 93 and 94 from NMR and mass data. The assigned 
NMR data for compounds 91 and 92 are also presented in Table 6. The IH NMR spectra for 
compounds 91 and 92 showed the C-14 olefinic proton (DH 5.65 and DH 5.60 respectively) and the 
C-21 ethyl ester methylene (DH 4.11 and DH 4.13). The IlC NMR spectra of compounds 91 and 92 
showed the desired C-13 (Dc 160.2 and Dc 159.9 respectively), C-14 ( Dc 115.3 and Dc 115.9 
respectively) and C-15 (Dc.166.9 and Dc.166.2 respectively) chemical shifts. IR spectra also 
confirmed the presence of the carbonyl moiety (vmax = 1717 em-I) and the hydroxyl functionality 
(vmox = 3450 em-I). From the available data, we identified compounds 91 and 92 as(13Z)-8P-
hydroxy-labd-13-en-15-ethanoate and (13E)-8 p-hydroxy-labd-13-en-15-ethanoate respectively. We 
were unable to explain the different E:Z ratios encountered when the HWE reaction was carried out 
on 55 and 90. Interestingly, the HRF ABMS spectra of 91 and 92 provided the molecular ions 
directly and did not show the loss of CHJ encountered with 93 and 94. No published spectroscopic 
data could be found for compounds 91 - 94 and we assume that these are new compounds. 
2.10 DIBALH Reduction of the Esters 91, 93 and 94. 
Initially we had hoped that the reduction of the terminal C-J5 ethyl ester functionality would give 
rise directly to the aldehyde of the target natural products 6 and 7. A precedent for the reduction of 
an ester directly to an aldehyde was provided by Luly, et a/.43 who successfully prepared Boc-
(cyclohexyl)-alaninal (95) by diisobutylaluminium hydride (DIBALH) reduction of the 
corresponding ester (96). Even though 96 is not related to our ex,p-unsaturated esters (91 and 92), 
it does demonstrate the possible conversion of a side chain ester to an aldehyde with DIBALH. 
o 
BOC-HN 
(95) (96) 
Although the DIBALH (1.2 equivalents) reduction was first attempted on 93 and 94 to ascertain the 
viability of this reaction, unexpected products were obtained. After purification by nOlmal phase 
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silica column chromatography, both 97 and 98 were identified using iH, J3C and 2D NMR 
experiments. HRF ABMS data gave the molecular formulae of 97 and 98 (C2oH360 2)' ([M+ I r 
309.2795, D.mmu = -0.13 and [M+lr 309.2793, D.mmu = -0.07). 
OH 
(97) (98) 
The molecular formula of 97 and 98 suggested three degrees of unsaturation and as there were no 
olefinic or carbonyl resonances evident in the J3C NMR spectra of these two isomers implied that 
both compounds possessed a tricyclic skeleton. The COSY NMR spectnun of97 clearly showed 
coupling between an oxymethylene (H2-15, OH 3.75) and two methylene protons (H2-14, OH 1.52 and 
1.66). No further coupling between this isolated spin system and the other protons was observed. 
The two oxygenated quaternary carbon resonances in the J3C NMR spectrum of 97 (Oc 75.8 and 
75.9) were assigned to a cyclic ether moiety with two bridgehead methyl substituents and proved 
crucial in establishing the structure of 97 and 98. As is shown in Scheme 10, we propose that 
cyclization may have occurred after the reduction of97 and 98 during the purification step on silica 
gel. The stereochemistry at C-13 could not be established by a NOESY NMR spectrum and is 
arbitrarily assigned. 
~OEt 
~""OH 0 DIBALH + • H OH 
OH OH 
Scheme 10 : A possible mechanism for the formation of compound 97 with a trace of acid. 
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We decided to attempt the reduction of compound 91 using one equivalent ofDIBALH despite the 
results obtained on the test compounds 93 and 94 (the small amount of compound 92 was retained 
for future studies). No change in the starting material was observed after the reaction of91 with one 
equivalent ofDIBALH. Compound 91 was further reacted with three equivalents ofDIBALH to 
give the corresponding C-15 alcohol 46 in an isolated yield of 46% after purification via normal phase 
HPLC (hexane:EtOAc/1:l) 
(46) 
HRFABMS data gave the molecular formula of 46 as C2oli3602 (308.2715, .6.mmu = -0.04). The 
structure of compound 46 was resolved using IH, BC and 2D NMR experiments. The IH NMR 
spectrum of compound 46 confirmed the presence of the C-14 olefinic proton (DH 5.41), the loss of 
the C-21 ethyl ester methylene (DH 4.11) and the formation of a C-15 methylene (DH 4.14). The BC 
NMR spectrum of compound 46 further substantiated the still intact olefinic moiety (C-13, Dc 140.30; 
C-14, Dc 123.l0) and the loss ofthe C-15 carbonyl moiety (Dc166. 85). The previously unassigned 
IH and BC NMR data for 46 are shown in Table 7. Finally, the optical rotation of 46 ([ alo = + 19°) 
was consistent with that reported by Cimino, et al. 8 ([ al D = +32°) confirming that we had successfully 
synthesized our target molecule. The I Hand BC spectra of 46 are presented in Figures 19 and 20 
respectively. 
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Table 7 : The 'H and l3C chemical shifts (400MHz and 1 OOMHz respectively, CDCl,) for compound 
46 (multiplicities and coupling constants in parentheses). 
Carbon Compound 46 
OH Oc 
C-I 0.84 (m), 1.66 (m) 39.2 
C-2 1.42 (m), 1.59 (dl) 18.2 
C-3 1.12 (m),1.38 (m) 42.1 
C-4 - 33.3 
C-5 0.90 (m) 55 .9 
C-6 - 18.3 
C-7 2.03 (m) 43.3 
C-8 - 73.2 
C-9 0.79 (m) 58.8 
C-IO - 39.0 
C-ll 1.38 (m), 1.52 (m) 24.0 
C-1 2 1.46 (m),1.73 (m) 42.2 
C-13 - 140.4 
C-14 5.41 (I, J = 6.8Hz) 123.1 
C-15 4.14 (d,J= 6.9Hz) 59.4 
C-1 6 1.69 (s) 16.4 
C-1 7 1.14 (s) 30.6 
C-18 0.82 (s) 21.7 
C-19 0.86 (s) 33.4 
C-20 0.95 (s) 15 .1 
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Figure 19: IH NMR spectrum (CDCI3, 400MHz) of compound 46. 
H-15 
H-14 
, , , , , , , , , , 
7.0 6 ' 6.0 ,., 50 .. , '0 3.' 3.0 2.' 
Figure 20: l3C NMR spectrum (CDCI3, lOOMHz) of compound 46. 
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3. CONCLUSION 
The initial focus of our synthesis was to identifY an optimized method of preparing the two isomeric 
marine natural products SP-hydroxylabd-13E-en-IS-al (5) and SP-hydroxylabd-13Z-en-IS-al (6) 
isolated by Cimino, et at. Having identified that the aldehydes (5 and 6) were unstable, our synthesis 
was redirected towards the synthesis of their alcohol derivatives (45 and 46). Accordingly labd-13E-
en-Sp , IS-diol (46) was prepared in ten steps from sclareol (32) in an overall yield of 3 .4%. The 
preparation of the labd-13Z-en-Sp, IS-diol (45) would also have been undertaken had it not been for 
time constraints and limited supplies of the required precursor (91). 
·' H ~ 
(5) t,13E 
(6) t,13Z 
CHO 
(45) 
OH 
OH 
(46) 
Problems associated with yields arose in the first oxidation step which gave 55 (51 %), the HWE step 
which yielded 91 and 92 (3S%) and the final DIBALH reduction step which produced 46 (46%). 
Given adequate time, optimization of these reactions could have been investigated. With the 
preparation of sufficient quantities of 46, the mild oxidation of the C-IS hydroxyl group could be 
attempted to synthesize the aldehyde natural product. Suitably activated manganese dioxide is a 
possible mild oxidant for synthesizing the aldehydes 5 and 6, from compounds 45 and 46 respectively 
and providing adequate amounts of these compounds for bioassay studies. 
It is hoped that the work presented in this thesis will facilitate future marine labdane diterpene 
synthetic studies at Rhodes University. 
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4. EXPERIMENTAL 
4.1 General Experimental 
Dried solvents were prepared as per procedures described by Perrin, et al. 'as THF was dried over 
benzophenone and sodium wire under nitrogen. All solvents used were redistilled prior to use. 
Anhydrous reactions were performed in flame dried glassware under dry nitrogen. Distilled solvents 
used for anhydrous reactions were stored over 4A molecular sieves. HPLC solvents used were of 
analytical grade. 
Normal phase TLC was carried out on Merck DC-Plastikfolien Kieselgel 60 F'54 and viewed under 
a 254nm UV light. TLC plates were developed using a 10% H,S04 in MeOH spray followed by 
heating on a hotplate. Iodine and 4-DNP staining were used as alternate methods of development 
when required. Column chromatography was performed using Merck 7734 Kieselgel 60 silica (70-
230 mesh). Flash column chromatography was performed using Merck 9385 Kieselgel 60 silica 
(230-400 mesh). Normal phase HPLC separations were achieved using a system comprising of a 
Spectra-Physics IsoChrom LC or Spectra-Physics SpectraSERIES PIOO pump, a Waters R401 
differential refractometer, a Whatrnan Magnum 9-Partisil 10 column and a Rikadenki chart recorder. 
'H (400MHz), llC (1 OOMHz), DEPT and 2D NMR spectra were acquired using a Bruker AMX400 
NMR spectrometer. Spectra were run in CDCI), with 'H and '3C shifts being referenced to 7.25ppm 
and 77ppm respectively. Chemical shifts are reported in 6 units (ppm) and coupling constants in 
hertz (Hz). IR spectra were recorded on a Perkin Elmer Spectrum 2000 FT -IR spectrophotometer. 
Optical rotations were measured on a Perkin-Elmer 141 polarimeter, with samples being run in 
CHCI). Low resolution mass spectra (ElMS) were obtained on a FilUligan Matt GCQ spectrometer. 
High resolution fast atom bombardment mass spectra (HRFABMS) were obtained by Dr Louis 
Fourie of the mass spectrometry unit at the University of Potchefstroom. The X-ray structure of 
ambraketal was determined by Professor Mino Caira ofthe University of Cape Town. Melting points 
were determined using a Kofler hot-stage apparatus. 
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4.2 Synthetic Procedures 
4.2.1 Preparation of Ketone 55. 
Compound 32 (40.00g) was dissolved in 4.0L of acetone. Powdered KMnO. (73.S0g) was added 
over 2 hours at a temperature between 15°C-20°C. H,O (40mL) was added and the mixture was 
stirred for a further 5 hours at 15°C-20°C. The mixture was then stirred overnight at RT (22°C), and 
then allowed to stand for 24 hours. The supernatant was removed with a pipette. NaOH (lOg) in 
H,O (50mL) was added to the MnO, residue, which was further extracted with acetone (3x1.5L). 
The combined acetone fractions were filtered through a cotton wool plug and concentrated under 
vacuum to give a crude crystalline product. The product was dried under vacuum and recrystallized 
from hexane to yield pure 55 (l8.00g; 51 %). 
Compound 55: 
o 
""OH 
'. H-.~ 
Light pink crystals. Mpt = 81-82°C. [a:10 27 = +5.0° (CHCI3; c 1.08). lR Vm" cm·1(NaCI): 3422(br), 
2925, 2859,1712,1447, 1387,1155, 1117,1074. ElMS (70 eV) mlz (rel.int.): 280 [Mr (2.5) , 
262(H,O-79), 244(41), 229(95), 217(12), 201 (22), 191 (57), m( 48), 159(30), 149(70), 135(60), 
121(65), 109(100),95(91),81(82), 67(52),55(20),41(26). HRF ABMS mlz: 280.240463. C1sH3,o, 
requires 280.240230. IH NMR (400 MHz, CDCI3) : 00.77 (3H, s, Me-18), 0.79 (3H, s, Me-16), 
0.85 (3H, s, Me-17), 0.88 (IH, m, H-5), 0.90 (JH, d, JI., = 2.4Hz, H-I) , 1.06 (JH, s, H-9), 1.14 (3H, 
s, Me-14), 1.21 (JH, d, J = 17.4, H-3), 1.25 (lH, m, H-6), 1.38 (lH, dd, J = 4.2Hz, 16.6Hz, H-3), 
1.50 (JH, m, H-2), 1.56 (JH, t, J = 2.2Hz, H-Il ),1.59 (JH, d, J = 2.5Hz, H-ll '), 1.61 (IH, m, H-l ') , 
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1.68 (lB, m, H-6') , 1.72 (IH, m, H-2'), 1.84 (2H, dt,J = 3.IHz, 12.2Hz, H-7), 2.11 (3H, s, Me-IS), 
2.53-2.68 (2H, m, H-12). DC NMR (100 MHz, CDCl3) • 0 15.2 (C-18), 18.4 (C-6), 18.8 (C-2), 205 
(C-II), 21.5 (C-17), 24.1 (C-14), 30.0 (C-15), 33 .2 (C-4), 33.4 (C-16), 393 (C-I 0),40.1 (C-I), 41.9 
(C-3), 44.5 (C-7), 46.3(C-12), 56.1 (C-5), 60.7 (C-9), 73.7 (C-8), 210.4 (C-13). 
4.2.2 Preparation of Diols 57 and 58. 
A solution of 55 (2.000g) in anhydrous THF (10mL) was cooled to O°C and stirred. A suspension 
ofLiAlH4 (0. 542g) in anhydrous THF was added gradually to the stirred solution. The mixture was 
allowed to stir for a further 2 hours. The reaction was quenched with the addition of cooled saturated 
NH4CI solution (4mL) and the resulting precipitate dissolved with the addition of 1M HCI (IOmL). 
The mixture was then extracted with EtOAc (3x30mL). Organic and aqueous fractions were 
separated and the aqueous fraction washed with EtOAc (30mL). The EtOAc fractions were 
combined and washed with saturated NaHC03 (50mL), H20 (50mL) and saturated brine (50mL), 
dried over MgS04 and reduced under vacuum. Purification was achieved via flash column 
chromatography(hexane.EtOAc!70:30) to give the diol 57 (1.lOlg) as a colourless oil and the diol 
58 (0.822g) as white needles in a 96% combined isolated yield. 
Compound 57: 
OH 
·"'OH 
Colourless oil. [ct]D25 = _30° (CHCI3; c 0.23). IR vrn",cm-1(NaCI) : 3347(br), 2930, 2871 , 1460, 1382, 
1131, 1080, 1025, 987, 936. EIMS (70 eV) mlz (reLint.) : 279(1.5), 264 (25), 249 (25), 231 (30), 
221 (18), 203 (10), 191 (22), 177 (100), 161 (19), 149 (69), 135 (29), 123 (45),109 (59), 95 (98), 
81 (48), 67 (55),55 (19). HRFABMS : 282.2551. C!8H3402 requires 282.2559. 'H NMR (400 
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l\1Hz, CDCI3) : 00.78 (3H, s, Me-17), 0.80 (3H, S, Me-I 8), 0.86 (3H, S, Me-16), 0.86 (lH, m, H-I), 
0.92 (lH, dd, J = 23Hz, 12.2Hz, H-S), 1.10 (IH, m, H-3), 1.15 (3H, d, J = 6.2Hz, Me-14), 1.61 
(3H, S, Me-IS), 1.21 (lH, m, H-9), 1.24-135 (lH, m, H-6), 135 (lH, m, H-ll), 137-1.41 (lH, m, 
H-2), 1.40 (lH, m, H-3'), 1.44-1.49 (2H, m, H-12), 1.45 (lH, m, H-7), 151 OH, m, H-ll'), 153-
1.59 (lH, m, H-2'), 1.60-1.63 (1H, m, H-l'), 1.66 (lH, m, H-6'), 1.83 (lH, dt, J= 3.2Hz, 12.2Hz, 
H-7'), 3.90 (lH, m, H-13). l3C NMR (l00 MHz, CDCI3) : 0 15.2 (C-18), 18.4 (C-2), 20.0 (C-ll), 
21.5 (C-17), 23.2 (C-14), 24.6 (C-15), 33 .2 (C-4), 33.4 (C-16), 39.2 (C-I0), 39.9 (C-l), 40.1 (C-12), 
42.0 (C-3), 44.3 (C-7), 56.2 (C-5), 58.4 (C-9), 65.4 (C-13), 74.4 (C-8) 
Compound 58: 
"" OH 
White needles. Mpt = 97°C-99°C. [0:]D25 = +8° (CHCI3; c 0.27). IR Vm", cm"(NaCl): 3346, 2931, 
2859,1460,1381, 1129, 1082, 936,756 . ElMS (70 eV) mJz (rel.int.) : 279(2.5), 264 (8), 249 (29), 
231 (30), 221 (12), 206 (8),191 (20), 177 (100), 161 (13),149 (28),135 (20), 123 (41),109 (41), 
95 (48), 81 (39),67 (40), 56 (18) . HRFABMS : 282.2551. C" H340 2 requires 282.2558. 'HNMR 
(400 MHz, CDCI3): 00.77 (3H, s, Me-17), 0.79 (3H, s, Me-18), 0.84 (3H, s, Me-16), 0.93 (lH, dd, 
J= 2.0Hz, 12.1Hz, H-5), 1.00 (1H, m, H-I), 1.13 (3H, s, Me-14), 1.15 (3H, s, Me-15), 1.22 (lH, 
s, H-9), 1.24-1.29 (lH, m, H-II), 1.28 (lH, m, H-12), 133 (lH, m, H-6), 1.49-1.55 (lH, m, H-6'), 
139 (lH, m, H-3), 1.44 (lH, m, H-7), 152-159 (1H, m, H-2), 1.60 (IH, m, H-I '), 1.61 (lH, m, H-
11'), 1.63 (lH, m, H-12'), 1.64 (lH, m, H-2'), 1.81 (lH, dt, J = 3.lHz, 123Hz, H-7'), 1.91 (lH, m, 
H-3'), 2.64 (lH, br s, OH), 3.76 (lH, m, H-13). l3C NMR (100 MHz, CDCI3) 0 15.2 (C-18), 18.4 
(C-2), 20.5 (C-ll), 215 (C-17), 22.1 (C-6), 23 .8 (C-15), 24.3 (C-14), 33.2 (C-4), 33.4 (C-16), 39.2 
(C-l0), 39.7 (C-l), 42.0 (C-3), 42.3 (C-12), 44.2 (C-7), 56.0 (C-5), 615 (C-9), 69.8 (C-13), 74.6 
(C-8) 
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4.2.3 Preparation of the (S)-MPTA Esters of Diols 57 and 58. 
This procedure is representative of both diol esterifications. A solution of 57 (20mg) and 4-DMAP 
(30mg) in anhydrous CH,Cl, (2mL) was added to a solution of (S)-MPTA (IOOmg) and 
dicyclohexylcarbodiimide (l47mg) in anhydrous CH2CI, (2ml) under N2. The mixture was stirred 
overnight at RT (20°C), diluted with EtOAc (lSmL) and H20 (2mL) and filtered. The filtered EtOAc 
solution was then washed with 0.2M HCI (IOmL), H20 (lOmL), saturated NaHC03 (lOmL) and 
saturated brine (lOmL), dried over MgSO" filtered and reduced under vacuum. Purification was 
achieved via gradient elution flash column chromatography (hexane:EtOAc/80:20) to yield 59 
(21mg). 
Compound 59: 
23 
"" OR 
Colourless oil. lH NMR (400 MHz, CDCI3): 60.63 (3H, s, Me-18), 0.72 (lH, m, H-I), 0.74 (3H, 
s, Me- I 7), 0.79 (lH, m, H-12), 0.83 (3H, s, Me-16), 0.83 (lH, m, H-S), 0.90 (lH, t, J= 4.0Hz, H-9), 
104 (lH, m, H-3), 1.10 (3H, s, Me-IS), 1.51 (lH, m, H-II), 1.21 (lH, m, H-6), 1.30 (lH, m, H-
12'), 1.33 (3H, d, J= 6.3Hz, Me-14), 1.34 (lH, m, H-3'), 140 (lH, m, H-7), 1.46 (lH, rn, H-2), 161 
(lH, m, H-ll'), 1.62 (lH, m, H-6'), 167 (IH, m, H-I'), 1.81 (IH, dt, J = 3.lHz, 12.2Hz, H-7'), 3.57 
(3H, s, Me-27), S.13 (lH, m, H-13), 7.38 (2H, m, H-23, H-2S), 7.39 (lH, m, H-24), 7.S4 (2H, m, 
H-22, H-26). I3C NMR (100 MHz, CDCl3) 6 IS.3 (C-18), 18.4 (C-2), 20 I (C-14), 205 (C-6), 21.1 
(C-II), 215 (C-17), 24.0 (C-IS), 33 .2 (C-4), 33.4 (C-16), 39.0 (C-I 0), 39.2 (C-I), 39.4 (C-12), 419 
(C-3), 44.6 (C-7), SS.4 (C-27), S6.0 (C-S), 61.5 (C-9), 74.1 (C-8), 74.8 (C-13), 122.1 (C-20), 12S. 1 
(C-28), 127.2 (C-22, C-26), 128.3 (C-24), 129.4 (C-23 , C-2S), 132.7 (C-21), 166.2 (C-19). 
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Compound 60: 
""OH 
Colourless oil. IHNMR (400 MHz, CDCI3) : 00.75 (3H, s, Me-IS), 0.77 (m, s, Me-17), 0.S5 (m, 
s, Me-I 6), 0. S7 (JR, m, H-12), 0.S9 (JR, m, H-5), 1 02 (lH, t, J = 4.0Hz, H-9), 1.09 (3H, s, Me-
15), 1.11 (JR, m, H-3) , 1.20 (JR, d, J= 3.2Hz, H-6), 1.22 (JR, m, H-ll), 1 27 (3H, d, J = 6.25Hz, 
Me-1 4), 1.31 (lH, m, H-3'), US (IH, m, H-7), 1.39 (JR, m, H-2), 1.57 (IH, m, H-6'), 163 (JR, 
m, H-12'), 1.67 (JR, m, H-l), LSI (JR, dt, J = 3.3Hz, 12.1Hz, H-7'), I S2 (IH, m, H-l'), 3.54 (m, 
s, Me-27), 5.12 (JR, m, H-13), 7.3S (2H, m, H-23 , H-25), 7.40 (IH, m, H-24), 7.53 (2H, m, H-22, 
H-26) !3CNMR(l00MHz, CDCI3) 015.3 (C-1S), IS.4(C-2), 19.4 (C-14), 20.5 (C-6), 210 (C-
11), 21.5 (C-17), 24.0 (C-15), 33.2 (C-4), 33.4 (C-16), 39.0 (C-I, C-IO), 39.S (C-12), 41.9 (C-3), 
44.5 (C-7), 55.3 (C-27), 56.1 (C-5), 61.5 (C-9), 74.1 (C-S), 74.S (C-13), 1219 (C-20), 124.S (C-2S), 
127.5 (C-22, C-26), 12S.4 (C-24), 129.5 (C-23 , C-2S), 132.4 (C-21 ), 166.2 (C-1 9). 
4.2.4 Preparation of the (R)-MPTA Esters of Diols 57 and 58. 
This procedure is representative of both diol esterifications. A solution of 57 (20mg) and 4-DMAP 
(30mg) in anhydrous CH2CI2(2ml) was added to a solution of(R)-MPTA (lOOmg) and DCC (147mg) 
in anhydrous CH2CI2 (2mL) under N2. The mixture was stirred overnight at RT (20°e). The mixture 
was diluted with EtOAc (15mL) and H20 (2mL) and filtered . The filtered EtOAc solution was 
washed with 0.2M HCI (IOmL), H20 (lOmL), saturated NaHC03 (10mL) and saturated brine 
(1 OmL), dried over MgSO 4, filtered and reduced under vacuum. Purification was achieved via flash 
column chromatography (hexane:EtOAc/SO:20) to yield 61 (22mg). 
Compound 61: 
'. H-
'-
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""OH 
Colourless oil 00.73 (3H, s, Me-18), 0.76 (3H, s, Me-17), 0.83 (3H, s, Me-16), 0.84 (!H, m, H-
11), 0,86 (!H, m, H-12), 0.88 (lH, m, H-5), 100 (!H, t, J= 4.0Hz, H-9), 1.12 (3H, s, Me-15), 1.18 
(lH, m, H-3), 1.25 (3H, d, J = 6.2Hz, Me-14), 1.33 (!H, m, H-7), 1.36 (JH, m, H-ll'), 1.39 (!H, 
m, H-3'), 1.52 (!H, m, H-12'), 1.52 (!H, m, H-2), 1.61 (IH, m, H-2'), 1.65 (!H, m, H-6), 1.73 (!H, 
m, H-I), 184 (!H, dt,J= 3.2Hz,12,2Hz, H-7'), 5.12 (!H, m, H-13), 7.38 (2H, m, H-23, H-25), 7.40 
(!H, m, H-24), 7,53 (2H, m, H-22, H-26). BC NMR (J 00 MHz, CDCI3): 0 15.3 (C-18), 18.4 (C-2), 
19.7 (C-14), 20.5 (C-6), 21.3 (C-II), 21.5 (C-1 7), 24.0 (C-15), 33.2 (C-4), 33.4 (C-16), 39.0 (C-IO), 
39. I (C-I), 396 (C-12), 419 (C-3), 44.7 (C-7), 55.3 (C-27), 56 . I (C-5), 61.5 (C-9), 74.1 (C-8), 74.9 
(C- 13), 122.1 (C-20), 125.0 (C-28), 127.5 (C-22, C-26), 128.4 (C-24), 129.5 (C-23, C-25), 132.4 
(C-21), 166.3 (C-19) 
Compound 62: 
''''OH 
Colourless oil 'HNMR (400 MHz, CDCl,): 0 0.7 1 (3H, s, Me-18), 0.76 (3H, 5, Me-17), 0.84 (3H, 
5, Me-1 6), 0,88 (!H, m, H-9, H-12), 0.89 (!H, m, H-5), 0.99 (3H, s, Me-15), 1.18 (!H, m, H-l1), 
1.22 (IH, m, H-3), 1.25 (JR, m, H-6), 1.29 (JR, m, H-7), 1.33 (3H, s, Me-14), 1.37 (JH, m, H-2), 
Experimental 77 
1.53 (IH, m, H-6'), 1.54 (IH, m, H-3', H-12'), 1.56 (IH, m, H-I), 1.61 (lH, m, H-II '), 1.78 (IH, m, 
H-2'), 1.79 (IH, dt, J= 3.0Hz, 12.7Hz, H-7'), 1.81 (IH, ill, H-I'), 3.56 (3H, s, Me-27), 5.10 (IH, 
m, H-13), 7.37 (IH, m, H-23 , H-25), 7.38 (IH, m, H-24), 7.54 (IH, ill, H-22, H-26). l3C NMR 
(100 MHz, CDCI3) 0 15J (C-18), 18.4 (C-2), 19.8 (C-14), 20A (C-6), 20.9 (C-ll), 21.5 (C-17), 
24.0 (C-15), 33.2 (C-4), 33.4 (C-16), 38.9 (C-IO), 39.0 (C-l), 39.7 (C-12), 41.9 (C-3), 44.2 (C-7), 
55.4 (C-27), 56.0 (C-5), 61.5 (C-9), 74.1 (C-8), 74.7 (C-13), 122.1 (C-20), 125.1 (C-28), 127.2 (C-
23, C-25), 128.3 (C-24), 129.5 (C-22, C-26), 132.6 (C-21), 166.1 (C-19) 
4.2.5 Preparation of the TBDMS Protected Ethers 63 and 64. 
The procedure for the t-butyldimethylsilyl protection presented here is representative. A solution of 
57 (0.800g) was dissolved in anhydrous CH2Cl2 (l OmL) and cooled (-78°C) under N2. 2,6-Lutidine 
(661 I"L) was added to the solution, followed by the dropwise addition ofTBDMS triflate (776I"L). 
After stirring for 2 hours, TLC of the solution indicated that the reaction was complete. The reaction 
was accordingly quenched with 50% aqueous acetic acid (30mL) and stirred for a further 30 minutes. 
The mixture was extracted with EtOAc (3x30mL) and the organic and aqueous fractions separated. 
The aqueous fraction was washed with EtOAc (3xI5ml). All the EtOAc fractions were combined 
and washed with H,O (30mL), saturated NaHC03 (2x30mL), H20 (30mL) and saturated brine 
(30mL), dried over MgSO, and reduced under vacuum to yield 63 (l .087g; 97%) as an oiL No 
further purification was required. 
Compound 63: 
22 
\ /" 
o ~ 
'Si 24 
/ \ 
19 20 
Colourless oiL [0:]D25 = _14° (CHCI3; c OJI). IR vmaxcm-1(NaCI): 3427, 2931 , 2859, 1464, 1381, 
1251, 1132, 1089, 1042, 1001 , 834, 774. EIMS (70 eV) m/z (reLint.): 396 (2),355 (2), 339 (12), 
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321 (22),299 (3), 279 (3), 264 (4), 247 (37), 231 (20),221 (5),204 (14),191 (50), 177 (44), 163 
(44), 149 (l00), 135 (32), 121 (40), 107 (44), 95 (65), 81 (55),67 (50), 55 (18). HRFABMS: [M+ 1-
H20] 379.3395. C24H4p,Si requires 379.3396. 'H NMR (400 MHz, CDC!)): 00.04 (6H, s, Me2-
Si), 0.77 (6H, 5, Me-17, Me-18), 0.79 (1H, m, H-l l), 0.84 (3H, 5, Me-16), 0.87 (9H, 5, (-butyl-Si), 
0.88 (IH, t,J = 4.2Hz,H-5), 0.91 (1H,m,H-l), 1.05 (lH, t,J=3.9Hz, H-9), 1.11 (3H, 5, Me-IS), 
1.11 (3H, d, J= 6.lHz, Me-14), 1.14 (1H, m, H-12), 1.21-1.25 (1H, d, J= 1.8, H-6), 1.34 (1H, m, 
H-ll '), 1.36 (1H, m,H-7), 1.38 (lH,m,H-12'), 1.41 (lH, m,H-2), 1.51 (lH,m, H-3), 1.57 (lH,m, 
H-2'), 1.66 (IH, m, H-l'), 1.69 (1H, m, H-6'), 1.84 (lH, dt, J = 2.9Hz, 12.2Hz, H-7'), 3.79 (lH, m, 
H-13). BC NMR (100 MHz, CDC!)): 0 -4.3 (C-19) , -4.6 (C-20), 15.3 (C-18), 18.1 (C-21) , 18.4 (C-
2),20.6 (C-6), 21 .2 (C-ll ), 21.5 (C-17) , 23.6 (C-14) , 23.9 (C-15), 25.9 (C-22, C-23, C-24), 33.2 (C-
4), 33.4 (C-16) , 39.3 (C-I 0) , 39.8 (C-l ), 42.1 (C-12) , 43.0 (C-3), 44.5 (C-7), 56.2 (C-5), 61.9 (C-9), 
69.4 (C-13), 74.2 (C-8). 
Compound 64: 
Colourless oil. [ex]02S= -9.00 (CHCl); c 0.26). IR vmaxcm"(NaCI): 3435, 2931, 2858, 1630,1455, 
1382, 1253, 1131,1081,1036,998, 834, 769. ElMS (70 eV) mlz (rel.int.): 380 (2), 363 (3), 339 
(17),321 (16),303 (2),279 (5), 264 (7),247 (48), 231 (22),221 (6), 205 (11), 191 (74), 177 (50), 
163 (43),149 (100),135 (35), 121 (42) , 109 (43), 96 (97), 81 (50),55 (14). HRFABMS: [M+l-
H20), 379.3397. C24H4)O,Si requires 379.3396. 'HNMR (400 MHz, CDCI)): 0 0.04 (6H, s, Me2-
Si), 0.77 (6H, s, Me-l7, Me-18), 0.85 (3H, s, Me-16), 0.87 (9H, s, (-butyl-Si), 0.91 (lH, m, H-5), 
0.95 (lB, m, H-l), 1.02 (lH, t,J= 3.6Hz, H-9), 1.11 (3H, 5, Me-IS), 1.13 (3H, d,.l= 6.lHz, Me-14 
),1.14 (1H, m, H-12), 1.22-1.26 (lH, m, H-6), 1.38 (lH, m, H-7), 1.35 (lH, m, H-12'), 1.40 (lH, m, 
H-2), 1.47-1.53 (lH, m, H-ll), 1.55 (1H, m, H-2'), 1.58 (lH, m, H-3), 1.64 (lH, m, H-l '),1.65 (IH, 
m, H-6'), 1.84 (lH, dt,J= 3.2Hz, 12.2Hz, H-7'), 3.75 (lH, m, H-13). IJC NMR (100 MHz, CDCl)) : 
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I) -4.4 (C-19), -4.6 (C-20), 15.4 (C-lS), IS.0 (C-21), IS.4 (C-2), 20.5 (C-II), 21.2 (C-6), 21.5 (C-
17),23.6 (C-15), 24.0 (C-14), 25.9 (C-22, C-23, C-24), 33.2 (C-4), 33.4 (C-16), 39.1 (C-lO), 39.S 
(C-I), 42.0 (C-12), 43.4 (C-3), 44.1 (C-7), 56.1 (C-5), 62.1 (C-9), 69.2 (C-13), 74.4 (C-S). 
4.2.6 Preparation of the Unsaturated Ethers 67 and 68. 
The dehydration described here is representative. Compound 63 (1.26Sg) was dissolved in dry, 
redistilled pyridine (8mL). 4-DMAP (0.392g) was added to the stirred solution at RT (25°C) and 
POCl3 (585flL) was added dropwise to the cooled solution (O°C). After stirring for 3 hours, TLC 
of the reaction mixture indicated a single spot with reduced polarity, cf 63. The reaction was 
accordingly quenched with ice. Glacial acetic acid (6.4mL) was added to remove excess pyridine 
and the mixture stirred for 30 minutes after which it was extracted with EtOAc (3x50mL). The 
EtOAc fractions were combined, washed with Hp (30mL), saturatedNaHC03(50mL), HP (50mL) 
and saturated brine (50mL). The combined EtOAc fraction was finally dried over MgS04 and 
reduced under vacuum. The product was passed through a plug of silica to remove any remaining 
pyridine salts. The reaction yielded 67 (0.925g, 73%) as an oil. Final purification was achieved via 
normal phase HPLC (hexane:EtOAc/95:5). 
Compound 67: 
--ji 
Colourless oil. [~lD25= +200 (CHCI3; c 0.23). IR vm",cm-'(NaCI): 2928, 2856,1642, 1460,1386, 
1253,1134, 1095,1048, 1003,888,835,772. ElMS (70 eV) mlz (rel.int.):379 [M+lr (2), 321 (90), 
303 (5),279 (12), 265 (3),245 (62),231 (6),204 (22),189 (20),171 (30), 157 (35),135 (12.5), 121 
(22), 110 (23), 95 (32), 75 (100), 55 (5). HRFABMS: [Mr 378.3317. C24H46SiO requires 378.3318. 
'HNMR (400 MHz, CDCI3): I) 0.05 (6H, s, Me2-Si), 0.65 (3H, s, Me-I 8), 0.80 (3H, s, Me-17), 0.86 
(3H, s, Me-16), 0.89 (9H, s, t-butyl-Si), 1.01 (1H, m, H-6), 1.02 (tH, m, H-3), 1.09 (IH, m, H-5), 
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1.11 (3H, d, J = 6.0Hz, Me-I 4), 1.17 (1 H, m, H-12), 1.18 (1 H, m, H-6'), 1.31 (lH, dd, J = 4.2Hz, 
8.6Hz, H-ll), 1.36 (1H, m, H-12'), 1.45 (lH, m, H-2), 1.58 (lH, m, H-9), 1.73 (lH, m, H-ll '), 1.76 
(lH, m, H-3'), 1.84 (IH, m, H-l), 1.97 (IH, m, H-7), 2.37 (lH, dt, J= 3.2Hz, 12.7Hz, H-T), 3.75 
(lH, m, H- 13),4.49 (lH, s, H-15), 4.80 (lH, s, H-15'). l3C NMR (I 00 MHz, CDCll ): 0 -4.4 (C-19), 
-4.6 (C-20), 14.5 (C-18), 18.2 (C-21 ), 19.5 (C-2), 19.8 (C-6), 21.8 (C-17), 23.7 (C-14), 24.5 (C-II), 
25.9 (C-22, C-23, C-24), 33.2 (C-4), 33.7 (C-16), 38.4 (C-I), 38.8 (C-7), 39.2 (C-3), 39.3 (C-IO), 
42.2 (C-12), 55 .6 (C-5), 57.1 (C-9), 69.2 (C-13), 106.4 (C-15), 148.8 (C-8). 
Compound 68: 
\.H 
Colourless oil. [alo25 = _5 ° (CHCll ; c 0.33). IR vm"cm-1(NaCl): 2928, 2856,1643,1461,1442, 
1372,1255,1137,1093,1043,1003,888,836,774. ElMS (70 eV) mlz (rel.int.): 379 [M+lr (3), 
321 (81),303 (9),279 (8), 245 (61),231 (15),204 (42), 189 (26),171 (30), 157 (36),137 (17),121 
(22), 107 (19) , 95 (30), 76 (100), 56 (5). HRFABMS: [M+lr 379.3396. C24H47SiO requires 
379.3396. lH NMR (400 MHz, CDClJ): 0 0.04 (6H, s, Me2-Si), 0.67 (3H, s, Me-18), 0.80 (3H, s, 
Me-17), 0.86 (3H, s, Me-16), 0.89 (9H, s, t-butyl-Si), 0.93 (IH, m, H-6), 0.97 (lH, m, H-3), 1.06 
(1 H, m, H-5), 1.1 0 (3H, d, J= 6.2Hz, Me-14), l.l8 (lH, m, H-12), 1.31 (IH, dd, J= 4.3Hz, 12.9Hz, 
H-ll), 1.38 (lH, m, H-12'), 1.42 (lH, m, H-2), 1.49 (lH, m, H-9), 1.60 (IH, m, H-2'), 1.73 (lH, m, 
H-ll '), 1.74 (J H, m, H-l), 1.84 (lH, m, H-3'), 1.95 (lH, m, H-7), 2.37 (IH, dt, J = 3.2Hz, 12.7Hz, 
H-T), 3.74 (lH, m, H-13), 4.54 (IH, s, H-15), 4.80 (lH, s, H-15'). l3C NMR (100 MHz, CDCIJ) : 
0-4.4 (C-19), -4.6 (C-20), 14.4 (C-18), 18.1 (C-21), 19.5 (C-2), 19.8 (C-6), 21.8 (C-17), 23.9 (C-
14),24.5 (C-ll), 25.9 (C-22, C-23 , C-24), 33.6 (C-4), 33.7 (C-16), 38.4 (C-l), 38.8 (C-7), 39.2 (C-
3), 39.7 (C-I0), 42.3 (C-12), 55.6 (C-5), 57.1 (C-9), 69.2 (C-13), 106.6 (C-15), 148.6 (C-8). 
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4.2.7 Ozonolysis ofthe Unsaturated Ethers 67 and 68. 
4.2.7.1 Dimethyl Sulphide (DMS) Workup ofthe Ozonolysis Reaction. 
Compound 67 (250mg) was dissolved in dry CH2Cl2 (5mL) and cooled (-78°C). 0) was bubbled 
through the solution for 30 minutes. N2 was bubbled through the solution for 30 minutes to remove 
excess 0 ). DMS (1.0mL) was added and allowed to stir for 2 hours. The solution was extracted 
with CH2Cl2 (3x30mL). The combined CH2Cl2 fractions were washed with saturated NaHCO) 
(30mL), H20 (30mL) and saturated brine (30mL), dried over MgS04 and reduced under vacuum. 
Final purification was achieved via normal phase HPLC (hexane:EtOAc/90: 1 0) to yield 69 (mg, 
83%) as a colourless oil. 
Compound 69: 
Colourless oil. 'H NMR (400 MHz, CDCl): 0 0.03 (6H, 5, Me2-Si), O.SO (6H, 5, Me-16, Me-17), 
0.86 (9H, s, t-butyl-Si), 0.87 (3H, s, Me-IS), 0.95 (lH, m, H-l), 1.09 (3H, d, J = 6.1 Hz, Me-14), 1.10 
(lH, m, H-12), 1.20-1.26 (lH, m, H-3), 1.39-1.42 (2H, m, H-2, H-2'), 1.72 (lH, m, H-l '),0.92 (IH, 
m, H-5), 1.61 (1H, m, H-ll), 1.54 (lH, m, H-6), 1.68 (1H, m, H-12'), 1.57 (lH, m, H-9) , 1.83 (!H, 
m, H-7) , 2.07 (lH, m, H-7'), 3.69 (IH, m, H-13), 5.03 (2H, d, J= 149.2, H-lS, H-1S'). 13C NMR 
(100 MHz, CDCl): 0 -4.5 (C-19, C-20), 14.4 (C-17), 18.1 (C-21), 18.6 (C-2), 19.7 (C-ll), 21.6 (C-
16), 19.7 (C-6), 23.7 (C-14), 25.9 (C-21 , C-22, C-23), 33.5 (C-15), 33.2 (C-4) , 42.7 (C-12) , 38.9 (C-
1),42.0 (C-3), 36.7 (C-7), 39.5 (C-l 0), 54.9 (C-5) , 57.0 (C-9), 69.1 (C-13), 93.4 (C- 18), 111.5 (C-S). 
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4.2.7.2 Triphenylphosphine (TPP) Workup of the Ozonolysis Reaction. 
The ozonolysis procedure is representative for our ozonolysis of both protected alkenes 67 and 68. 
Compound 67 (1.000g) was dissolved in dry CH2CI2(5mL) and cooled (-78°C). 0 3 was bubbled 
through the solution for 30 minutes. N2 was bubbled through the solution for 30 minutes to remove 
excess 0 3' TPP (2.771g) was added and the solution allowed to stir for 2 hours. Excess TPP was 
removed as triphenylphosphine oxide by the addition of H20z (30%, 5mL). After the 
triphenylphosphine oxide was removed by filtration, the solution was extracted with CH2CI2 
(3x30mL). The combined CH2CI2 fractions were washed with saturated NaHC03 (30mL), HzO 
(30mL) and saturated brine (30mL), dried over MgS04 and reduced under vacuum. An EtOAc 
solution of the product was passed through a plug of silica to remove any remaining TPP. Final 
purification was achieved via normal phase HPLC (hexane:EtOAc/95 :5) to yield 70 (0.975g, 97%) 
as a colourless oil. 
Compound 70: 
o 
Colourless oil. [cxlD25 = _37° (CHCI3; c 0.34). lR vm",cm·1(NaCI): 2947,2924,2847,1710,1455, 
1368,1250,1143, 1093,1047,998,830, 770. ElMS (70 eV) mlz (rel.int.): 381 [M+ It (1), 365 (2), 
323 (65),281 (22),305 (3),281 (22),267 (3), 249 (5), 231 (100),215 (4),199 (28),189 (26),175 
(35), 161 (30), 149 (39), 119 (21), 107 (18), 95 (36), 76 (38), 67 (9), 55 (4). HRFABMS: 380.3119. 
C23H44Si02 requires 380.3111. lH NMR (400 MHz, CDCI3): 60.04 (6H, s, Me2-Si), 0.70 (3H, s, 
Me-17) , 0.84 (3H, s, Me-16), 0.86 (9H, s, t-butyl-Si), 0.95 (3H, s, Me-IS), 1.01 (1H, m, H-I), 1.11 
(3H, d,J= 6.1 Hz, Me-14), 1.12 (lH, m, H-12), 1.22-1.25 (lH, m, H-3), 1.36 (1H, m, H-2), lAO (!H, 
m, H-l'), 1.41 (lH, m, H-5), lA8 (lH, m, H-3'), 1.57 (lH, m, H-Il), 1.65 (!H, m, H-6), 1.74 (IH, 
m, H-1 2'), 1.98 (IH, d, J911 = 9.9Hz, H-9), 2.03 (1H, m, H-6'), 2.26 (!H, m, H-7), 2.39 (1H, ddd, J 
= 2.1 Hz, 7.0Hz, 13.IHz, H-7'), 3.74 (IH, m, H-13). llC NMR (100 MHz, CDCI3): 6 -4.3 (C-18, C-
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19), 14.7(C-17), 18.1 (C-20), 18.7(C-2), 19.1 (C-11),21.7(C-1 6),24.1 (C-6), 24.2(C-14),25.9 (C-
21 , C-22, C-23), 33.5 (C-15), 33.7 (C-4), 39.3 (C-12), 39.5 (C-l), 42.0 (C-3), 42.7 (C-7), 42.8 (C-
10),54.3 (C-5), 64.5 (C-9), 69.2 (C-13), 212.4 (C-8). 
Compound 71: 
o 
Colourless oil. [a]025= -320 (CHCI); c 0.33). IR vmax cm-'(NaCI): 2952, 2929, 2856,1714,1461, 
1386, 1367, 1254, 1184, 1140, 1097, 1055, 1006, 834,773 . EIMS (70 eV) mlz (rel.int.): 381 [M+ It 
(1), 365 (1),323 (29),305 (2), 281 (15),249 (3), 231 (100),215 (3),199 (13),189 (18), 175 (30), 
161 (25), 149 (50),133 (12), 119 (17),107 (17) , 95 (25), 76 (32), 55 (4). HRFABMS: [M+lt 
381.3188. C2)H45Si02 requires 381.3189. 'HNMR (400 MHz, CDCI) : 0 0.04 (6H, s, Me2-Si), 0.69 
(3H, s, Me-1 7), 0.82 (3H, s, Me-16), 0.86 (9H, s, t-butyl-Si), 0.94 (3H, s, Me-15), 1.09 (3H, d, J= 
6.0Hz, Me-14), 1.15 (IH, m, H-12), 1.21 (1H, m, H-3), 1.47 (IH, m, H-2), 1.55 (1H, m, H-l'), 1.49 
(IH, m, H-5), 1.41 (lH, m, H-3'), 1.07 (1H, m, H-Il), 1.69 (1H, m, H-ll') , 1.62 (1H, dd, J=4.9Hz, 
13. 1Hz, H-6), 1.75 (lH, m, H-12'), 2.04 (IH, m, H-9), 2.03 (lH, m, H-6'), 2.28 (1H, m, H-7), 2.38 
(lH, ddd,J= 2.0Hz, 6.9Hz, 13.1Hz, H-7'), 3.77 (1H,m, H-13). 13CNMR(IOO MHz, CDCI): 0 -4.6 
(C-18, C-19), 14.6 (C-17), 18.1 (C-20), 17.0 (C-2), 19.0 (C-l1), 21.7 (C-16), 24.1 (C-6), 24.2 (C-
14),25.9 (C-21, C-22, C-23), 33.5 (C-15), 33.7 (C-4), 39.1 (C-12), 39.3 (C-I), 42.0 (C-3), 42.7 (C-
7),42.8 (C-IO), 54.4 (C-S), 64.5 (C-9), 68.7 (C-13), 212.0 (C-8). 
4.2.8 Ruthenium Trichloride Oxidation of 67. 
To a solution of 67 (25mg) dissolved in CCI4 (0.50mL), H5I06 (18mg) and a catalytic amount of 
RuCI).3HP, dissolved in acetonitrile (0.50mL) and H20 (0.75mL), was added and allowed to stir 
for 4 hours. TLC indicated the formation of a less polar product. The mixture was extracted with 
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CH1CI1 (3x5mL), the CH2CI2 fractions combined and washed with Hp (lOmL) and saturated brine 
(lOmL), dried over MgSO" filtered and reduced under vacuum, An EtOAc solution of the crude 
product was passed through a silica gel plug to remove any remaining ruthenium residues, The 
ruthenium trichloride oxidation product (2Img) was an inseparable mixture of compowlds, 
4.2.9 Preparation of the Unsaturated Ketone (72). 
4-DMAP (230mg) was added to the stirred solution of 55 (500mg) in dry, redistilled pyridine (4mL) 
at RT (25°C), POCI, (342f!L) was added dropwise to the cooled pyridine solution (O°C) and the 
solution stirred for 3 hours, TLC indicated a single spot less polar than 55, The reaction was 
quenched with the addition of ice, Glacial acetic acid (3mL) was added to the mixture and stirred 
for 30 minutes to remove excess pyridine. The mixture was extracted with EtOAc (50mL), and the 
EtOAc fraction washed with HP (30mL), saturated NaHCO, (2x50mL), Hp (SOmL) and saturated 
brine (SOmL), dried over MgSO, and reduced under vacuum, Excess pyridine was removed under 
high vacuum, Further purification was achieved by gradient elution column chromatography, with 
elution of 72 occurring in hexane:EtOAc (80:20), The reaction yielded 72 (344mg) as a yellow oiL 
Compound 72: 
o 
Yellow oiL [0:]D25= +24° (CHCI,; c 0.32). lR vm",cm"(NaCI): 2939, 2845,1717, 1644, 1460, 1442, 
1410,1387, 1363, 1160,889, ElMS (70 eV) mlz (reLint.): 262 [Mt(lO), 244 (38), 215 (2), 204 
(31), 189 (33), 173 (49), 159 (79),147 (22),133 (24), 121 (26), 107 (28), 96 (52), 82 (39), 67 (19), 
56 (5), HRFABMS: [Mr 262,2296. C18H,aO requires 262,2297, 'H NMR (400 MHz, CDCI3): 0 
0,66 (3H, s, Me-I8), 0,77 (3H, s, Me-I7), 0,84 (3H, s, Me-16), 2.07 (3H, s, Me-14), 4.41 (lH, s, H-
15), 4,83 (lH, s, H-lS'), "C NMR (l 00 MHz, CDCI,): 0 14.3 (C-18), 17,5 (C-ll), 19,3 (C-2), 21.7 
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(C-17), 24.4 (C-6), 29.9 (C-14), 33.6 (C-4), 33 .6 (C-16), 38 .2 (C-7), 39.7 (C-IO), 42.1 (C-3),42.8 
(C-12), 55.5 (C-9), 56.3 (C-5), 10603 (C-15), 148.3 (C-8), 209.2 (C-I3). 
4.2.10 Ruthenium Trichloride Oxidation of 72. 
To a solution of 72 (90mg) dissolved in CCI, (5mL), Hsl06 (387mg) and a catalytic amount of 
RuCIl o3H20 dissolved in acetonitrile (5mL) and H,o (10mL) was added and allowed to stir for 16 
hours. TLC indicated the formation of two products. H,o (I OmL) was added and the mixture was 
extracted with CH2CI2(3x20mL). The CH2Ci2solution was dried over MgSO" filtered and reduced 
under vacuum. The black crude product was purified by gradient elution flash column 
chromatography, with elution in hexane:EtOAc (80:20) yielding a mixture of the lactone ether 
isomers 74, 75 (59mg) and the dihydroxylated product 73 (32mg). 74 and 75 were separated via 
normal phase HPLC (hexane:EtOAc/95:5) as white crystalline products. 
Compound 74: 
White needles. Mpt = 122-124°C. [alo2S = +43° (CHCIl ; c 0030). lR vmax cm·1(NaCI): 2948, 2924, 
2867, 2846, 1791, 1462, 1448, 1391, 1286, 1176, 1100, 1083, 1060, 972, 892. ElMS (70 e V) mlz 
(rel.int.): 277 (2), 259 (12), 248 (51),233 (60),215 (100), 199 (10), 190 (16), 175 (36), 159 (34), 149 
(32),125 (26), 105 (25), 95 (27), 79 (22), 67 (18), 55 (8). HRFABMS: [M+ 1 r 293.2115. C18H2Pl 
requires 293.2117. lH NMR (400 MHz, CDCIl ): 0 0.84 (3H, s, Me-17), 0.87 (JH, m, H-l), 0.89 
(3H, s, Me-16), 0.91 (3H, s, Me-18), 0.93 (1H, m, H-5), 1.15 (1H, m, H-3), 1.39 (1H, m, H-9), 1.42 
(1H, m, H-3') , 1.43 (1H, m, H-2), 1.50 (IH, m, H-7), 1.51 (3H, s, Me-14), 1.53 (IH, m, H-11), 1.62 
(1H, m, H-I ') , 1.71 (1H, m, H-6), 1.80 (lH, m, H-l1 '), 1.94 (1H, m, H-12), 2.07 (1H, dt, J = 3.IHz, 
13.1Hz, H-T). J3CNMR (1 00 MHz, CDCI l ): 0 13.4 (C-18), 17.9 (C-11),18.3 (C-2), 19.1 (C-6),21.8 
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(C-17), 23.8 (C-14), 32.5 (C-7), 32.7 (C-12), 33.1 (C-4), 33.7 (C-16), 37.5 (C-l 0), 39.3 (C-l), 4 J.8 
(C-3), 51.9 (C-9), 55.0 (C-5), 81.1 (C-8), 108.0 (C-13), 175.3 (C-15). 
Compound 75. 
White needles. Mpt = 120-122°C. [a]D25 = +41 ° (CHCI3; c 0.38). IR vrn"cm-l(NaCl): 2950, 2926, 
2864, 2845, 1791,1460,1390, 1286,1174,1097, 1085,1058, 1048, 973 , 894, 884. ElMS (70 eV) 
m/z (rel.int.) : 278 (5), 259 (8), 248 (32),233 (39),215 (54), 190 (12), 175 (22) , 159 (24), 149 (100), 
133 (15), 121 (20), 105 (22), 91 (23), 81 (25),67 (19), 55 (10). HRFABMS: [M+lt 293.2116. 
C1,H290 3 requires 293.2117. IH NMR (400 MHz, CDCI3): 0 0.S5 (3H, s, Me-17), 0.87 (lH, m, H-l), 
0.90 (3H, s, Me-16), 0.92 (3H, s, Me-I 8), 0.97 (IH, m, H-5), 1.15 (lH, m, H-3), 1.41 (lH, m, H-ll), 
1.42 (lH, m, H-9), 1.43 (lH, m, H-3'), 1.54 (lH, m, H-12), 1.59 (3H, s, Me-14), 1.59 (lH, m, H-2), 
1.62 (lH, m, H-l'), 1.70 (lH, m, H-6), 1.74 (lH, m, H-11'), 1.77 (lH, m, H-7), 1.59 (lH, m, H-2'), 
1.94 (lH, m, H-12') , 2.09 (IH, dt, J= 3.1 Hz, 13.IHz, H-7'). \3C NMR (100 MHz, CDCI3): 0 13.4 
(C-lS), 17.9 (C-II), 18.3 (C-2), 19.1 (C-6), 21.8 (C- 17), 24.3 (C-14), 32.5 (C-7), 32.7 (C-12), 33.1 
(C-4), 33.7 (C-16), 37.5 (C-IO), 39.2 (C-I), 41.8 (C-3), 51.9 (C-9), 55.0 (C-5), 81.3 (C-8) , 108.0 (C-
13),175.4 (C-15). 
4.2.11 Preparation of Cetyl Trimethyl Ammonium Permanganate (CTAP). 
A solution of cetyl trimethyl ammonium bromide (8.04g) in H20 (lOOmL) was added dropwise to 
a stirred solution ofKMn04 (3 .17g) in H20 (l OOmL) over a period of20 minutes at RT (20°C). The 
mixture was allowed to stir for I hour. A light purple precipitate formed, which was collected via 
vacuum filtration. The product was repeatedly washed with H20 until the washes were uncoloured. 
The product was dried over phosphorous pentoxide to yield CT AP (8.20g) as a purple solid. 
Experimental 87 
4.2.12 CT AP Dihydroxylation of 67. 
To a stirred solution of67 (50mg) in I-butanol (ImL), a solution ofCTAP (54mg) in I·butanol (5mL) 
and H20 (1.5mL) was added dropwise at RT (20°C) and the mixture stirred for 19 hours. CHCll 
(25mL) and 5% aq. NaOH (5mL) was added to the mixture which was stirred for a further 30 
minutes. The mixture was extracted with CHCll (3x25mL). The combined CHCIl fractions were 
washed with H20 (50mL) and saturated brine (50mL), dried over MgS04, filtered and reduced under 
vacuum. Separation was achieved by gradient elution column chromatography, with elution in 
hexane:EtOAc (80 :20) to yield 76 (19mg, 22%) as a colourless oil. 
Compound 76: 
-', Ii: 
OH 
OH 
[a]D25 = _7° (CHCll; c 0.30). IR vmox cm'l(NaCl): 3509 (br), 2926, 2855, 1715, 1461, 1385, 1370, 
1254, 1136,1046,836,773. ElMS (70 eV) mlz(rel.int.): 381 (2),337 (6), 293 (2) , 279 (6),249 (22), 
231 (11),203 (6) , 189 (18), 177 (5),167 (29),149 (l00), 135 (12),121 (15), 107 (16), 95 (22), 81 
(18),55 (7) . HRFABMS: [M+lr 413.3451. C24H49SiOl requires 413 .3451. IH NMR (400 MHz, 
CDCl,): 0 0.04 (6H, s, Me2-Si), 0.76 (3H, s, Me-17), 0.77 (3H, s, Me-18), 0.84 (3H, s, Me-16), 0.85 
(9H, s, t-butyl-Si), 1.20 (3H, d, J = 6.0Hz, Me-14 ), 2.28 (1H, dt, J = 3.2Hz, 12.2Hz, H-7) , 3.50 (H, 
d, J = 7.0Hz, H-15), 3.59 (H, d, J = 7.0Hz, H-15'), 3.81 (IH, m, H-13). IlC NMR (100 MHz, 
CDCI3): 0 -4.3 (C-19), -4.6 (C-20), 16.4 (C-18), 18.4 (C-21), 18.4 (C-2), 21.0 (C-ll), 21.5 (C-6), 
21.7 (C-17), 23 .9 (C-14), 25.7 (C-22, C-23, C-24), 32.2 (C-4), 33.6 (C-16), 39.0 (C-IO), 39 .9 (C-l), 
41.0 (C-12), 43.4 (C-3), 43 .7 (C-7), 56.5 (C-5), 62.3 (C-9), 67.7 (C-15), 69.2 (C-13), 76.1 (C-8). 
Experimental 88 
4.2.13 Epoxidation of Compound 72. 
Compound 72 (83mg) was dissolved in anhydrous CH2Cl2 (SmL) and cooled (-10°C) under N2. 
mCPBA (273mg) dissolved in anhydrous CH2Cl2 (2mL), was initially dried over MgS04• The dry 
mCPBA solution was transferred via a cannula to the reaction vessel. The solution was stirred 
vigorously for 1 hour then allowed to warm to O°C. TLC indicated the formation of a mixture of 
products. Saturated NaHCOl (lSmL) was added and the solution was stirred for a further 30 
minutes. The solution was extracted with CHCll (2x40mL). The combined CHCll fractions were 
washed with aqueous Nli:2S20J (20%, 30mL), HP (30mL) and saturated brine (30mL), dried over 
MgS04, filtered and reduced under vacuum to give an inseparable mixture of epoxide products 79 
and 80 (81mg) as a colourless oil. 
4.2.14 Periodic Acid Oxidation of the Epoxide Mixture 68. 
Periodic acid (H,I06, 2S0mg) was dissolved in diethyl ether (SmL) and cooled (O°C). Compound 
68 (81mg), dissolved in diethyl ether (lmL), was added to the H,I06 solution and stirred for 6.5 
hours. The mixture was allowed to warm to RT (21 °C) and stirred overnight. The reaction was 
quenched with saturated NaHCOl (10mL) and extracted with diethyl ether (3x30mL). Thecombined 
diethyl ether fractions were washed with saturated NaHCOl (30mL), H20 (30mL) and saturated 
brine (30mL), dried over MgS04, filtered and reduced under vacuum to yield a mixture of products 
(79mg). Separation was achieved via normal phase HPLC (hexane:EtOAc/90: 1 0) to give the acetal 
83 (lO.3mg, 13%) as a crystalline product. 
Compound 83. 
\ H 
White needles. Mpt = 117-119°C. [0:]D2'= _2° (CHCll; c 0.35). IR vmox cm-'(NaCl): 3430, 2925, 
Experimental 89 
2868, 2844, 1634, 1451,1386, 1261,1207,1 111,1037, 1027, 1005,952,916,862. EIMS (70 eV) 
mlz (relint.): 279 [M+!r (10),261 (1),229 (I), 206 (4), 177 (I), 167 (30), 149 (100), 121 (3),91 
(2), 71 (2), 55(2). HRFABMS: [Mr 278.2246. C!8H3002 requires 278.2246. IH NMR (400 MHz, 
CDCI3): 00.82 (lH, m, H-I), 0.86 (3H, s, Me-17), 0.87 (3H, s, Me-16), 0.90 (lH, m, H-9), 1.02 
(lH, d, J=6.2Hz, H-5), 1.08 (3H, s,Me-18), 1.15 (lH, dd, J=4.0Hz, 133Hz, H-3), 139 (lH, m, 
H-3'), 1.41 (3H, s, Me-14), 1.54 (lH, m, H-6), 1.55 (lH, m, H-2), 1.68-1.73 (lH, m, H-Il), 1.82 
(JH, m, H-ll'), 1.83 (lH, m, H-I'), 1.85 (lH, m, H-7), 341 (lH, d, J= 6.8Hz, H-15), 3.75 (lH, d, 
J = 6. 8Hz, H-15'). l3C NMR (I 00 MHz, CDCI3) 0 16.5 (C-18), 16.9 (C-Il), 185 (C-2), 193 (C-6), 
21. 9 (C-17), 25.0 (C-14), 33.2 (C-4), 33.7 (C-12), 33.9 (C-16), 353 (C-7), 38.6 (C-I 0), 40.1 (C-I), 
42.0 (C-3), 50.4 (C-5), 54.9 (C-9), 76.2 (C-15), 81.8 (C-8), 108.5 (C-13) 
4.2.15 Epoxidation of Compound 68. 
Compound 68 (85mg) was dissolved in anhydrous CH2CI2 (ImL) and cooled (-10°C) under N2. 
mCPBA (17 5mg) dissolved in anhydrous CH2CI2 (I mL), was dried over MgSO 4 and the dry mCPBA 
solution was transferred via a cannula to the reaction vessel containing the solution of 68. The 
mixture was stirred vigorously for 2 hours before warming to O°C. TLC indicated the formation of 
a mixture of products. Saturated NaHC03 (15mL) was added and the mixture allowed to stir for 
a further 30 minutes. The mixture was extracted with CH2CI2 (3x30mL), and the combined CH2Cl2 
fractions was washed with aqueous Na2S20 3(20%, 30mL), H,0 (30mL) and saturated brine (30mL), 
dried over MgS04, filtered and reduced under vacuum to give an inseparable mixture of epoxide 
products 81 and 82 (78mg) as a colourless oil 
4.2.16 Preparation of Compounds 86 and 87. 
This procedure is representative for the methyl lithium methylation of the TDBMS protected ketones 
70 and 71. A solution of70 (460mg) in anhydrous THF (5mL) was cooled (_78°C) underN2. A 
standard I. 6M diethyl ether solution ofMeLi (4. 96mmol, 3. I mL) was added dropwise to the stirred 
solution. The mixture was warmed to RT (25°C) and allowed to stir overnight. TLC indicated 
conversion of 70 into a more polar product. The reaction was quenched by addition of an ice cold 
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NaHCO l slurry. The mixture was extracted with diethyl ether (3x30mL) and the combined ether 
fractions washed with H,O (2x30mL) and saturated brine (50mL), dried over MgSO. and reduced 
under vacuum. Purification was achieved by gradient elution column chromatography, with elution 
in hexane:EtOAc (90: 1 0) to yield 86 (352mg, 73%). 
Compound 86: 
Colourless oil. [CX]D25 = +15 0 (CHCIl ; c 0.30). IR vmax cm'\NaCI): 3420, 2954, 2927, 2858, 1636, 
1471,1463,1388, 1371,1255,1182,1137, 1091,1047,1003, 902, 835, 773. ElMS (70 eV) mlz 
(rel.int.): 397 [M+ 1 r (1),379 (2), 339 (9) , 321 (4), 293 (1), 264 (4),247 (50), 23 1 (17),221 (3),205 
(9),191 (83), 177 (38), 163 (48), 149 (71),135 (35), 121 (41), 109 (45), 96 (100), 82 (81), 67 (41), 
55 (17). HRF ABMS: [Mr 396.3424. C'4H.sSiO, requires 396.3423. IHNMR (400 MHz, CDCI l ): 
00.04 (6H, s, Me,-Si), 0.74 (1H, m, H-9), 0.81 (3H, s, Me-17), 0.82 (1H, m, H-5), 0.85 (1H, m, H-
1), 0.85 (3H, s, Me-16), 0.87 (9H, s, t-butyl-Si), 0.93 (3H, s, Me-18), 1.11 (3H, s, Me-IS), 1.12 (3H, 
s, Me-14), 1.13 (1H, m, H-12), 1.28 (1H, m, H-II), 1.36 (lH, m, H-12'), 1.40 (IH, m, H-2), 1.41 
(IH, m, H-7), 1.43 (lH, m, H-ll'), 1.44-1.45 (2H, m, H-3, H-3'), 1.48 (lH, s, H-6), 1.57 (IH, dt,J 
= 3.3Hz, 13.6Hz, H-6'), 1.69 (lH, m, H-I'), 1.73 (lH, m, H-7'), 3.73 (lH, m, H-13). llC NMR (100 
MHz, CDCIl ): 0 -4.5 (C-19), -4.7 (C-20), 15.0 (C-18), 18.1 (C-6), 18.2 (C-21), 18.3 (C-2), 21.3 (C-
11),21.7 (C-17), 23.6 (C-14), 25.9 (C-22, C-23, C-24), 30.5 (C-15), 33.2 (C-4), 33.4 (C-16), 39.0 
(C-IO), 39.1 (C-I), 42.1 (C-12), 42.1 (C-7), 43.8 (C-3), 55.9 (C-5) , 59.1 (C-9), 69.1 (C-13), 73.2 (C-
8). 
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Compound 87: 
Colourless oil. [CXjD25 = + II D (CHCI3; c 0.24). IR vm• x cm·l(NaCl): 3427, 2955,2928,2858, 1640, 
1458, 1388, 1373, 1253, 1136, 1098, 1043, 1004, 838, 772. ElMS (70 eV) mlz (rel.int.): 381 [M+ 1-
CH3r (2), 363 (I), 339 (18), 321 (5),303 (1), 279 (3), 264 (8), 247 (54),231 (20), 221 (6),204 (12), 
191 (100), 177 (52), 163 (60), 149 (90), 135 (42), 121 (48), 109 (53), 95 (80) , 82 (96), 67 (47), 55 
(19). HRFABMS :[Mr 396.3425. C24H,sSi02 requires 396.3424. lH NMR (400 MHz, CDCI,): 0 
0.04 (6H, s, Me2-Si), 0.74 (lH, m, H-9), 0.81 (3H, s, Me-17), 0.82 (lH, m, H-5), 0.84 (IH, m, H-I), 
0.85 (3H, s, Me-16), 0.87 (9H, s, t-butyl-Si), 0.93 (3H, s, Me-18), 1.08 (lB, m, H-12), 1.11 (3H, s, 
Me-I 5), 1.11 (3H, d, J= 6.0Hz, Me-14), 1.22 (IH, m, H-Jl), 1.35 (I H, m, H-12'), 1.35 (lB, s, H-6), 
1.42 (IH, m, H-3), 1.43 (IH, m, H-I1'), 1.48 (IH, m, H-7), 1.49 (IH, m, H-2), 1.52 (lH, m, H-3'), 
1.57 (lB, m, 13.6Hz, H-6'), 1.67 (lB, m, H-I'), 1.73 (IH, m, H-T) , 3.74 (lH, m, H-13). 13C NMR 
(100 MHz, CDCI3): 0 -4.5 (C-19), -4.7 (C-20), 15.1 (C-18), 18.1 (C-6), 18.1 (C-21), 18.3 (C-2) , 2 J.] 
(C-II ), 21.7 (C-17), 23.5 (C-14), 25.9 (C-22, C-23, C-24), 30.5 (C-15), 33.2 (C-4), 33.4 (C-16), 38.9 
(C-I 0),39.2 (C-I) , 42.1 (C-12), 42.1 (C-7), 43.7 (C-3) , 55 .9 (C-5), 59.1 (C-9), 69.0 (C-13), 73.2 (C-
8). 
4.2.17 Deprotection of the Protected Diols 73 and 74. 
This reaction is representative for the deprotection of both 73 and 74. To a solution of73 (230mg) 
in THF (5mL), 1M TBAF (3 .5mL) was added and the solution refluxed for 4 hours. The solution 
was allowed to cool to RT (20DC) and stirred overnight. TLC indicated that a more polar product 
had formed. Saturated NH,CI (20mL) was added to the solution and the solution stirred for a further 
30 minutes. The solution was extracted with EtOAc (3x30mL), the combined EtOAc fractions were 
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washed with H20 (30mL) and saturated brine (50mL), dried over MgSO. and reduced under vacuum 
to yield the white crystalline product 88 (140mg, 85%). Final purification was achieved by gradient 
elution column chromatography, with elution in EtOAc:hexane (60:40). Compound 88 was 
recrystallized from hexane. 
Compound 88: 
White powder. Mpt = 95°C-97°C. [alD25 = +8° (CHCI3; c 0.30). IR vrn"cm-'(NaCI): 3430, 2925, 
1642,1463, 1389, 1187, 1130, 1080, 1033, 983 , 909. EIMS (70 eV) m/z (rel.int.): 264 [M-Hpr 
(8), 249 (20), 231 (30),221 (20), 206 (10),195 (12),177 (100),167 (18),149 (80), 13S (21),123 
(45),109 (53),96 (96), 81 (49), 67 (53), 55 (19). HRFABMS: [Mr 282.2559. C18H'402 requires 
282.2559. 'H:NMR (400 MHz, CDCI3): 60.78 (tH, m, H-9), 0.81 (3H, s, Me-17), 0.83 (lH, m, H-
S), 0.85 (3H, s, Me-16), 0.86 (tH, m, H-1), 0.95 (3H, s, Me-18), 1.12 (3H, s, Me-IS), 1.15 (lH, m, 
H-12), 1.19 (3H, d, J = 65Hz, Me-14), 138 (IH, m, H-12'), 138 (tH, m, H-ll), 1.43 (lH, m, H-
3), 1.44 (IH, m, H-6), 1.46 (tH, m, H-7), 1.49 (lH, m, H-3'), 1.50 (1H, m, H-I1'), 1.52 (tH, m, H-
2), 1.59 (lH, m, H-6'), 1.69 (lH, m, H-I'), 1.73 (tH, m, H-7'), 3.75 (tH, m, H-13). l3C NMR (100 
MHz, CDCI3) : 6 15.1 (C-18), 18.3 (C-2), 213 (C-ll), 21.7 (C-17), 23:4 (C-14), 30.6 (C-1S), 33 .2 
(C-4), 33:4 (C-16), 39.0 (C-IO), 39.2 (C-I), 42.0 (C-12), 42.2 (C-7), 43.3 (C-3), 55.9 (C-5), 59.1 
(C-9), 68.6 (C-13), 73.2 (C-8) 
Compound 89: 
OH 
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White powder. Mpt = 98°C- I 01 0c. [alo25 = + 18° (CHCI3; c 0.26). IR V rn", cm-l(NaCl): 3420, 
2915,1638,1460, 1387, 1371, 1217, 1187, 1l31, 1075, 1030, 1022,988. EIMS (70 eV) m/z 
(reLin!.): 264 [M+Hpr (8), 249 (22), 231 (25), 221 (J 5), 206 (J 0), 191 (12), 177 (100), 167 (15), 
149 (60), 135 (18),123 (40), 109 (50),95 (59), 82 (73),67 (51), 55 (17). HRFABMS [MJ+ 
282.2558. C,sH340, requires 282.2559 . 'H NMR (400 MHz, CDCI3): 00.77 (IH, m, H-9), 0.81 
(3H, s, Me-17), 0.82 (lH, m, H-5), 0.85 (3H, s, Me-16), 0.87 (IH, m, H-I), 0.94 (3H, s, Me-18), 
1.12 ( IH, m, H-12), 118 (3H, d, J = 6.2Hz, Me-14), 1.21 (3H, s, Me-IS), 1.25 (lH, m, H-ll), IJ7 
(lH, m, H-12'), 1.39 (lH, m, H-6), 1.44 (lH, m, H-3), 145 (lH, m, H-7), 1.50 (lH, m, H-2), 1.51 
(lH, m, H-3'), 1.54 (lH, m, H-II'), 1.59 (lH, m, H-6'), 1.67 (lH, m, H-I'), 1.74 (lH, m, H-T), 3.76 
(lH, m, H-13) 13C NMR (l00 MHz, CDCI3) : 0 15.1 (C-18), 18.3 (C-2), 21.2 (C-lI), 21.6 (C-17), 
234 (C-14), 30.6 (C-15), 33.3 (C-4), 334 (C-16), 38 .9 (C-IO), 39.2 (C-I), 42.0 (C-12), 42.0 (C-7), 
43.1 (C-3), 55.9 (C-5), 59.0 (C-9), 68 .5 (C-l3), 73.2 (C-8). 
4.2.18 Oxidation of the Diols 88 and 89. 
This procedure is representative for the oxidation of both diols 88 and 89. Oxalyl chloride (70IlL) was 
added to anhydrous CH,Cl, (3mL) and cooled (_78°C) under N,. DMSO (106IlL) was added and 
the solution allowed to stir for 10 minutes. Compound 75 (140mg), dissolved in anhydrous CH,Cl, 
(3 mL), was transferred via a cannula to the reaction vessel containing the oxalyl chloride solution and 
stirred for I hour. Triethylamine ( 41 SilL) was added dropwise to the mixture and was stirred for I 
hour. The mixture was allowed to warm to O°C and stirred for a further 2 hours. TLC with 2,4-DNP 
development indicated that the reaction was completed. Saturated NH,Cl (5mL) was added to the 
oxidation reaction and the solution stirred for 30 minutes. The solution was extracted with EtOAc 
(3x3 OmL), and the combined EtOAc fractions washed with H,O (3 OmL) and saturated brine (3 OmL), 
dried over MgSO" filtered and reduced under vacuum to yield the crude product 90 (139mg). No 
separation was attempted because of the compounds sensitivity to acidic media. 
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Compound 90: 
° 
IR v"""cm·1(NaCI): 3417, 2918,1712,1463 ,1388,1371,1190,1130,1078,1025, 987, 915, 862, 
734. 
4.2.19 Preparation of the a,p-Unsaturated Esters 91 and 92. 
60% NaH (36mg) was washed with anhydrous THF (2xlmL) and resuspended in ImL of the same 
solvent. Triethylphosphonoacetate (492~L) was added dropwise to the reaction vessel and the 
solution was stirred for 30 minutes. Compound 90 (13 8mg), dissolved in anhydrous THF (2mL), was 
transferred via a cannula to the reaction vessel under N2. The mixture was allowed to stir overnight 
at RT (22°C) after which 5% aqueous NH,CI (IOmL) was added and the mixture stirred for a further 
30 minutes. The mixture was extracted with EtOAc (3x30mL), the EtOAc fractions washed with 
Hp (30mL) and saturated brine (50mL), dried over MgSO" filtered and reduced under vacuum. 
Purification was achieved by gradient elution column chromatography, with elution in hexane:EtOAc 
(85: IS) to give a mixture ofE and Z isomers (60mg). Compounds 91 (12mg) and 92(47mg) were 
finally separated using normal phase HPLC (hexane:EtOAc/90 : I 0) 
Compound 91: 
° 
0'-../"22 
21 
Experimental 95 
Colourless oil. [a]D25 = +340 (CHCI3; c 0.30). IR Vm" cm-l(NaCl): 3450, 2920, 2934, 1712, 1638, 
1467, 1387, 1219, 1142, 1070, 1032, 910. EIMS (70 eV) mlz (reLint.) : 350 [Mf (7), 333 (8), 317 
(10),304 (55), 289 (10), 280 (89), 258 (19), 243 (40),229 (18), 218 (12), 205 (22),192 (30),1 77 
(SO), 163 (30), 149 (100), 135 (32), 123 (49), 110 (86), 95 (57), 81 (46), 67 (54), 55 (18). 
HRFABMS: [M)' 350.2820. C22H3.03 requires 350.2821. IHNMR (400 MHz, CDCI3): 0077 (IH, 
m, H-9), 0.80 (3E, s, Me-IS), 0.S2 (IH, m, H-5), 0.87 (IH, m, H-I), 0.85 (3H, s, Me-19), 0.93 (3H, 
S, Me-20), 1.12 (3H, s, Me-17), 1.14 (IH, m, H-12), 1.24 (3H, m, Me-16), 1.38 (IH, m, H-12'), 1.38 
(IH, m, H-ll), 1.40 (IE, m, H-2), 1.44 (IH, m, H-7), 1.48 (IE, m, H-6), 1.55 (IH, m, H-II'), 1.57 
(lH, m, H-2'), 1.65 (lH, m, H-I'), 1.72 (IH, m, H-7'), 2.12 (IH, m, H-3), 2.15 (3H, S, Me-22), 4.11 
(2H, m, H,-21), 5.65 (IH, s, H-14). !3CNMR (100 MHz, CDCI3) 014.3 (C-16), 15.1 (C-20), 18.1 
(C-6), IS.2 (C-2), 19.0 (C-22), 21.6 (C-18), 23.6 (C-11), 30.6 (C-17), 33.2 (C-4), 33.4 (C-19), 39.0 
(C-I0), 39.2 (C-l), 41.7 (C-12), 42.2 (C-7), 44.6 (C-3), 55.9 (C-5), 5S.8 (C-9), 59.4 (C-21), 73.1 
(C-S), 115.3 (C-14), 160.2 (C-13), 166.9 (C-15). 
Compound 92: 
° o'-./" 
Colourless oil. [a]D25 = +420 (CHCI3; c 0.24). IR Vrnax cm-1(NaCI):3445, 2923, 2939, 2866, 2S43, 
1717,1700,1647,1461,1444,1388, 1369,1291,1223,1147, 1075, 1037,914,866. EIMS (70 eV) 
mlz (reLint.) : 350 [Mf (5), 333 (7), 317 (8), 304 (21),289 (10), 280 (100), 259 (12), 243 (20),229 
(11), 218 (10), 205 (20), 192 (25), 177 (53),163 (20), 149 (70), 135 (30), 121 (45), 110 (58), 95 
(42), 81 (28), 68 (40), 55 (13). HRFABMS: [Mf 350.2821. C22H3S03 requires 350.2821. IHNMR 
(400 MHz, CDCI3): 00.83 (IH, m, H-9), 0.82 (3H, s, Me-I 8), 0.90 (IH, m, H-5), 0.96 (IH, m, H-
1),0.86 (3H, S, Me-19), 0.94 (3H, s, Me-20), l.ll (IH, m, H-3), 1.23 (3H, s, Me-17), 2.56 (IH, 
ddd, J = 5.4Hz, 12.2Hz, H-12), 1.23 (3H, m, Me-16), 2.74 (IH, ddd, J = 5.2Hz, 12. 1Hz, H-12'), 
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1.16 (IH, m, H-ll), 1.39 (lH, m, H-2), 1.49 (IH, m, H-7), 1.49 (IH, m, H-6), 1.43 (IH, m, H-ll'), 
1.56 (IH, m, H-2'), 1.79 (lH, m, H-1'), 1.74 (JH, m, H-7'), 1.38 (IH, m, H-3'), 1.90 (3H, s, Me-22), 
4.13 (2H, m, H2-21 ), 5.60 (JH, s, H-14). J3C NMR (100 MHz, CDCI3) (; 14.3 (C-16), 15.1 (C-20), 
18.2 (C-6), 18.3 (C-2), 19.0 (C-22), 21.7 (C-18), 23.8 (C-ll), 30.6 (C-17), 33.3 (C-4), 33.4 (C-19), 
39.1 (C-lO), 39.1 (C-1), 42.4 (C-12), 42. 0 (C-7), 44.6 (C-3), 55.9 (C-5), 59.3 (C-9), 59.4 (C-21), 
73.3 (C-8), 115.9 (C-14), 159.9 (C-13), 166.2 (C-15). 
4.2.20 Preparation of the o:,p-Unsaturated Esters 93 and 94. 
60% NaH (79mg) was washed with anhydrous THF (3x1mL) and resuspended in 1mL of the same 
solvent. TEPA (396IlL) was added dropwise to the reaction vessel and the solution was stirred for 
30 minutes. Compound 47 (JOOmg), dissolved in anhydrous THF (lmL), was transferred via a 
cannula to the reaction vessel under N2. The mixture was allowed to stir overnight at RT (26°C), 
after which 5% aqueous NH4Cl (5mL) was added and the mixture stirred for a further 30 minutes. 
The mixture was extracted with diethyl ether (3x30mL), the EtOAc fractions washed with Hp 
(30mL) and saturated brine (50mL), dried over MgSO., filtered and reduced under vacuum. 
Purification was achieved by gradient elution flash column chromatography, with elution in 
hexane:EtOAc (80:20) to give a mixture ofE and Z isomers (J18mg, 94%). Compounds 93 (34mg) 
and 94(74mg) were finally separated using normal phase HPLC (hexane:EtOAc/80:20). 
Compound 93 : 
0-..../ 
o 
"" OH 
Colourless oil. [0:]D25 = +42° (CHCl3; c 0.27). IR Vm" cm·l(NaCl): 3519,2935, 2869, 1698, 1645, 
1460, 1444, 1387, 1377, 1238, 1176, 1143, 1037,939, 858. EIMS (70 eV) mlz (rel.int.): 350 [Mr 
(22), 333 (21), 317 (40), 304 (100), 286 (20), 276 (83), 258 (26), 243 (70), 229 (22), 205 (38),192 
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(40), 177 (70),163 (32), 149 (55),135 (25), 121 (49), 110 (98), 95 (70), 82 (40), 67 (38), 55 (18). 
HRFABMS: [M-CH3r 335.2428. CZ,H3sO, requires 335.2430. 'H NMR (400 MHz, CDCI,): 00.78 
(3H, s, Me-20), 0.78 (3H, s, Me-18), 0.86 (3H, s, Me-19), 0.91 (IH, m, H-5), 0.94 (lB, m, H-I), 
104 (IH, t, J = 3.2Hz, H-9), 1.14 (3H, s, Me-17), 1.16 (IH, m, H-3), 124 (IH, m, H-6), 128 (3H, 
d, J = 7. 1Hz, Me-16), 1.37 (IH, m, H-11), 1.37 (IH, m, H-7), 1.41 (lB, m, H-2), 1.56 (IH, m, H-
11'), 1.56 (IH, m, H-2'), 1.63 (1H, m, H-6'), 1.64 (IH, m, H-I'), 1.85 (IH, dt, J = 33Hz, 12.2Hz, 
H-7'), 2.15 (3H, s, Me-22), 2.16 (IH, m, H-12), 2.28 (IH, m, H-12'), 4.14 (2H, q, Hz-21 ), 5.66 (IH, 
s, H-14). 13CNMR(100MHz,CDCI,) 014.3 (C-16), 15.4 (C-20), 18.4 (C-2), 19.1 (C-22), 20.6 
(C-6), 21.5 (C-18), 23 .6 (C-II), 24.0 (C-17), 33 .3 (C-4), 33.4 (C-19), 39.2 (C- IO), 39.8 (C-I), 42.0 
(C-3), 44.4 (C-12), 44.8 (C-7), 56.1 (C-5), 59.4 (C-21), 61.5 (C-9), 74.2 (C-8), 1152 (C-14), 160.9 
(C-13), 167.0 (C-15). 
Compound 94: 
o 0 '-.,/ 
"" OH 
Colourless oil. [('(.]025 =+11° (CHCI,;cO.31). IR vm",cm-'(NaCI): 3500, 2931 , 2868, 1715,1698, 
1644, 1463,1444,1387,1367,1350,1224, 1147, 1076, 1040, 972, 940, 911 , 861. EIMS (70 eV) 
m1z (relint) 350 [Mr (2), 332 (11),317 (40), 304 (10), 289 (10), 280 (35), 259 (20), 244 (32), 229 
(31), 205 (40),191 (60), 177 (100),161 (40), 149 (57), 135 (54), 122 (60), 107 (47),95 (6 1), 81 
(40), 67 (38), 55 (13) . HRFABMS: [M-CH,r 335.2429. C2,H350, requires 335.2430 . 'H NMR 
(400 MHz, CDCI,): 00.75 (3H, s, Me-20), 0.77 (3H, s, Me-18), 0.85 (3H, s, Me-19), 0.91 (1R, m, 
H-5), 0.96 (IH, m, H-I ), 1.11 (IH, m, H-9), 1.16 (3H, s, Me-1 7), 1.19 (IH, m, H-3), 1.34 (IH, m, 
H-3), 122 (lB, m, H-6), 123 (3H, d, J = 7. 1Hz, Me-16), 1.46 (IH, m, H-II), 1.44 (IH, m, H-7), 
1.41 (IH, m, H-2), 1.56 (IH, dt, J= 3.4Hz, 13 .6Hz, H-2'), 1.62 (IH, m, H-6'), 1.74 (lB, m, H-I'), 
184 (IH, dt, J = 3.2Hz, 12.5Hz, H-7'), 1.89 (3H, d, J= 1.3Hz, Me-22), 2.21 (IH, m, H-12), 2.93 
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(lH, m, H-12'), 4.12 (2H, q, H2-21 ),5.64 (JR, s, H-14). 13C NMR (J 00 MHz, CDCI»): 0 14.3 (C-
16),15.5 (C-20), 19.5 (C-2), 25.7 (C-22), 20.3 (C-6), 21.5 (C-18), 24.3 (C-11), 24.2 (C-17), 33.3 (C-
4) ,33.4 (C-19), 38.8 (C-1 0), 37.4 (C-1), 39.3 (C-3), 42.0 (C-12), 43.2 (C-7), 56.1 (C-5), 56.8 (C-21), 
61.5 (C-9), 73.9 (C-8), 115.6 (C-14), 161.7 (C-13), 166.6 (C-15). 
4.2.21 DIBALH Reduction of the Esters 93 and 94. 
This reaction is representative for the reduction of both esters 93 and 94. Compound 93 (220mg) was 
dissolved in anhydrous CR2CI2 (2mL) and cooled (O°C) under N2. DIBALH (J.88mL) was added 
dropwise and the solution stirred for 4 hours, after which saturated NH,CI (5mL) was added and 
stirred for a further 30 minutes. The mixture was extracted with EtOAc (3x30mL), the combined 
EtOAc fractions washed with H,o (30mL) and saturated brine (50mL), dried over MgSO" filtered 
and reduced under vacuum. Purification was achieved via normal phase column chromatography, 
with elution in hexane:EtOAc (50:50) to yield 97 (J84.7mg; 95%). 
Compound 97: 
OH 
Colourless oil. [cxl0 25 = +4° (CHCI); c 0.28). IR vmaxcm·1(NaCI): 3435,2930, 1630, 1455,1371, 
1150, 1097, 1040, 983. EIMS (70 e V) mlz (rel .in!.): 309 [M+ 1 r (2),293 (6),275 (11), 263 (9),245 
(l 00),231 (6),205 (3), 189 (7), 175 (7), 161 (6), 149 (J2), 135 (6), 121 (9), 107 (8), 95 (9), 82 (12), 
67 (6). HRFABMS: [M+ 1t 309.2795. C2oH370 2 requires 309.2794. lHNMR (400 MHz, CDCI»): 
00.73 (3H, s, Me-20), 0.75 (3H, s, Me-19), 0.81 (3H, s, Me-18), 0.83 (lH, m, H-l), 0.92 (JR, m, 
H-5), 1.1 0 (JH, m, H-3), 1.14 (JR, m, H-9), 1.21 (JR, m, H-6), 1.24 (3H, s, Me-17), 1.25 (l H, m, 
H-7), 1.26 (3H, s, Me-16), 1.34 (JR, m, H-3'), 1.40 (lH, m, H-2), 1.45-1.60 (2H, m, H2-11), 1.52 
(lR, m, H-14), 1.53 (JR, m, H-12), 1.58 (IH, m, H-l '), 1.60 (lH, m, H-6'), 1.61 (lH, m, H-2'), 1.62 
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(lH, m, H-12'), 1.66 (lH, m, H-14'), 1.72 (1H, m, H-7'), 3.75 (2H, ddd, J= 3.0Hz, 4.3Hz, 14.7Hz, 
H2-1 5). 13C NMR (100 MHz, CDCI,): I) 15.1 (C-II), 15.7 (C-20), 18.5 (C-2), 19.7 (C-6), 21.2 (C-
19),24.5 (C-17), 27.5 (C-16), 33.2 (C-18), 33.2 (C-4), 36.8 (C-IO), 36.9 (C-12), 39.0 (C-I), 42.0 (C-
3), 43.1 (C-7), 45.7 (C-14), 56.2 (C-5), 58.1 (C-9) , 59.6 (C-15), 75.8 (C-13), 75 .9 (C-8). 
Compound 98: 
Colourless oil. [a]025= +7° (CHCl,; c 0.19). lR vmaxcm-'(NaCl): 3437, 2932, 1648, 1633, 1383, 
1121,1028,980. ElMS (70 eV) m/z (rel.int.): 293 (6), 275 (12),263 (9), 245 (100), 231 (5),205 (3), 
189 (8),175 (9), 161 (7),149 (15),135 (6),121 (6),107 (7), 96 (13),81 (6),67 (6). HRFABMS: 
[M+lr 309.2793. C2oH370 2requires 309.2794. 'HNMR(400 MHz, CDCl,): I) 0.77 (3H, s,Me-20), 
0.77 (3H, s, Me-19) , 0.83 (3H, s, Me-18), 0.83 (1H, m, H-I), 1.40 (1H, m, H-5), 1.15 (1H, m, H-3), 
1.38 (IH, dd, J= 2.5Hz, 9.7Hz, H-9), 1.14 (1H, m, H-6), 1.27 (3H, s, Me-17), 1.30 (1H, m, H-7), 
1.20 (3H, s, Me-16), 1.33 (1H, m, H-3'), 1.36 (lH, m, H-2), 1.43 (1H, m, H-ll), 1.58 (1H, m, H-l1 '), 
1.42 (1H,m,H-14), 1.48 (1H, m,H-12), 1.57 (1H, m,H-l'), 1.61 (1H,m,H-6'), 1.56 (IH,m,H-2'), 
1.86 (1H, m, H-1 2'), 1.81-1.90 (lH, m, H-14'), 1.70 (lH, dt, J = 3.3Hz, 5.8Hz, H-7'), 3.69 (1H, m, 
H-15), 3.88 (1H, m, H-15'). 13C NMR (100 MHz, CDCl,): I) 14.8 (C-ll), 15.1 (C-20), 18.4 (C-2), 
19.9 (C-6), 21.3 (C-19), 25.2 (C-17), 28 .7 (C-16), 33.3 (C-18), 33.1 (C-4), 37.1 (C-I0), 35.0 (C-12), 
38.9 (C-l), 42.0 (C-3), 43.7 (C-7), 43.9 (C-14), 54.2 (C-5), 56.4 (C-9), 59.9 (C-15), 74.3 (C-13), 
75.4 (C-8). 
4.2.22 Preparation of the Target Compound 46 [Labd-13(14)-en-8a,15-diol] . 
Compound 92 (18mg) was dissolved in anhydrous CH2Cl2 (lmL) and cooled (O°C) under N2. 
DIBALH (154!lL) was added dropwise and the solution stirred for 4 hours. Saturated NH4Cl (2mL) 
was added and the mixture stirred for a further 30 minutes. The mixture was extracted with EtOAc 
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(3x30mL), the combined EtOAc fractions washed with H20 (J OmL) and saturated brine (20mL), 
dried over MgSO" filtered and reduced under vacuum. Purification was achieved via normal phase 
HPLC (hexane:EtOAcf50:50) to yield 46 (8.2mg, 46%) as a white amorphous powder. 
Compound 46: 
Amorphous powder. [0:1025 = +19° (CHCI3; c 0.35). IR vm",cm'l(NaCI) : 3366, 2924, 2400,1459, 
1436,1383,1368, 1185, 1120, 1070, 1017, 907. ElMS (70 eV) mlz (rel.int): 293 (3), 275(4), 257 
(8),245 (10), 217 (4), 203 (5),191 (20), 177 (100), 163 (18), 149 (52), 135 (20), 122 (69), 107 
(42), 95 (38), 80 (39), 67 (29), 55 (9) . HRFABMS: [Mt 308.271492. C2Ji3602 requires 
308.271531. lHNMR (400 MHz, CDCI3): 0079 (lH, m, H-9), 0.82 (3H, s, Me-18), 0.84 (IH, m, 
H-I), 0.86 (3H, s, Me-19), 0.90 (lH, m, H-5), 0.95 (3H, Me-20), 1.12 (IH, m, H-3), 1.14 (3H, s, 
Me-l7), 1.38 (lH, m, H-ll), 1.38 (lH, m, H-3'), 1.42 (JH, m, H-2), IA6 (lH, m, H-12), 1.52 (IH, 
m, H-ll '), 1.59 (lH, dt, J = 3.3Hz, 13. 6Hz, H-2), 1.66 (lH, m, H- I '), 1.69 (3H, s, Me-16), 1.73 (lH, 
m, H-12'), 2.03 (lH, m, H-7), 4.14 (2H, d, J = 6.9Hz, H2-15), 5AI (IH, t , J= 6. 8Hz, H-14). BC 
NMR (100 MHz, CDCI3) 0 15.1 (C-20), 16A (C-16), 18.2 (C-2), 18.3 (C-6), 21.7 (C-18), 24.0 (C-
ll), 30.6 (C-17), 333 (C-4), 33.4 (C-19), 39.0 (C-I 0),39.2 (C-l), 42.1 (C-3), 42.2 (C-12), 433 (C-
7), 55 .9 (C-5), 58.8 (C-9), 59A (C-15), 73.2 (C-8), 123.1 (C-14), 140A (C-13), 
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Table 8 : Sample and crystal data for ambraketal (83) . 
Crystallization solvents 
Crystallization method 
Empirical Formula 
Temperature (K) 
Wavelength (A) 
Crystal Size (mm) 
Crystal System 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) [glcm'] 
Absorption coefficient (cm-I ) 
F(OOO) 
Diffractometer 
Data collection method (Type and range) 
Theta range for data collection 
Index ranges 
Nref, Npar 
Observed data [I> 2.00(1)] 
Minimum and Maximum residual density [e/A'] 
Function minintized 
DatalRestraintslParameters 
R, wR, S 
Ethyl acetate 
Slow evaporation 
CI8 H 30 0, 
173 
0.71073 
0.06 x 0.32 x 0.41 
Monoclinic 
C2 (No.5) 
a = 13.916(2) 
b = 6.0133(U) 
c = 19.703(4) 
1566.1(5) 
4 
1.181 
0.7 
616 
Nonius Kappa CCD 
0.5 0 scans aroundj and w 
2.90 to 25.40 
-16: 13 ; -7 : 7; -19: 23 
2093, 185 
1532 
-0.22, 0.17 
w = 1I[02(F02)+(0.0416P)2+0.7404P] 
where P = (Fo'+2Fc' )/3 
2723, 2093 , 0.D25 
0.0514,0.1152, 1.11 
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Table 9 : Atomic co-ordinates and equivalent isotropic thermal parameters for the non-hydrogen 
atoms for ambra!cetal (83). 
Atom x y z U(eg) [.A>J 
019 0.1374(19) 0.3760(3) 0.5526(14) 0.0419(9) 
020 0.0994(16) 0.6688(3) 0.6114(12) 0.0328(8) 
Cl 0.2874(3) 0.3734(6) 0.8444(2) 0.0387(14) 
C2 0.2859(3) 0.2739(7) 0.9153(2) 0.0466(14) 
C3 0.1918(3) 0.3434(6) 0.9330(2) 0.0422(14) 
C4 0.0926(3) 0.2871(6) 0.8753(19) 0.0337(12) 
C5 0.0987(2) 0.3805(5) 0.8027(19) 0.0291(1l) 
C6 0.0028(3) 0.3503(6) 0.7401(19) 0.0345(12) 
C7 0.0025(3) 0.5088(6) 0.6794(19) 0.0342(12) 
C8 0.0935(3) 0.4770(5) 0.6552(19) 0.0273(11) 
C9 .0.193 1(2) 0.4719(5) 0.7172(18) 0.0275(1l) 
CIO 0.1934(2) 0.3191(5) 0.7815(2) 0.029 1(12) 
Cll 0.2817(3) 0.4411(5) 0.6882(2) 0.0380(14) 
C12 0.2739(3) 0.6020(6) 0.6266(2) 0.0393(14) 
C13 0.1670(3) 0.6008(6) 0.5743(2) 0.0345(12) 
C14 0.1528(3) 0.7479(6) 0.5104(2) 0.0435(14) 
C15 0.0835(3) 0.2942(6) 0.5991(2) 0.0396(12) 
C16 0.1984(3) 0.0709(5) 0.7632(2) 0.0419(14) 
C17 0.0715(3) 0.0369(6) 0.8747(2) 0.0449(14) 
C18 0.0067(3) 0.4056(6) 0.8943(2) 0.0474(17) 
U(eq) = 1/3 of the trace of the orthogonalized U Tensor 
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Table 10 : Hydrogen atom positions and isotropic thermal parameters for ambraketal (83) . 
Atom x y z U(iso) [A'] 
H5 0.10420 0.54510 0.81010 0.0350 
H9 0.20120 0.62630 0.73710 0.0330 
H11 0.34790 0.31770 0.83350 0.0460 
HI2 0.29380 0.53700 0.84960 0.0460 
H21 0.28820 0.10970 0.91260 0.0560 
H22 0.34670 0.3 2360 0.95390 0.0560 
H31 0.19230 0.27010 0.97810 0.0510 
H32 0.19450 0.50600 0.94130 0.0510 
H61 -0.00 ISO 0.19490 0.72290 0.0420 
H62 -0.05690 0.38010 0.75580 0.0420 
H71 -0.05940 0.48350 0.63850 0.0410 
H72 0.00100 0.66410 0.69570 0.0410 
Hill 0.34600 0.46740 0.72690 0.0450 
H112 0.28220 0.28620 0.67120 0.0450 
HI21 0.29150 0.75400 0.64560 0.0470 
HI22 0.32240 0.55760 0.60150 0.0470 
Hl41 0.08280 0.73650 0.47890 0.0650 
HI42 0.19890 0.70080 0.48430 0.0650 
H143 0.16750 0.90230 0.52610 0.0650 
Hl51 0.01140 0.26770 0.57200 0.0480· 
HI52 0.11360 0.15330 0.62210 0.0480 
HI61 0.20970 -0.01850 0.80660 0.0630 
HI62 0.25430 0.04700 0.74360 0.0630 
HI63 0.13460 0.02640 0.72780 0.0630 
HI71 0.05150 -0.00220 0.91660 0.0680 
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HI72 0.01680 -0.00150 0.83120 0.0680 
HI73 0.13280 -0 .04550 0.87590 0.0680 
Hl81 -0.05860 0.35330 0.86260 0.0710 
HI82 0.01170 0.37280 0.94400 0.0710 
Hl83 0.01230 0.56650 0.88840 0.0710 
Appendix 113 
Table 11 : Anisotropic thermal parameters for ambraketal (83). 
Atom U(I,I) or U(2,2) U(3,3) U(2,3) U(I,3) U(I,2) 
019 0.0531(17) 0.0328(15) 0.0461(17)-0.0080(12) 0:0245(15) -0.0103(12) 
020 0.0311(14) 0.0296(13) 0.0420(15) 0.0011(12) 0.0175(13) -0.0006(11) 
CI 0.032(2) 0.037(2) 0.045(3) 0.0039(19) 0.009(2) -0.0018(18) 
C2 0.036(2) 0.050(2) 0.045(3) 0.000(2) 0.000(2) 0.0012(19) 
C3 0.056(3) 0.031(2) 0.036(2) 0.0013(18) 0.009(2) -0.0012(18) 
C4 0.034(2) 0031(2) 0.038(2) 0.0001(18)· 0.014(2) 0.0017(16) 
C5 0.029(2) 0.0210(18) 0.037(2) 0.0020(16) 0.010(2) 0.0006(14) 
C6 0.032(2) 0.036(2) 0.037(2) 0.0053(17) 0.013(2) 0.0012(16) 
C7 0.026(2) 0.038(2) 0.038(2) 0.0031(19) 0.0093(19) 0.0023(16) 
C8 0.026(2) 0.0241(18) 0.033(2) 0.0027(16) 0.0109(19) -0.0018(15) 
C9 0.025(2) 0.0219(18) 0.038(2) -0.0028(17) 0.0134(19) -0.0018(14) 
CIO 0.025(2) 0.023(2) 0.038(2) -0.0001(16) 0.0078(19) 0.0005(14) 
Cll 0.029(2) 0.040(2) 0.044(3) -00022(18) 0.010(2) -0.0037(16) 
CI2 0.030(2) 0.044(2) 0.048(3) -0.0016(19) 0.018(2) -0.0048(17) 
C13 0.033(2) 0.035(2) 0.Q40(2) 0.0008(17) 0.0 18(2) -0.0053(16) 
CI4 0040(2) 0051(3) 0.043(2) -0 .002(2) 0.018(2) -0.0070(18) 
CI5 0.040(2) 0.034(2) 0.046(2) -0.005(2) 0.015(2) -0.0104(17) 
CI6 0.045(2) 0.023(2) 0.057(3) -0.0019(17) 0.015(2) -0.0013(17) 
CI7 0.047(2) 0.038(2) 0.051(3) 0005(2) 0.017(2) -0.0067(19) 
CI8 0.054(3) 0.055(3) 0.039(3) 0.004(2) 0.023(2) 0.005(2) 
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Table 12 : Bond Distances (A) fo r ambraketal (83). 
019 -C13 1439(4) C3 -H31 0.9900 
019 -CIS 1440(S) C3 -H32 0.9901 
020 -C8 1457(4) CS -HS 1.0000 
020 -C13 1.420(5) C6 -H61 0.9894 
CI -C2 1.526(5) C6 -H62 0.9893 
CI -CIO 1.530(5) C7 -H7 1 0.9898 
C2 -C3 1.515(6) C7 -H72 0.9901 
C3 -C4 1.527(6) C9 -H9 10005 
C4 -CS 1.565(5) CIl -HIlI 0.9901 
C4 -Cl7 1.532(5) CIl -HIl2 0.9906 
C4 -C18 1.535(6) CI2 -H12 1 0.9891 
C5 -C6 1.518(5) CI2 -HI22 0.9900 
C5 -CIO 1.546(4) CI4 -HI4I 0.9801 
C6 -C7 1.529(5) Cl4 -Hl42 0.9811 
C7 -C8 1499(6) Cl4 -H143 0.9798 
C8 -C9 1.535(5) CIS -Hl51 0.9910 
C8 -CIS 1.533(5) CIS -HIS2 0.9899 
C9 -CIO 1.564(S) CI6 -H16 1 0.9802 
C9 -Cll 1.524(S) CI6 -Hl62 0.9812 
CIO -C16 1.542(4) CI6 -HI 63 0.9793 
Cll -C12 1.529(5) Cl7 -Hl71 0.9788 
CI2 -C13 1.522(6) CI7 -HI72 0.9794 
CI3 -C14 1.500(5) Cl7 -Hl73 0.9804 
CI -HII 0.9901 CI8 -H181 0.9797 
CI -H12 0.9902 CI8 -Hl82 0.9798 
C2 ·H21 
C2 ·H22 
0.9899 CI8 ·H183 
0.9905 
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Table 13 : Bond Angles (0) for ambraketal (83). 
Cl3 -019 -CIS 106.8(3) CS -CIO -C9 106.9(2) 
C8 -020 -Cl3 104.2(2) CS -CIO -C16 I 13.S(3) 
C2 -CI -CIO 113.9(3) C9 -CIO -C16 111.6(3) 
CI -C2 -C3 111.3(3) C9 -Cll -C12 110.8(3) 
C2 -C3 -C4 114.4(3) CII -C12 -C13 110.3(3) 
C3 -C4 -CS 107.8(3) 019 -C13 -020 104.4(3) 
C3 -C4 -C17 1I0.S(3 ) 019 -C13 -C12 109.S(3) 
C3 -C4 -C18 107.9(3) 019 -Cl3 -C14 110.7(3) 
C5 -C4 -C17 114.2(3) 020 -Cl3 -C12 108.4(3) 
CS -C4 -C18 109.0(3) 020 -C13 -C14 109.1(3) 
C17 -C4 -C1 8 107.2(3) CI2 -Cl3 -C14 114 2(3) 
C4 -CS -C6 114.S(3) 019 -CI S -C8 105.4(3) 
C4 -C5 -CIO 117.1(3) C2 -CI -H11 108.78 
C6 -CS -CIO 111.1(3) C2 -CI -H12 108.75 
CS -C6 -C7 110.3(3) CIO -CI -H11 108.77 
C6 -C7 -C8 112.0(3) CIO -CI -HI 2 108.81 
020 -C8 -C7 107.3(3) HII -CI -H12 107.67 
020 -C8 -C9 106.S(3) C I -C2 -HZ I 109.39 
020 -C8 -C IS 98.7(3) CI -C2 -H22 109.37 
C7 -C8 -C9 113.0(3) C3 -C2 -HZ I 109.40 
C7 -C8 -CIS IIS .2(3) C3 -C2 -H22 109.40 
C9 -C8 -CIS 114.S(3) H2 1 -C2 -HZ2 107.94 
C8 -C9 -CIO 115.S(3) C2 -C3 -H31 108.6S 
C8 -C9 -Cll 109.8(3) C2 -C3 -H32 108.63 
CIO -C9 -Cll l1S.8(3) C4 -C3 -H31 108.68 
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C I -CIO -C5 IOS.4(3) C4 -C3 -H32 IOS .7 1 
CI -CIO -C9 IOS.4(3) H31 -C3 -H32 107.59 
CI -CIO -C16 107.S(3) C4 -C5 -H5 104.15 
C6 -C5 -H5 104.19 C13 -C14 -H143 109.51 
CIO -C5 -HS 104.09 HI41 -C14 -HI 42 109.34 
C5 -C6 -H61 109.56 HI41 -C14 -H143 109.53 
C5 -C6 -H62 109.60 H142 -C14 -HI43 109.44 
C7 -C6 -H61 109.61 019 -CIS -HISI 110.66 
C7 -C6 -H62 109.S6 019 -CIS -HIS2 110.7 1 
H61 -C6 -H62 10S.14 CS -CIS -HISI 110.60 
C6 -C7 -H7l 109.2S CS -C15 -HIS2 1I0.n 
C6 -C7 -Hn 109.20 HISI -CIS -HIS2 IOS.73 
CS -C7 -H71 109.17 CIO -C16 -HI61 109.4S 
CS -C7 -Hn 109.25 CIO -C16 -HI 62 109.45 
H71 -C7 -Hn 107.93 CIO -C16 -H163 109.50 
CS -C9 -H9 104.S7 HI61 -C16 -HI62 109.41 
CIO -C9 -H9 104.84 HI61 -C16 -HI63 109.50 
CI1 -C9 -H9 104.75 HI62 -C16 -H163 109.4S 
C9 -Cli -Hili 109.53 C4 -C17 -H171 109.47 
C9 -Cli -H112 109.46 C4 -C17 -HI72 109.46 
CI2 -Cll -Hill 109.4S C4 -C17 -H173 109.45 
CI2 -Cll -HI 12 109.44 Hl71 -Cl7 -Hln 109.47 
Hlli -Cll -H112 10S.OS HI71 -C17 -Hl73 109.45 
CI1 -C12 -H121 109.67 Hln -C17 -Hl73 109.53 
Cll -C12 -HI22 109.61 C4 -CIS -HIS! 109.4S 
C13 -C12 -HI2I 109.5S C4 -C18 -HIS2 109.43 
C13 -C12 -HI22 109.S9 C4 -CIS -HIS3 109.42 
HI2I -C12 -HI 22 IOS.15 HISI -CIS -HIS2 109.53 
C13 -C14 -H141 
C13 -C14 -Hl42 
109.52 HI81 -C18 -H183 
109.48 HI82 -C18 -H183 
109.48 
109.49 
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Table 14 : Torsion Angles (0) for ambraketal (83). 
CI5 -019 -C13 -020 -21.6(4) 
CIS -019 -C13 -C12 94.3(4) 
CIS -019 -C13 -C14 -13S.9(3) 
C13 -019 -CIS -CS -6.1(4) 
CI3 -020 -CS -C7 -164.0(3) 
CI3 -020 -CS -C9 74.S(3) 
C13 -020 -CS -CIS -44.1(3) 
CS -020 -C13 -019 42.S(3) 
CS -020 -C13 -C12 -74.2(3) 
CS -020 -C13 -C14 160.9(3) 
CIO -CI -C2 -C3 -SS .S(4) 
C2 -CI -CIO -C16 -71.6(4) 
C2 -CI -CIO -C9 167.4(3) 
C2 -CI -CIO -CS SI.7(4) 
CI -C2 -C3 -C4 S5.9(4) 
C2 -C3 -C4 -CS -51.8(4) 
C2 -C3 -C4 -C17 73.7(4) 
C2 -C3 -C4 -CIS -169.4(3) 
C3 -C4 -CS -C6 -176.S(3) 
CI7 -C4 -CS -CiO -72.3(4) 
CIS -C4 -C5 -C6 -59.6(4) 
CIS -C4 -CS -CIO 167.S(3) 
CI7 -C4 -CS -C6 603(4) 
C3 -C4 -C5 -CIO SO.9(4) 
CIO -C5 -C6 -C7 -63.3(4) 
C4 -C5 -C6 -C7 161.3(3) 
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C4 -CS -CIO -C16 68 .8(4) 
C6 -CS -CIO -CI 174.8(3) 
C6 -CS -CIO -C9 S8.1(3) 
C6 -CS -CIO -C16 -6S.4(4) 
C4 -CS -CIO -CI -SI.0(4) 
C4 -CS -CIO -C9 -167.7(3) 
CS -C6 -C7 -C8 S7.1(4) 
C6 -C7 -C8 -C9 -48.7(4) 
C6 -C7 -C8 -020 -16S.8(3) 
C6 -C7 -C8 -CIS 8S.6(4) 
020 -C8 -C9 -Cll -62.0(3) 
C7 -C8 -C9 -CIO 47.4(4) 
CIS -C8 -C9 -C IO -87.2(4) 
CIS -C8 -C9 -Cll 4S.9(4) 
C7 -C8 -C9 -Cll -1 79.S(3) 
020 -C8 -C9 -CIO 164.9(3) 
C9 -C8 -C15 -0 19 -82.4(3) 
C7 -C8 -C15 -019 144.0(3) 
020 -C8 -C15 -019 30.3(4) 
C8 -C9 -CIO -C5 -50.5(3) 
C8 -C9 -CIO -CI -167.2(3) 
Cll -C9 -CIO -CS 179.2(3) 
C8 -C9 -CI0 -C16 74.1(4) 
Cll -C9 -CI0 -C I 62.5(4) 
CIO -C9 -Cll -C12 -179.0(3) 
Cll -C9 -CIO -C16 -56.2(4) 
C8 -C9 -Cll -C12 48 .1(3) 
C9 -CII -C12 -C13 
CII -C12 -C13 -C14 
Cll -C12 -C13 -019 
-46.6(4) 
-177.9(3) 
-53.1(4) 
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Table 15 : Contact Distances (A) for ambraketal (83). 
019 .H1l2 2.6210 C16 .H21 2.82S0 
019 .Hl51_a 2.7491 C16 .H6 ! 2.746S 
019 .Hl42_b 2.8043 C16 .H9 f 2.72S1 
020 .HI41_a 2.6336 CI6 .HlS2 2.7047 
C6 . C12_c 3.S9S(6) CI6 .H173 2.7426 
C12 .C6_d 3.S9S(6) C16 .H1l2 2.7648 
CIS .C16 3.403(S) C17 .H2! 2.9043 
C16 .ClS 3.403(S) C17 .H61 2.9967 
CI6 .C17 3.227(6) C17 .H161 2.6877 
C17 .C16 3.227(6) C17 .H183j 2.9819 
Cl .Hlll 2.7432 CI8 .H62 2.5967 
C2 .H173 2.7922 HS .C8 3.037S 
C2 .Hl61 2.7171 HS .H9 2.3116 
C4 .H161 3.0408 H5 .H12 2.S071 
C6 .Hl63 2.7376 HS .H32 2.S070 
C6 .Hl72 2.74 16 HS .H72 2.3729 
C6 .H181 2.8010 H5 .H183 2.2948 
C6 .HI21_c 3.0040 H9 .C13 3.0958 
C8 .H163 3.0341 H9 .CI6_g 2.72S1 
C8 .HS 3.0375 H9 .H5 2.3116 
Cll .Hl62 2.6858 H9 .Hl2 2.2S29 
Cll .Hll 2.8188 H9 .Hl61~ 2.S 199 
CII .Hl52 2.8737 H9 .HI63_g 2.5641 
Cl3 .H9 3.0958 Hll .C11 2.8188 
CI4 .HI22_c 2.9873 Hll .HIll 2.2777 
CIS .H61 3.0838 Hll .H162 2.4578 
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CI5 .H1l2 2.6850 HI2 .H5 2.5071 
CI5 .H163 2.8985 Hl2 .H9 2.2529 
H21 .C16 2.8250 HII2 .H162 2.1450 
H21 .C17 2.9043 H121 .C6_d 3.0040 
H21 .H161 2.1732 HI21 .H71_d 2.5319 
H21 .H173 2.2566 HI22 .Hl42 2.5584 
H31 .Hl71 2.5502 Hl22 C14_b 2.9873 
H31 .H182 2.4684 HI41 .020_a 2.6336 
H31 .H32_h 2.4415 HI42 .H122 2.5584 
H32 .H5 2.5070 Hl42 .019_e 2.8043 
H32 .H183 2.4484 Hl51 .H71 2.2757 
H32 .H3U 2.4415 HlSI .019_a 2.7491 
H61 .Cl5 3.0838 HI52 .Cll 2.8737 
H61 .C 16 2.7465 Hl52 .Cl6 2.7047 
H61 .C17 2.9967 HI52 .H1I2 2.3790 
H61 .Hl63 2.1234 Hl52 .H163 2.1504 
H61 .HI72 2.3818 H161 .C2 2.7171 
H61 .HIll_c 2.5468 Hl61 .C4 3.0408 
H62 .C18 2.5967 Hl61 .C17 2.6877 
H62 .HISI 2.1179 Hl61 .H9j 2.5199 
H71 .HISI 2.2757 Hl61 .H21 2.1732 
H71 .Hl21_c 2.5319 Hl61 .Hl73 1.9874 
H72 .H5 2.3729 HI62 .CIl 2.6858 
Hill .CI 2.7432 HI62 .HII 2.4578 
Hill .HIl 2.2777 HI62 .H1l2 2.1450 
Hill .H61_d 2.5468 HI63 .C6 2.7376 
HIl2 .019 2.6210 Hl63 .C8 3.0341 
Appendix 124 
H1l2 .Cl5 2.6850 H163 .C15 2.8985 
H1l2 .C16 2.7648 Hl63 .H9J 2.5641 
H1l2 .Hl52 2.3790 Hl63 .H61 2.1234 
Hl63 .Hl52 2.1504 Hl81 .C6 2.8010 
H171 .H31 2.5502 H181 .H62 2.1179 
HI71 .Hl82 2.4228 HI81 .Hl72 2.5380 
HI72 .C6 2.7416 Hl82 .H31 2.4684 
Hl72 .H61 2.3818 Hl82 .Hl71 2.4228 
HI72 .Hl81 2.5380 Hl82 .Hl82j 2.3292 
Hl73 .C2 2.7922 HI83 .C17_g 2.9819 
H173 .Cl6 2.7426 Hl83 .H5 2.2948 
HI73 .H21 2.2566 Hl83 .H32 2.4484 
HI73 .H161 1.9874 
Translation of Symme!iy Code to Equivalent Position 
a =[ 2556.001 = -x,y,l-z 
b =[ 4546.00 1 = 112-x,-1I2+y,l-z 
c =[ 3445.001 = -1/2+x,-1I2+y,z 
d =[ 3555.00 1 = 1I2+x,112+y,z 
e =[ 4556.001 = II2-x,1I2+Y,I-z 
f=[ 1545.001 = x,-l+y,z 
g =[ 1565.001 = x, I +y,z 
h =[ 4547.001 = 1I2-x,-1I2+Y,2-z 
i =[ 4557.001 = 1I2-x,112+y,2-z 
j =[ 2557.001 = -x,y,2-z 
